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ABSTRACT 
Hox genes are evolutionarily conserved transcription factors which act to control 
important developmental pathways involved in morphogenesis of the embryo.  Hoxa2 is 
expressed in the developing CNS in rhombomeres 2-7 in the presumptive hindbrain.  
During development Hoxa2 expression extends caudally throughout the spinal cord and 
persists into adulthood.  Although previous analysis of Hoxa2 expression indicates its 
possible role in neuronal circuit specification and/or dorsal-ventral patterning within the 
spinal cord, the precise genetic pathways through which Hoxa2 affects spinal cord 
development have not been characterized.  We have used immunoprecipitation of 
Hoxa2-target DNA complexes from chromatin preparations of E18 mouse spinal cord 
and hindbrain tissue to isolate in vivo downstream target genes of Hoxa2.  Seven DNA 
fragments were isolated, sequenced and were shown to exhibit in vitro DNA binding by 
Hoxa2.  A search of sequence databases for the target sequences revealed that of these, 
two displayed high identity with novel mouse genes: toll-associated serine protease 
(Tasp) and the murine homolog of the human dual specificity tyrosine phosphorylation 
regulated kinase 4 (Dyrk4).  Also, two of the isolated clones are presumably bacterial 
sequences containing the canonical homeodomain binding site TAAT, and the remaining 
three clones have not yet been mapped in the mouse genome.  A potential core Hoxa2 
binding motif consisting of 5' CCATCA/T 3', which is based on a previously 
characterized Hoxa2-Pbx consensus sequence (Lampe et al., 2004), has been identified 
in both the Tasp and Dyrk4 intronic elements.  Both Dyrk4 and Tasp mRNA have been 
detected within the developing mouse from E10-18 and in the adult CNS.  Analysis by 
RT-PCR of Tasp expression in Hoxa2-/- newborn mice hindbrain and spinal cord tissues 
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showed an upregulation of Tasp, and transient transfection experiments indicated that 
Hoxa2 may act as a transcriptional repressor of Tasp through an intronic regulatory 
element.  Transfection studies using the intronic sequence of Dyrk4 indicated that it may 
function as an enhancer of transcription of Dyrk4 in the presence of Hoxa2.  Both Dyrk4 
and Tasp belong to large protein subfamilies whose members play a role in numerous 
developmental pathways in several organisms.  Tasp, also known as HtrA3, interacts 
with TGFβ signaling molecules which are known to be key regulators of development, 
dorsoventral patterning and are involved in various neuronal pathways.  Although the 
function of Dyrk4 is not known, many of its family members are involved in the 
regulation of transcription factors and signaling molecules via phosphorylation that are 
involved in neuronal pathways also.  Hoxa2 may act in specifying neuronal subtypes and 
dorsoventral patterning in the CNS through down and upregulation of its downstream 
targets Dyrk4 and Tasp, respectively.  
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1. INTRODUCTION 
 Homeotic genes were first discovered in the fruit fly, Drosophila (Balkaschina, 
1929; Bridges and Dobzhansky, 1933; Bridges and Morgan, 1923; Ouweneel, 1976) 
where they were found to play a role in determining segmental identity (reviewed in: 
Lewis, 1978; McGinnis and Krumlauf, 1992; Peifer and Wieschaus, 1990; Castelli-Gair, 
1998; Akam, 1998a, b; Gellon and McGinnis, 1998; Rijli et al., 1998).  In Drosophila, a 
single homeotic complex (HOM-C) comprised of two separate clusters [the Bithorax 
(BX-C) and Antennapedia (ANT-C) cluster] is located on chromosome 3 (Lewis, 1978; 
Kaufman et al., 1990; Scott et al., 1983).  Many homeotic genes contain a 180 base pair 
(bp) homeobox sequence which encodes a conserved 60 amino acid region referred to as 
the homeodomain (McGinnis et al., 1984; Scott and Weiner, 1984; Gehring et al., 1994).  
Genes encoding the homeodomain motif are referred to as homeobox (Hox) genes.  
These genes are conserved during evolution and have been identified in all major 
metazoa, plants and fungi examined thus far (Bürglin, 1997, 2003).  Hox genes generally 
function as transcription regulators that govern various aspects of morphogenesis and 
cell differentiation.  Homeobox-containing genes that are homologs to the Drosophila 
homeotic genes have also been identified in vertebrates, where in many instances they 
function to control embryonic morphogenesis (reviewed in: McGinnis and Krumlauf, 
1992; Favier and Dollé, 1997; Prince, 2002). 
 The Hoxa2 gene and its paralog Hoxb2 are homologs of the Drosophila 
proboscipedia gene.  High levels of Hoxa2 expression during embryogenesis occurs in 
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the neural tube and neural crest cells that contribute to the second branchial arch, as well 
as other tissues (Prince and Lumsden, 1994; Davenne et al., 1999; Hao et al., 1999; 
Barrow et al., 2000; Grammatopoulos et al., 2000).  Within the neural tube, the anterior 
boundary of Hoxa2 expression is situated at the rhombomere (r) 1/2 interface (Davenne 
et al., 1999; Barrow et al., 2000).  Hoxa2 expression extends from the hindbrain caudally 
throughout the spinal cord, with expression initiated at first within the ventral mantle 
region at embryonic day 10 (E10).  However, expression of Hoxa2 at E18.5 is 
predominantly found within the dorsal horn (Hao et al., 1999).  Hence, Hoxa2 may 
potentially contribute to both anteroposterior (A-P) positioning as well as dorsoventral 
(D-V) patterning (Hao et al., 1999). 
 Targeted disruption of Hoxa2 results in patterning defects of the hindbrain at its 
most anterior domain of expression, resulting in the absence of the r1/2 boundary and an 
alteration of the r2/3 border (Gavalas et al., 1997; Davenne et al., 1999; Barrow et al., 
2000).  Morphological A-P and D-V patterning defects are observed in Hoxa2 null 
mutant mice with respect to the r2 and r3 segments (Davenne et al., 1999).  Additionally, 
external defects of the branchial arch derivatives, such as cleft palate (Barrow and 
Capecchi, 1999), are quite severe in Hoxa2 mutants.  Studies using haploinsufficient 
Hoxa2 mutant mice reveal dose dependent mechanisms of development within the 
hindbrain and branchial arches (Ohnemus et al., 2001).  The branchial arches, in 
particular the second arch, are highly sensitive to a reduction in Hoxa2 activity.  In 
contrast, the anterior hindbrain is unaffected even by an extreme decline in Hoxa2 levels.  
Therefore, general A-P and D-V patterning of the CNS is maintained even at low levels 
of Hoxa2 activity, possibly due to functional redundancy between anterior Hox genes or 
  3
the presence of parallel pathways in segmental regulation (Ohnemus et al., 2001).  
However, at the molecular level differential sensitivity to Hoxa2 inactivation between 
specific neuronal subtypes has been observed, which when considered with previous 
studies of neuronal expression is suggestive of Hoxa2 involvement in the specification 
of neuronal phenotypes (Davenne et al., 1999; Hao et al., 1999; Ohnemus et al., 2001). 
 Mutations of Hoxa2 and Hoxb2 in mice demonstrated that both homeoproteins 
are responsible for differential regulation of several genes along the D-V axis in a 
rhombomere specific pattern (Davenne et al., 1999).  For example, a severe reduction in 
Pax6 expression and a ventral shift in the border of Pax3 expression in r2 and r3 were 
observed in early stages of development (E10).  Hoxa2 and MDK1/EphA7 have shown 
coinciding spatial and temporal patterns of expression within the hindbrain (Taneja et 
al., 1996).  Studies using Hoxa2 null mutant mice revealed a selective lack of 
MDK1/EphA7 expression in r3 and alterations in expression within other rhombomeres 
(Taneja et al., 1996).  Although direct regulation of these genes by Hoxa2 has not been 
determined, these genes may act together with Hoxa2 in specifying early development of 
the hindbrain.  In later stages of development the expression of Hoxa2 within the rostral 
somites and in r2 of the hindbrain is directed by an enhancer sequence located at the 3′ 
end of Hoxa2 that contains a 10 bp Hox/Pbx binding element (Frasch et al., 1995; Ren et 
al., 2002).  Activation of transcription by this element is mediated by Hoxa2 DNA 
binding in the presence of cofactors Pbx1a and Prep1 (Lampe et al., 2004).   
 The activity of Hox paralogs 1-4 which mediate rhombomeric patterning is not 
well characterized, except in regard to their highly conserved auto and crossregulatory 
mechanisms.  Few direct downstream target genes of the anteriorly expressed Hox genes 
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have been isolated with regard to CNS development. The majority of targets isolated 
thus far have been genes regulated by the labial class of Hox proteins (Chen and Ruley, 
1998; Studer et al., 1998; Gavalas et al., 1998; Guazzi et al., 1998).  Targets identified 
for the proboscipedia homeobox genes are the Otx1 homeobox gene regulated by 
Hoxb2, and the autoregulation of Hoxa2 within the rhombomeres (Guazzi et al., 1998; 
Lampe et al., 2004).  We have employed an increasingly popular method of target gene 
isolation that utilizes chromatin immunoprecipitation of Hox proteins complexed to 
target DNA.  This method allows the identification of in vivo rather than in vitro target 
genes.  Also, both novel targets in addition to previously characterized genes may be 
isolated.  Chromatin preparations from E18 spinal cord and hindbrain tissues were used 
for immunoprecipitation of Hoxa2 target sequences. 
 
1.1  Hypothesis 
Hoxa2 is a transcription factor that is important in CNS development.  I will test the 
hypothesis that there are several downstream target genes under the direct regulation of 
Hoxa2 and that Hoxa2 protein interacts with the regulatory elements of these target 
genes. 
 
 1.2  Goal 
To isolate and characterize regulatory elements of novel genes identified as direct in vivo 
downstream targets of Hoxa2 during murine CNS development. 
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1.3  Objectives 
1. Purification of bacterially expressed recombinant Hoxa2 protein. 
2. Purification of Hoxa2 specific antibody from polyclonal antisera by affinity 
chromatography. 
3. Immunoprecipitation of Hoxa2 specific target DNA sequences from regulatory 
complexes isolated from E18 mouse hindbrain and spinal cord chromatin 
preparations. 
4. Cloning of putative Hoxa2 responsive regulatory elements and identification of 
potential target genes by BLAST sequence analysis. 
5. Confirmation of Hoxa2 recognition of target sequences by in vitro DNA binding 
analyses. 
6. An analysis of the regulatory activity exhibited by Hoxa2 on the target sequences 
using reporter assays in cell culture. 
7. In vivo verification of target gene regulation by Hoxa2 through an analysis of target 
gene expression in Hoxa2 wildtype and null mutant mice. 
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2. LITERATURE REVIEW 
2.1  Organization of the Vertebrate Hox Gene Complex 
 
 In vertebrates, more than 200 homeobox-containing genes have been identified 
thus far [for a complete list of vertebrate and insect Hox-like genes refer to: Hox ProDB 
at http://www.iephb.nw.ru/hoxpro (Spirov et al., 2002) and the homeodomain resource 
database at http://genome.nhgri.nih.gov/homeodomain/ (Banerjee-Basu et al., 2000, 
2003)].   Traditionally these genes were subdivided into the "clustered" homeobox genes 
known as the Hox genes, the "dispersed" Hox-like genes, as well as several distinct 
classes of atypical homeodomain containing genes.  The "clustered" Hox genes were 
identified in mammals and other vertebrates based on their similarity to genes of the 
Drosophila HOM-C.  Therefore, all genes within this group have a single Antennapedia 
(Antp) class homeodomain (Duboule, 1994a; Gehring et al., 1994).  In mice, the Hox 
complex is comprised of 39 genes that are arranged into four separate chromosomal 
clusters designated Hox a, b, c and d (Figure 2.1).  Hox genes are arranged in a 3′ to 5′ 
order in each cluster, with their position reflecting not only their homology with each 
other but also their similarity with genes in the Drosophila HOM-C.  This arrangement 
is believed to be due to a two-step process of duplication, a lateral expansion (gene 
duplication within a cluster or linkage unit) followed by chromosomal duplication of the 
expanded cluster (Kappen et al., 1989).  This two-step process is also referred to as the 
"2R" hypothesis, representing the double modes of duplication 
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Figure 2.1  Schematic representation of Hox gene clusters 
The 39 murine Hox genes are present on four separate chromosomal clusters (Hox a, 
Hox b, Hox c, Hox d).  Hox genes (illustrated by black boxes) are arranged into 13 
paralog groups based on their homology to the Drosophila homeotic complex (HOM-C), 
as well as sequence similarity between genes on different clusters, and according to their 
positions on their respective chromosomes (Chr).  The Drosophila HOM-C is composed 
of two clusters: Antennapedia (ANT-C) and Bithorax (BX-C).  ANT-C contains: 
lab=labial, pb=proboscipedia, Dfd=Deformed, Scr=Sex Combs Reduced, and 
Antp=Antennapedia; BX-C contains: Ubx=Ultrabithorax, abd-A=abdominal-A, Abd-
B=Abdominal-B.  The direction of transcription 5´ to 3´ is indicated, with those genes 
present at the 3´ end of the clusters expressed more anteriorly in the developing embryo 
than those at the 5´ end.  The anterior Hox genes exhibit higher sensitivity to 
transactivation by retinoic acid than their 5´ neighbors along the chromosomal cluster.  
In general, paralogs 1-4 display anterior limits of expression within the early developing 
murine hindbrain, with expression extending posteriorly along the neural tube.  The 
exception being Hoxc4, where its anterior limit of expression begins at the rhombomere 
(r) 7/spinal cord boundary approximately one rhombomere length posterior to that of its 
paralog Hoxb4, which is expressed at the r6/7 boundary (Geada et al., 1992).  This figure 
has been adapted from Krumlauf (1993) with permission (www.elsevier.com). 
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involved in the evolutionary process (reviewed in: Friedman and Hughes, 2001; Sidow, 
1996; Prince, 2002).  The application of the "2R" hypothesis to Hox evolution is still 
under debate (Hughes et al., 2001).  There is some evidence to support the evolution of 
Hox genes by chromosome polyploidization (Larhammar et al., 2003).  
 Genes within each cluster that occupy the same linear position along the length 
of the chromosome are further subdivided into 13 paralogous groups in relation to their 
similarity with the HOM-C genes (Figure 2.1).  There are some irregularities in that Hox 
genes in positions 6-8 are related to more than one HOM-C gene, and not all Hox 
clusters have members in each paralog group; for example, Hox c has no members in 
groups 1-3.  Paralogs exhibit greater sequence similarity between each cluster than 
individual genes share with adjacent genes along the same chromosomal cluster.  
Many homeobox genes have since been identified that encode a homeodomain 
similar to the clustered Hox genes (Antp-type homeodomain) and have been referred to 
as Hox-like.  Initially these Hox-like genes did not display any clustered organization, 
and were therefore often designated as the "dispersed" Hox-like genes.  These genes 
were grouped together into various families based on a variety of criteria such as their 
functional and structural characteristics.  For example, the Cdx genes were identified as 
the vertebrate homologs of the Drosophila caudal gene, which is so named because of 
its role in specifying development of the caudal region of the embryo.  Many members 
of the caudal gene family are found to be predominantly expressed in the posterior 
region of the embryo or have been shown to function in the development of posterior 
structures such as the intestine (reviewed in: Freund et al., 1998; Lohnes, 2003).  
Similarly, many homeobox-containing genes were identified that did not encode 
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homeodomains similar to that of the Hox genes (i.e. Antp-type homeodomain), and these 
have been classified into a number of distinct groups based on sequence similarity, 
structural characteristics and phylogenetic analyses (e.g. Paired class, NK class, POU 
class, LIM class) (Banerjee-Basu and Baxevanis, 2001; Bürglin, 1994; Galliot et al., 
1999; Wada et al., 2003). 
Recent investigations have indicated that some of the "dispersed" Hox-like genes 
may have been organized into clustered formations as well, which have then "dispersed" 
to some degree in vertebrates during evolution from their ancestral source (Coulier et al., 
2000a, b; Brooke et al., 1998; Popovici et al., 2001; Ferrier and Holland, 2001; Luke et 
al., 2003).  This hypothesis has been supported by the discovery of the paraHox cluster 
in Amphioxus (Brooke et al., 1998), and the 93D/E cluster of genes or NKL cluster in 
Drosophila (Kim and Nirenberg, 1989; Jagla et al., 1994, 2001).  The NKL cluster was 
later reported to be present as four clusters in humans and is referred to as the metaHox 
gene class (Coulier et al., 2000b).  Four paraHox clusters bearing similarity to the 
Amphioxus paraHox cluster have also been identified in humans (Coulier et al., 2000a).  
In humans, the majority of the ANTP superclass genes are arranged into 14 homeobox 
gene clusters derived from four ancient genomic arrays and homeobox-containing genes 
that do not fit into these clusters were referred to as "dispersed" (or so-called orphan) 
genes (Pollard and Holland, 2000).  These four arrays are believed to have evolved by a 
series of duplications from an ancestral Hox complex (reviewed in: Patel and Prince, 
2000; Holland, 2001).  Two of these genomic arrays consist of the paraHox (Cdx, Xlox, 
Gsx) and NKL/metaHox clusters (which includes several genes such as Msx, NK and 
Lbx).  The third array is grouped into the ‘extended Hox’, i.e. the traditional Hox clusters 
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(Figure 2.1) as well as Evx and Mox, and the fourth array consists of the EHGbox genes 
(En, HB9, and Gbx) (Pollard and Holland, 2000).  The ‘extended Hox’, paraHox, and the 
EHGbox subclasses can be grouped together into a larger Hox class (Pollard and 
Holland, 2000; Banerjee-Basu and Baxevanis, 2001; Popovici et al., 2001; Wada et al., 
2003).  The metaHox genes in addition to several other groups of genes make up the NK 
class of homeobox genes (Banerjee-Basu and Baxevanis, 2001; Wada et al., 2003).  
There is a significant amount of literature on the "dispersed" Hox-like and other 
homeobox containing genes (Bendall and Abate-Shen, 2000; Panganiban and 
Rubenstein, 2002; Bürglin and Cassata, 2002; Tremblay and Gruss, 1994; St.-Jacques 
and McMahon, 1996; Stuart and Gruss, 1995, 1996; Boncinelli, 1997; Kammermeier 
and Reichert, 2001; Owens and Hawley, 2002; Vollmer and Clerc, 1998). These genes 
have many varied functions in various organisms, including the development of the 
central nervous system (CNS).  However, since the focus of my research is on the targets 
of "clustered" Hox genes, a discussion of the dispersed or atypical homeobox genes has 
not been included. 
2.2  Structure of the Antennapedia Homeodomain 
Many homeobox genes, in particular the Hox genes, encode a homeodomain that 
belongs in the Antp-class, based on its relatedness to the homeodomain of the 
Drosophila Antennapedia gene.  This class of homeodomain proteins is defined by the 
presence of an evolutionarily conserved helix-turn-helix motif (reviewed in Gehring et 
al., 1994).  The solution structure of the Antp homeodomain expressed as a 68 amino 
acid recombinant polypeptide (Müller et al., 1988) was determined by nuclear magnetic 
resonance (NMR) spectroscopy (Qian et al., 1989; Billeter et al., 1990).  The structure is 
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composed of three alpha helical regions folded into a tight globular structure, plus a 
more disordered and flexible fourth helix that consists of several basic amino acid side 
chains that appears to be a direct extension of the third helix (helix III/IV).  The first 
helix is preceded by a flexible N-terminal arm that has a conserved hexapeptide motif 
which is involved in protein-protein interactions.  Helix I is connected via a loop to helix 
II, and the second helix in conjunction with helix III forms the helix-turn-helix DNA 
binding motif.  Helices I and II are arranged in an antiparallel fashion relative to each 
other, while helix III/IV is perpendicularly aligned to the first two helices.  The helix-
turn-helix motif formed by helices II and III is a common motif present in many 
prokaryotic transcription factors (reviewed in: Pabo and Sauer, 1992; Gehring et al., 
1990).  The backbone structure of the Antp helix-turn-helix motif is superimposable with 
that of several of these prokaryotic transcription factors, demonstrating the evolutionary 
conservation of the homeobox (Qian et al., 1989; reviewed in Gehring et al., 1990).  In 
vitro analyses of DNA binding by Hox proteins have determined that all proteins 
encoded by the class I homeobox (Antp) genes recognize an element of approximately 
10-12 bases consisting of a 5′ TAAT 3′ (β strand) core motif with varying flanking 
sequences (Kalionis and O’Farrell, 1993; Kumar and Nazarali, 2001; reviewed in: 
Laughon, 1991; Gehring et al., 1994). NMR spectroscopy analysis of the Antp 
homeodomain complexed to a DNA duplex containing this TAAT core sequence 
revealed that helix III (recognition helix) forms contacts with the major groove of the 
target DNA.  The N-terminal flexible arm makes additional specific contacts to the bases 
in the minor groove, while the loop between helix I and helix II interacts with the DNA 
backbone.  Sequence alignment within the HOX class has also revealed the conservation 
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of Arg-5 within the N-terminal arm, as well as residues Gln-12, Glu-15, Leu-16, Glu-17 
and Glu-19 within the first helix (Banerjee-Basu and Baxevanis, 2001).  It is the 
recognition helix that is responsible for establishing specific DNA recognition with the 
TAAT motif.  For example, homeodomains of the Antp class have a characteristic Gln 
residue found at position 50 within the recognition helix.  Gln-50 in addition to other 
conserved residues of helix III, such as Ile-47 and Met-54, are important in establishing 
contacts with bases within the target sequence (Kumar and Nazarali, 2001; reviewed in 
Gehring et al., 1994).  These residues also function in the binding of DNA by HoxB1 
within the HoxB1-Pbx1-DNA complex, as determined by X-ray crystallography (Piper 
et al., 1999).  An invariant characteristic residue Asn-51, found within helix III, is 
essential in target site recognition for both monomeric and heterodimeric complexes.  
This residue is believed to mediate base contacts to the polar groups on the DNA 
through hydrogen bonding in both the Drosophila Antp and HoxB1 homeodomains 
(Billeter et al., 1993;  Piper et al., 1999; reviewed in Billeter, 1996).   
2.3  DNA-binding of Hox Proteins and their Cofactors  
Although in vitro binding analyses have determined that Hox proteins bind to 
similar DNA sequences with similar affinities (Pellerin et al., 1994; Catron et al., 1993; 
Kumar and Nazarali, 2001), their ability to function in vivo as regulatory factors 
controlling highly specialized cellular mechanisms during morphogenesis requires the 
coordinate action of homeodomain proteins and cofactors within a transcriptional 
complex (Remacle et al., 2002; Chan and Mann, 1996; Ryoo and Mann, 1999; reviewed 
in: Chariot et al., 1999; Mann and Affolter, 1998).  Several Hox cofactors have been 
identified (Pbx, Meis, Prep, Sox and Oct proteins) which modulate the action of Hox 
  13
proteins to: bind DNA with a higher specificity, increase their affinity for a particular 
recognition site within a regulatory element, or modify the activity of specific domains 
by conformational variation (Di Rocco et al., 2001; reviewed in Mann and Affolter, 
1998). 
In some instances the functional specificity of Hox factors is conferred by their 
ability to act differentially on a given target in a cell-specific manner. This is due mainly 
to the availability of varying interacting proteins within a transcription complex (Saleh et 
al., 2000; Di Rocco et al., 1997, 2001).  For example, for efficient binding of HOX/PBC 
(homeobox/Pbx family of proteins) to targets in vivo recognition by SOX/OCT (SRY-
like HMG-box/Octamer protein) heterodimer(s) are required.  For HOXA1 to function 
efficiently in vivo on the b1-ARE (autoregulatory enhancer from the murine Hoxb1 
gene), both SOX and OCT proteins are recruited to the SOct site (Di Rocco et al., 2001).   
Peifer and Wieschaus (1990) identified the homeotic cofactor Extradenticle 
(Exd) in Drosophila through the isolation of mutants displaying homeotic-like patterning 
defects in the absence of any disruption in homeotic gene expression.  The mammalian 
homologs of Exd are the pre-B cell homeobox factors, Pbx1, Pbx2, Pbx3 and Pbx4, 
which collectively are referred to as the PBC family of proteins.  The PBC proteins 
together with the MEIS protein family (myeloid ecotropic insertion site genes: MEIS1, 
MEIS2, MEIS3; and Pbx regulating protein genes: PREP1, PREP2) are part of a larger 
family of atypical homeodomain proteins that make up the TALE class of 
homeodomains (Bürglin, 1997), many of which have been found to act cooperatively 
with Hox proteins in regulation of transcription (Fognani et al., 2002; Ferretti et al., 
2000; Jacobs et al., 1999). 
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Exd/Pbx family members have the ability to alter activity of Hox proteins in vivo 
(Rauskolb and Wieschaus, 1994).  Since many Hox proteins have been found to bind 
DNA cooperatively with Pbx it has been postulated that this interaction increases the 
selectivity of the Hox proteins, allowing for regulated transcription of its target(s) in a 
highly specified manner (Pöpperl et al., 1995; Chang et al., 1996; Knoepfler and Kamps, 
1995; Lu et al., 1995; Phelan et al., 1995; van Dijk et al., 1995; Piper et al., 1999; Jabet 
et al., 1999).  
Although some studies have indicated that alterations in functional specificity 
can occur due to enhanced Hox selectivity of DNA target site recognition by Hox-Pbx 
heterodimers (Chang et al., 1996; Chan et al., 1997), this cannot be generalized to 
account for all Hox responsive elements where Pbx is involved in Hox interactions.  In 
fact, in some instances Pbx proteins and their Hox partners display a lack of selectivity 
in binding, instead recognizing identical consensus sequences (Neuteboom and Murre, 
1997).  Rather than enhancing the selectivity of DNA binding by Hox-Pbx heterodimers, 
affinity of DNA target recognition by Hox proteins in the presence of a Pbx cofactor was 
greatly increased due to decreased specificity in DNA recognition (Neuteboom and 
Murre, 1997). 
Initially, interactions between Pbx and Hox proteins in heterodimer formation 
were believed to be solely mediated through contacts between the Pbx interacting motif 
(located in the N-terminal region upstream of the homeodomain in Hox proteins) with 
the C-terminal region of Pbx that contains a Hox interacting motif (Chang et al., 1995; 
Phelan et al., 1995; Knoepfler et al., 1996).  The N-terminal Pbx interacting motif of the 
Hox proteins is highly conserved and its integrity is considered to be critical for Hox-
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Pbx heterodimer formation (Chang et al., 1995; Chan et al., 1996; Knoepfler and Kamps, 
1995; Neuteboom et al., 1995).  However, the linker joining the motif to the N-terminal 
end of the homeodomain is highly variable in sequence and length for different Hox 
family members (Knoepfler and Kamps, 1995; Bürglin, 1994; Chan et al., 1996; Chan 
and Mann, 1996; Mann, 1995; Pöpperl et al., 1995; Merabet et al., 2003).  In vitro 
studies have shown that the Hox-Pbx dimers bind to sequences where each protein 
recognizes a specific DNA half site (Lu et al., 1995; van Dijk et al., 1995).  Variations 
found in the N-terminal arm region may contribute to differential selectivity and affinity 
of heterodimers for different types of Hox/Pbx binding sequences (Chan and Mann, 
1996; Chang et al., 1996; Chan et al., 1997; Lu and Kamps, 1997; Phelan and 
Featherstone, 1997). 
The Hox cooperativity motif found in the C-terminal region downstream of the 
Pbx homeodomain that was initially reported to be required for Pbx interactions with 
Hox proteins was found not to be absolutely essential in the formation of cooperative 
complexes (Green et al., 1998).  This 16 amino acid C-terminal tail however was 
implicated in stabilizing Pbx-DNA contacts, and therefore is required indirectly for 
maximal cooperative interactions with Hox factors; its contribution is perhaps variable 
depending on the Hox partner involved (Chang et al., 1995; Lu and Kamps, 1996; 
Peltenburg and Murre, 1997; Green et al., 1998). 
Experimental analyses of Pbx domains have demonstrated the requirement of 
specific residues within the Pbx homeodomain, in addition to residues in the TALE loop 
between helices I and II for interaction with Hox proteins (Bertolino et al., 1995; Shen et 
al., 1996; Peltenburg and Murre, 1997; Green et al., 1998).  This has been confirmed by 
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X-ray crystallography and NMR spectroscopy analyses of Pbx1-Hox heterodimers and 
Pbx1 proteins.  Upon binding of DNA by Pbx1 (in the presence or absence of a Hox 
partner) residues in the C-terminal end of the third α-helix of the homeodomain become 
ordered, favoring folding of the C-terminal tail that follows it into a fourth α helical 
structure (Piper et al., 1999; Jabet et al., 1999; Sprules et al., 2000).  The fourth α helical 
extension is not involved in DNA contact, instead it interacts with the Pbx homeodomain 
structure resulting in increased structural stability of the DNA bound protein (Sprules et 
al., 2000).  This stability also contributes to the formation of the hydrophobic pocket 
which consists of the C-terminus of helix III and the TALE, against which helix IV is 
packed forming an additional side to the pocket (Sprules et al., 2000, 2003; Slupsky et 
al., 2001; Piper et al., 1999; Jabet et al., 1999).  Hydrophobic residues form contacts 
when the third α helix, which is bound within the major groove of the DNA, lengthens. 
The result is contact between TALE residues and the DNA duplex, thereby bringing the 
TALE closer to residues in the third helix (Sprules et al., 2003).  Insertion of the Hox 
protein’s N-terminal Pbx interacting motif, which is itself partially folded, into the 
hydrophobic pocket is then favored and results in stable Hox-Pbx heterodimer formation 
on the target DNA (Sprules et al., 2000, 2003; Piper et al., 1999; Jabet et al., 1999; 
Slupsky et al., 2001). 
Hox paralogs 1-10 have been shown to form heterodimeric complexes with Pbx 
proteins that requires DNA binding by both proteins (Chang et al., 1996).  However, 
only the Abd-B class of Hox proteins (paralogs 9 and 10) are able to complex directly 
with MEIS  (Shen et al., 1997).  Hox paralogs 11-13 are incapable of a direct interaction 
with Pbx due to an absence of a Pbx interacting motif, but they are able to interact with 
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MEIS/PREP proteins (Shen et al., 1997).  In addition, MEIS is capable of affecting the 
DNA binding specificity of Hox proteins by forming trimeric complexes through 
protein-protein interaction with Pbx (Shanmugam et al., 1999; Shen et al., 1999; 
Waskiewicz et al., 2001; reviewed in Owens and Hawley, 2002).  The Meis-related 
factors Prep1 and Prep2 can also form trimeric complexes with Hox and Pbx proteins 
(Berthelsen et al., 1998a, b; Ferretti et al., 2000; Fognani et al., 2002).  
Finally, dimerization between Hox-Pbx, Hox-Prep/Meis and Pbx-Prep/Meis may 
occur even when all three factors are present (Jacobs et al., 1999; Ferretti et al., 1999).  
Hox-Pbx and Hox-Meis protein interactions are mostly DNA dependent, whereas MEIS-
PBC protein interactions are DNA independent (Fognani et al., 2002).  Association of 
Hox proteins with both the MEIS and PBC proteins in heterodimers has been shown to 
require specific conserved regions in the respective N-terminal arms of all three proteins 
(Phelan and Featherstone, 1997; Shanmugam et al., 1997; Remacle et al., 2002).  
Trimeric Hox-Pbx-Meis/Prep complexes have been isolated and analyzed with respect to 
various regulatory elements and recognition sites (Swift et al., 1998; Jacobs et al., 1999; 
Liu et al., 2001; Shanmugam et al., 1999; Shen et al., 1999).  The activity of variable 
Hox-cofactor complexes on transcription appear to be highly dependent on the context 
of the cell-type and enhancer element used in analysis (Saleh et al., 2000; Shen et al., 
2001).  In some instances, it is speculated that all three proteins are involved in 
recognition and binding of sequences within a regulatory element, while in others two 
proteins act as a tether for interaction with a third factor (Jacobs et al., 1999; Berthelsen 
et al., 1998a; Fognani et al., 2002).  However, in all scenarios it is apparent that 
formation of these trimeric complexes enhances the functional specificity of Hox 
  18
proteins, and that these functions could potentially vary greatly between any given cell-
type or tissue.  Within the trimeric complexes there is also a potential for the formation 
of a second hydrophobic pocket by the PBC or MEIS component that is not directly 
interacting with the Hox protein in question, potentially favoring insertion of a Pbx 
interacting motif from another Hox or Hox-related protein (Shen et al., 1997; Kroon et 
al., 1998; Swift et al., 1998; Affolter et al., 1999). 
 DNA recognition is not the sole variable in determining the function of a Hox 
protein, but rather it is the interaction of the N-terminal region of these Hox proteins 
with other factors that is responsible for mediating their differential activities in a tissue- 
or cell-specific manner.  Studies in Drosophila using lab and Dfd gene products in 
association with the Exd/Pbx cofactor indicated that, in the context of certain Hox 
responsive elements, the functional specificity is determined by other cofactor binding 
sites in a manner independent of the Hox protein or Hox-Exd heterodimer binding 
preferences (Li et al., 1999a).  There is also evidence supporting a regulatory role for 
Hox proteins that is independent of DNA binding specificity, i.e. through alteration of 
their transcriptional activities via functional domains rather than affecting their binding 
to response elements.  For example in Drosophila, Exd was necessary but not sufficient 
for full activation of the Dfd homeotic protein and a combination of other cofactors may 
be required for maximal activity (Li et al., 1999b).  It seems apparent that the functional 
specificity of Hox proteins is determined not only by their ability to recognize specific 
target sequences within a regulatory element, but also by the activation of various 
functional domains through protein-protein interactions.  The ability to identify the 
functional domains of mammalian Hox proteins is very much dependent on the 
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physiological context of a specific regulatory element in vivo (Vigano et al., 1998).  
Additional mechanisms of regulation such as phosphorylation and nuclear translocation 
by a variety of cofactors that are mainly independent of the DNA target specificity may 
also be at play (reviewed in Chariot et al., 1999a).  For example, PREP/MEIS factors are 
required to translocate EXD/PBX to the nucleus (Abu-Shaar et al., 1999; Berthelsen et 
al., 1999; Jaw et al., 2000).  Hence, due to the involvement of several different 
mechanisms involving cofactors and their in vivo context, the dissection of Hox activity 
and functional specificity is complex. 
2.4  Hox Gene Function and Expression  
 A characteristic of both the vertebrate Hox and Drosophila HOM-C homeobox 
clusters is spatial colinearity, which is the expression of the Hox genes along the 
anteroposterior axis of the embryo in congruence with their arrangement along the 
chromosome (Figure 2.1) (Lewis, 1978; Duboule and Dollé, 1989; Dressler and Gruss, 
1989; Graham et al., 1989; Izpisua-Belmonte et al., 1991; reviewed in Kmita and 
Duboule, 2003).  Thus, the 3′ genes within a chromosomal cluster are expressed more 
anteriorly than the 5′ genes with respect to the rostrocaudal axis of the embryo.  In 
general, vertebrate Hox genes also display temporal colinearity (Izpisua-Belmonte et al., 
1991; Gaunt and Strachan, 1996; Dollé et al., 1989; Duboule, 1994b) and colinear 
sensitivity to RA, a known inducer of Hox gene expression (Acampora et al., 1989; 
Simeone et al., 1990; Dekker et al., 1992; Krumlauf and Gould, 1992; Papalopulu et al., 
1991; reviewed in Marshall et al., 1996; Conlon, 1995; Lufkin, 1997).  Hence, there is a 
3′ to 5′ colinear sequence where genes at the extreme 3′ end of the individual clusters are 
activated the earliest, have the most anterior boundaries of expression, and exhibit the 
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most sensitivity to RA.  A direct correlation (colinearity) appears to exist between the 
Hox gene order along the chromosomal cluster and the relative dose response of each 
gene to RA (reviewed in: Boncinelli et al., 1991; Simeone et al., 1991; Conlon and 
Rossant, 1992; Morrison et al., 1997).  The precise mechanisms of temporal and spatial 
regulation of Hox genes are not entirely understood, although several upstream 
regulatory factors have been implicated.  These involve an interplay of both positive and 
negative regulatory actions on the Hox promoter and enhancer elements by such factors 
as kreisler, Krox-20, trithorax and Polycomb proteins, as well as RA induced nuclear 
factors (Barrow et al., 2000; Bel-Vialar et al., 2000; Dupé et al., 1997; Frasch et al., 
1995; Gould, 1997; Huang et al., 2002; Maconochie et al., 2001; Manzanares et al., 
1997, 2002; Marshall et al., 1994, 1996; Nolte et al., 2003; Nonchev et al., 1996a; 
Oosterveen et al., 2003; Schumacher and Magnuson, 1997; Studer et al., 1994; 1998).  
Additionally, the clustered organization of Hox genes has been postulated to play a role 
in the establishment of colinear expression based on the identification of shared 
enhancer elements (Gould et al., 1997; Sharpe et al., 1998; Kmita et al., 2000; Sham et 
al., 1992).  However, to what degree this influences colinearity may depend on the 
context of the specific tissue, or the Hox gene in question (Kmita et al., 2000; reviewed 
in: Duboule, 1998; Prince, 2002).  Hox gene products also contribute to the maintenance 
of their expression domains through auto and crossregulation (Barrow et al., 2000; 
Faiella et al., 1994; Hooiveld et al., 1999; Maconochie et al., 1997; Manzanares et al., 
2001). 
 Spatial and temporal colinearity of Hox genes is observed along a chromosomal 
cluster and does not extend to expression between paralog members, i.e. Hoxa1 is not 
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expressed before Hoxb1 nor does it have a more anterior domain of expression.  In 
general most paralogous genes have identical or similar domains of expression (Gaunt et 
al., 1989; Manley and Capecchi, 1997; Rossel and Capecchi, 1999; Morrison et al., 
1997; Greer et al., 2000 and referenced therein; reviewed in: Keynes and Krumlauf, 
1994; Hunt et al., 1991a, b).  The overlapping expression patterns of various paralogs, in 
addition to the high degree of sequence similarity between paralogous genes is indicative 
of some degree of functional redundancy (Rossel and Capecchi, 1999; Davenne et al., 
1999; Manley and Capecchi, 1998).  Thus, a gene within a paralog group may in part or 
entirely function to replace the activity of another member of that same group that has 
been disrupted (Horan et al., 1995a, b).  As an example, Hoxa3, Hoxb3, and Hoxd3 
generally have very similar patterning, and gene targeting has shown that members of 
paralogy group 3 functionally compensate for each other (Manley and Capecchi, 1997, 
1998; Greer et al., 2000).  This functional equivalency has been observed for the paralog 
3 Hox proteins, even though they do not exhibit a high degree of identity in amino acid 
sequence.  It is probable that the functional specificity of each paralog 3 member is 
dependent on quantitative differences in expression levels since they display overlapping 
expression domains, and is likely determined by the actions of cis-regulatory sequences 
present in each gene (Greer et al., 2000). 
 Although Hox genes follow these general arrangements of expression along the 
anteroposterior body axis, the most common parallels between Drosophila and mouse 
Hox gene function can be made with regard to the development of the hindbrain and 
spinal cord.  During early embryonic development in the mouse all Hox genes are 
expressed in the CNS and adjacent mesoderm.  The division of the hindbrain into 
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metameric units referred to as rhombomeres (r), and the restricted expression of the Hox 
genes within the hindbrain, resembles that of the segmental organization of the 
Drosophila embryo by the HOM-C genes.  Also, the expression of Hox genes in defined 
rostrocaudal domains in the developing spinal cord is indicative of a role for Hox genes 
in spinal cord patterning.  It is also very probable that the coordinated activity of the Hox 
paralogs rather than an individual Hox gene is responsible for establishing unique 
domains during pattern formation of the spinal cord and hindbrain (reviewed in 
Carpenter, 2002). 
2.6  Expression of Hox Genes in the Developing Hindbrain and Spinal Cord  
The generation of Hox gene expression during embryonic development has been 
described as encompassing three distinct phases: initiation, establishment, and 
maintenance (Deschamps and Wijgerde, 1993; Deschamps et al., 1999).  During 
gastrulation Hox gene transcription is initiated within the primitive streak.  As 
development progresses specific domains of Hox expression are observed, such as those 
within the developing CNS.  These restricted domains of expression are maintained 
through a series of molecular mechanisms that also involve Hox auto and 
crossregulatory networks, in addition to upstream factors such as kreisler and Krox-20 
(Akasaka et al., 2001; Brend et al., 2003; Di Rocco et al., 2001; Kwan et al., 2001; 
Manzanares et al., 1997, 1999, 2002; Nonchev et al., 1996 a, b; Packer et al., 1998; Ren 
et al., 2002; Seitanidou et al., 1997; Sham et al., 1993). The molecular mechanisms 
involved in the generation of Hox gene expression during these phases of development 
in the hindbrain and spinal cord have been reviewed in Deschamps et al. (1999). 
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Nested expression of members of the Hox paralogs 1 through 4 in the rhombomeres 
has been observed in the developing murine hindbrain (Figure 2.2), where their anterior 
boundaries of expression coincide with that of the rhombomeric boundaries (reviewed 
in: Rijli et al., 1998; Krumlauf, 1993; Krumlauf et al., 1993; Wilkinson, 1995; Lumsden 
and Krumlauf, 1996).  General colinearity among the Hox genes is evident, particularly 
in the developing spinal cord (Figure 2.3). The 3′ anterior Hox paralogs have rostral 
expression limits in the hindbrain, with expression extending in longitudinal domains to 
varying extents through the spinal cord.  The 5′ Hox groups (5-13) generally have 
anterior boundaries of expression limited to domains within the spinal cord (Figure 2.3) 
although expression of some 5′ posterior Hox genes may extend rostrally into caudal 
structures of the hindbrain either in later development stages or postnatally (Sakach and 
Safaei, 1996; Zhang et al., 1997a; Oosterveen et al., 2003).  
One exception with regard to colinear expression is the Hoxa2 gene. In the 
hindbrain, the rostral boundary of Hoxa2 expression is anterior to the Hoxa1 boundary 
(r4) at the r1/r2 interface (Prince and Lumsden, 1994; reviewed in Krumlauf, 1993).  At 
later stages of development Hoxa2 was expressed in the diencephalon and the forebrain 
(Wolf et al., 2001; Tan et al., 1992).  Although members of paralogs 1 and 2 do not 
follow strict colinearity, members of paralog groups 3 and 4 from clusters a, b, and d 
share rostral boundaries of expression at the r4/r5 and r6/r7 interface, respectively 
(reviewed in: Krumlauf, 1993; Krumlauf et al., 1993; Lumsden and Krumlauf, 1996).
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Figure 2.2  Schematic drawing of Hox gene expression patterns within the 
rhombomeres 
Hox gene expression patterns of the anterior paralog members within the rhombomere 
segments of the early embryonic (E9.5) murine hindbrain.  Expression of the clustered 
Hox genes is absent within the early embryonic forebrain and midbrain (MB) structures.  
In general, Hox genes display spatial colinearity within the rhombomeric (r) subdivisions 
1-7 of the hindbrain, with the exception of the paralog 2 genes.  Transient expression of 
Hoxa1 and Hoxb1 (dashed bars) is observed within the hindbrain, where expression 
begins prior to rhombomere formation.  Light grey bars indicate low levels of 
expression, while dark grey bars indicate areas of high expression.  Many of the more 5´ 
Hox genes also display rostral boundaries within the hindbrain, however this is not 
observed until later stages of embryonic development after rhombomeric segmentation is 
accomplished.  For example, Hoxb5, Hoxb6 and Hoxb8 are expressed in the spinal cord 
(SP) region in early development and their expression extends into the posterior 
hindbrain where they form their distinctive anterior boundaries of expression by E11.5 
(Oosterveen et al., 2003).  This figure has been adapted from Hunt et al. (1991a) with 
permission (The Company of Biologists Ltd., http://www.biologists.com/). 
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Figure 2.3  Hox gene expression in the spinal cord 
Schematic illustration of Hox gene expression within the developing murine spinal cord 
at embryonic (E) 12.5 (Carpenter, 2002 and referenced therein).  The anterior boundaries 
of expression for Hoxa5, Hoxb5, and Hoxc5 at E12.5 lie within the posterior 
myelencephalon of the hindbrain rather than within the spinal cord region (indicated by 
dashed boxes) (Gaunt et al., 1990; Geada et al., 1992; Holland and Hogan, 1988; Hogan 
et al., 1988; Zakany et al., 1988; Nowling et al., 1999; Tuggle et al., 1990).  The rostral 
limit of expression for Hoxc4 also lies within the posterior hindbrain of E12.5 mice at a 
position slightly anterior to that of Hoxc5 (Geada et al., 1992).  Genes are grouped 
according to the region of their anterior boundary limit, with regions of the spinal cord 
separated according to the coordinate vertebrae (cervical, thoracic, lumbar, sacral, 
caudal).  The different shades of grey do not represent intensity of expression but instead 
paralog members are separated by shades of grey with Hox a genes shown in the darkest 
shade of grey followed respectively, with decreasing shades of grey for Hox b, c and d 
genes.  (Adapted from Carpenter, 2002 with permission from author and S. Karger AG, 
Basel) 
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Generally, the ordered expression of Hox genes within the hindbrain is well conserved 
across the vertebrate species (reviewed in Glover, 2001). 
In the developing murine spinal cord spatial colinear expression of paralogs 6-13 is 
observed within individual clusters (Figure 2.3), but this is not the case when comparing 
expression between members within a paralog group (reviewed in Carpenter, 2002).  
Expression of Hox genes in positions 6-9 extends rostrally to the cervical region whereas 
paralogy groups 10-13 generally extend expression only into the lumbar region of the 
spinal cord.  The Hoxd9 gene is atypical in that it is the one member of paralog 9 that 
mostly has restricted expression to the lumbar level of the spinal cord (reviewed in 
Carpenter, 2002).  However, the majority of other posterior members of the Hox c and d 
groups share overlapping domains of expression along the spinal cord with highly 
analogous boundaries of expression.  The Hox b genes at positions 6-9 have the most 
extreme rostral boundary of expression within the cervical spinal cord in comparison to 
the other paralog members, including the Hox a group (reviewed in: Krumlauf et al., 
1993; Carpenter, 2002).  In vertebrate development, Hox genes exhibit overlapping 
domains of expression in the caudal regions, although they exert most of their functional 
activity at or in close proximity to their rostral boundaries of expression such that in 
mutant mice, abnormalities are generally observed at or near the anterior boundary of 
expression (reviewed in Prince, 2002). This has been attributed to the functional 
dominance of posterior genes over anterior genes expressed in the same domain and is 
called posterior prevalence in vertebrates and phenotypic suppression in Drosophila 
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(Gonzales-Reyes et al., 1990: Duboule, 1994a; Schöck et al., 2000; Kmita and Duboule, 
2003). 
The patterning of Hox gene expression within the developing spinal cord is not 
restricted to the anteroposterior (A-P) axis, but is also demonstrated in a dorsoventral 
manner along the transverse plane.  At the E12.5 stage of development, Hoxa4, a5, and 
a6 genes exhibit a ventral domain of expression in the spinal cord, as do Hoxc5 and c6 
(Gaunt et al., 1990; reviewed in Gaunt, 1991).  In addition, expression analyses of genes 
in the Hox b cluster have revealed a dynamic dorsoventral pattern of expression during 
development of the spinal cord (Graham et al., 1991; reviewed in: Krumlauf et al., 1991; 
Keynes and Krumlauf, 1994).  Within the developing spinal cord and the hindbrain, 
Hoxa2 expression exhibits dorsoventral patterning that may determine the location of 
specific groups of neurons (Davenne et al., 1999; Hao et al., 1999).  The dorsally 
restricted expression of Hoxb7 and Hoxb8, and the ventral specific expression of paralog 
10 members as well as Hox c members (at position 8, 10, 11, and 12), may be indicative 
of Hox mediated dorsoventral specification of cell populations (Awgulewitsch and 
Jacobs, 1990; Deschamps and Wijgerde, 1993; Hostikka and Capecchi, 1998; Peterson 
et al., 1994; reviewed in Carpenter, 2002).  
Hox genes play an important role in CNS development, especially in determining 
neuronal organization within the hindbrain (Studer et al., 1996; Pattyn et al., 2003; 
reviewed in: Lumsden and Krumlauf, 1996; Rijli et al., 1998; Pasqualetti and Rijli, 
2001) and the spinal cord (reviewed in Carpenter, 2002).  Although Hox genes may play 
an instructive role in specification of neuronal cell types, this most likely involves a 
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combinatorial effect of various signals rather than the actions of a specific Hox gene 
(reviewed in Glover, 2001). 
Finally, Hox genes are also involved in patterning of the cranial neural crest cells, 
and therefore contribute to the development of the pharyngeal arches and craniofacial 
structures (reviewed in: Trainor and Krumlauf, 2001; Santagati and Rijli, 2003). In 
particular, Hoxa2 has a clear role as a homeotic ‘selector’ gene in development of the 
second pharyngeal arch (Gendron–Maguire et al., 1993; Rijli et al., 1993; Pasqualetti et 
al., 2000; Grammatopoulos et al., 2000; Hunter and Prince, 2002).  Recent data has 
suggested that in neural crest cells, Hox genes act as negative modulators of skeletogenic 
fate (Creuzet et al., 2002; Abzhanov et al., 2003; discussed in Santagati and Rijli, 2003). 
2.7  Criteria for Direct Regulation by a Hox Protein  
Promiscuous DNA binding of Hox proteins in vitro may result in the 
identification of false target genes.  Hence, it is important that various critieria are 
fulfilled to demonstrate that a potential target gene is regulated by a Hox protein in vivo 
(discussed in: Andrew and Scott, 1992; Chalepakis et al., 1993; Damante et al., 2001).  
Overlapping patterns of expression for an induced target should be evident, whereas a 
repressed target gene will display restricted expression in relation to the Hox protein.  
This infers regulatory control of the target gene by the Hox protein in vivo and should be 
confirmed by analysis of Hox mutant mice, where an increase or decrease in expression 
of the target gene should coincide with alterations in Hox gene expression.  Often the 
requirement for regulation by a Hox protein is shown through reporter assays in cell 
culture, where determination of the precise mode of action of a Hox responsive element 
is relatively rapid and straightforward to ascertain.  However, ultimately the responsive 
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element needs to be assessed in a transgenic system to demonstrate repression or 
activation via a specific Hox binding site in vivo.   
A prerequisite for characterization of a gene as a direct target of a Hox protein is 
the evidence of DNA binding either in vitro or in vivo by the Hox protein to the 
regulatory sequence.  However, most DNA binding assays do not reveal whether the 
Hox protein regulates transcription by directly binding to a DNA sequence, or through 
protein-protein interactions with other transcription factors.  Binding studies using 
purified Hox protein may help determine if the target is controlled by direct recognition 
of DNA.  Additionally, if the homeodomain binding site is well characterized then 
mutation analyses of the regulatory region may also provide evidence of a direct Hox-
DNA interaction.  However, many Hox proteins are known to require additional 
cofactors to help stabilize their binding to various regulatory elements.  More recently 
several DNA binding defective Hox proteins or various homeodomain truncations and 
mutations have been designed for use in DNA binding assays and transgenic analysis. 
These assays could be used to demonstrate a direct regulatory requirement of Hox 
proteins and their function within a transcription regulatory complex (Koizumi et al., 
2003; Remacle et al., 2002; DiRocco et al., 2001; Sloop et al., 2001; Quentien et al., 
2002).  Transgenic mutants of the target gene should in principle exhibit phenotypes 
similar to that of its corresponding Hox mutants.  This can however be complicated by 
functional redundancy among Hox paralogs.  However, this problem can be overcome 
with advancements in transgenic technology.  For example, the production of temporal 
and/or tissue specific mutants, as well as partially active (haploinsufficient) mutants may 
be able to specifically target a single Hox regulator. 
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2.8  Approaches to Target Gene Identification  
In order to decipher pathways through which Hox genes function in regulating 
regional specification, we need to identify the downstream targets of Hox transcription 
factors.  Vertebrate Hox genes are believed to specify this regional identity through 
regulation of common cellular processes such as cell death, adhesion, proliferation, and 
migration.  It appears that the Hox genes are the ‘selector’ genes of Garcia-Bellido 
(1975), which are at the top of a genetic hierarchy controlling development by regulating 
the transcription of ‘realizator’ genes and regulatory molecules (Andrew and Scott, 
1992).  Genes involved in regulating cellular mechanisms such as mitotic rate, cell-cell 
adhesion and cell migration during morphogenesis have been identified as targets for 
many homeobox gene products (Edelman and Jones, 1995, 1998; van Oostveen et al., 
1999; Boncinelli and Morgan, 2001; Dailey and Basilico, 2001; Valarche et al., 1993; 
Jones et al. 1997; Drouin et al., 1998; Meier et al., 1999; McWhirter et al., 1997), 
however the direct downstream targets of Hox genes have not been well defined.  Most 
of the potential targets that have been identified for the Hox transcription factors are 
involved in either auto or crossregulation of other Hox genes (Gould et al., 1997; 
Maconochie et al., 1997; Manzanares et al., 2001; Packer et al., 1998; Pöpperl and 
Featherstone, 1992; Pöpperl et al., 1995; Wu and Wolgemuth, 1993), in addition to 
crossregulation between "dispersed" homeobox and Hox genes (Charite et al., 1998; 
Guazzi et al., 1998).   
 Several cell adhesion molecules such as cytotactin, L-CAM, N-CAM, and E-
cadherin have been identified as potential targets (Izon et al., 1998; Jones et al., 1992a,b, 
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1993; Goomer et al., 1994; Boersma et al., 1999; reviewed in Edelman and Jones, 1998).  
However, many of these targets have not been analyzed as direct targets in vivo.  This in 
part is dependent on the method used for identification of a potential downstream target 
gene.  
Various strategies have been utilized to identify targets of homeobox proteins in 
both vertebrates and Drosophila (reviewed in: Andrew and Scott, 1992; Chalepakis et 
al., 1993; Pradel and White, 1998; Martinez and Amemiya, 2002).  A significant amount 
of information available that delineates the pathways by which homeotic genes regulate 
morphogenesis is due to the availability of mutants in Drosophila.  The earliest and most 
common method for target gene isolation involves genetic screening and indicative gene 
expression pattern analyses (Pradel and White, 1998).  Thus, previously characterized 
genes are identified as targets based on a change in their expression pattern in Hox 
mutants (Graba et al., 1997).  A similar approach is the observation of suppression or an 
enhancement of a homeotic phenotype in genetic mutants, implying that the genes 
isolated may belong to a common developmental pathway with the homeotic gene.  
However, both of these methods may also potentially identify regulators of Hox genes or 
parallel factors within the same developmental pathway.  These methods also cannot 
preclude whether the Hox gene directly regulates the downstream target in question or if 
it is merely a downstream effector within the Hox genetic pathway (reviewed in 
Mannervik, 1999).  Therefore, further molecular analysis is required to verify actual 
direct regulation.  Identification of targets in vertebrates using these approaches is 
further complicated by the functional redundancy observed between several paralogous 
Hox genes.  The ability to produce double and triple mutants in mice has increased our 
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ability to determine the specific function of an individual Hox gene to some extent, 
however isolation of direct targets based solely on this approach is still inadequate as a 
whole. 
Subtractive hybridization, based on differential expression patterns to identify 
potential targets, is a useful method for identification of target genes.  The method 
involves isolation of genes by an up or downregulation of specific mRNAs in a cell 
system or in tissues where a particular Hox gene is activated at a specific developmental 
stage.  Different approaches have been used where the Hox gene in question may be 
ectopically expressed in tissue (Hooiveld et al., 1999; Tkatchenko et al., 2001), and 
overexpressed or suppressed in cell culture (Bromleigh and Freedman, 2000; Carè et al., 
1996).  However, these approaches are limited since the isolated gene may not be a 
direct target and it can be difficult to identify those targets whose relative expression 
patterns are altered during development rather than being entirely abolished or activated.  
Hence, if there is a shift in the expression pattern during development, or if there is only 
a minimal up/downregulation rather than a gene being turned "on" or "off", this method 
of target gene isolation becomes unreliable (reviewed in: Pradel and White, 1998; 
Martinez and Amemiya, 2002). Subtractive hybridization has progressed significantly 
with the use of microarrays, enabling the isolation of several potential target genes 
within a short time frame (Zhao and Potter, 2001; reviewed in Martinez and Amemiya, 
2002).  New methodologies are being employed to improve the integrity of this approach 
by increasing its sensitivity for low abundance mRNA (Werner, 2001).  However, direct 
regulation of these potential targets by a particular Hox protein still needs to be 
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demonstrated by DNA binding analysis and Hox regulation of the target promoter in 
vivo. 
Targets of Hox and HOM-C genes have been identified by various transfection 
assays using fusion proteins with GAL or VP16 activation domains (Mastick et al., 
1995; Friedman-Einat et al., 1996).  This approach can be used as a random genetic 
screen of mouse genomic DNA fragments for the identification of target sequences 
(Mastick, 1995; discussed in Pradel and White, 1998).  It may also be used for 
investigating the transcription activites of Hox proteins on previously identified targets 
(Nasiadka et al., 2000), or for the isolation of transcription regulators of a previously 
identified promoter/enhancer element through a one-hybrid screen (Rausa et al., 1997; 
Chen et al., 1997; Hayashi et al., 2000).  One limitation is that the presence of non-
physiological concentrations of Hox proteins has been known to sometimes result in 
promiscuous DNA binding (Ekker et al., 1994).  Also, it has been documented that the 
use of various forms of Hoxa2-VP16 fusion protein in cell culture resulted in VP16-
mediated squelching (Matis et al., 2001).  The VP-16 is the moiety from the herpes 
simplex viral protein that is acts as a strong transactivator when fused to various DNA 
binding domains.  When expressed at high levels in vitro, strong transcription activators 
are believed to bind endogenous factors of transcription complexes independent of DNA 
thereby resulting in non-specific inhibition of transcription (Gill and Ptashne, 1988).  
Therefore, it is important to assess the regulatory activity of Hox proteins on their targets 
using in vivo studies as well. 
All of the above methods, in addition to the demonstration of in vitro DNA-
binding of the Hox protein to the candidate target gene, are good indicators of the 
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identification of an in vivo regulated target gene.  After the initial isolation of the core 
TAAT binding motif of Hox proteins, characterization of specific binding sites for 
several homeodomain factors and identification of the potential cofactors involved in 
Hox binding specificity was established  (discussed in section 1.2).  One example is the 
homeobox-containing protein hepatocyte nuclear factor 1 (HNF1), which has over 50 
potential target genes isolated based on the presence of its in vitro DNA binding site 
within the promoter regions of various genes (Tronche et al., 1997).  Hence, a candidate 
target gene can first be characterized based on the presence of a Hox binding site within 
its regulatory element.  These targets can then be further analyzed for a regulatory 
requirement for a particular Hox protein by reporter assays in cell culture.  As with other 
methods, this approach is restricted in that only well-characterized genes may be 
identified.  Additionally, it is difficult to assess the relevance of an in vitro DNA binding 
site in relation to an in vivo environment due to potential promiscuous binding of Hox 
proteins in vitro.  The absence of appropriate cofactors may affect the DNA binding 
affinities or the type of consensus sequence required for Hox recognition and should 
therefore be taken into consideration (reviewed in Pradel and White, 1998). 
In Drosophila, Gould et al. (1990) isolated in vivo targets of the Ubx homeotic 
protein by immunoprecipitation of chromosomal-protein DNA complexes.  
Modifications of this method have been successfully used in the murine system for the 
isolation of Hoxc8 (Tomotsune et al., 1993), Hoxb5 (Safaei, 1997), and Hoxa2 (Akin 
and Nazarali, unpublished data) candidate target genes.  This technique is believed to be 
advantageous over other approaches in that it allows for the isolation of more than one 
target gene in vivo.  Also, isolation of targets by immunoprecipitation alleviates 
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difficulties presented by promiscuous DNA binding in vitro and allows for the 
identification of targets controlled by a Hox protein in conjunction with cofactors.  
However, it is possible that the targets isolated are actually regulated by the Hox protein 
via protein-protein interactions with other cofactors and not by direct DNA binding of 
the Hox protein.  Therefore, in all approaches, the criteria presented in section 2.0 must 
be fulfilled in order to confirm the validity of a candidate target gene in terms of direct 
regulation by a Hox protein. 
2.9  Targets of Hox genes in the Developing Murine Hindbrain and Spinal Cord 
Hox proteins are important developmental regulators that interact in multiple 
germ layers to coordinate cell division and cellular functions such as cell migration, 
differentiation, proliferation and apoptosis.  In order to decipher the mechanisms through 
which Hox genes regulate development it is necessary to characterize their downstream 
targets (reviewed in Andrew and Scott, 1992).  The following section provides a review 
of several candidate downstream targets of Hox proteins in the developing hindbrain and 
spinal cord. 
2.9.1  Cell Adhesion  
Many of the target gene candidates for homeobox proteins that are involved in 
cellular processes such as migration and differentiation belong to the cellular adhesion 
molecule (CAM) family such as N-CAM, L-CAM and cytotactin (Jones et al., 1992a, b, 
1993; Sorkin et al., 1993; Goomer et al., 1994; reviewed in Edelman and Jones, 1993).  
However, several of these target genes have been identified in systems other than the 
CNS (Tables 2.1 and 2.2).  Various members of the CAM family have coinciding 
expression patterns with several homeobox genes, and homeodomain DNA binding sites 
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Table 2.1  Examples of candidate cell adhesion targets of divergent homeobox-
containing genes in the CNS 
 
Homeobox gene Target Gene Transcriptional 
Activity 
Function Reference 
Mouse Pax8 Mouse N-CAM + Neuron specific cell adhesive 
actions during neural development 
Holst et al., 
1994; Edelman 
and Jones, 
1995, 1998. 
Mouse Pax6 Mouse N-CAM +                        as above Edelman and 
Jones, 1995, 
1998. 
Mouse Phox2 
and Cux1 
Mouse N-CAM +                        as above Valarche et al., 
1993. 
Mouse Cux2 Mouse N-CAM +                        as above Quaggin et al., 
1996. 
Mouse Pax3 Chicken Ng-CAM - Immunoglobulin N-CAM family 
cell adhesion molecule, specific 
for peripheral glial cells and post-
mitotic neurons 
Kallunki et al., 
1995; Edelman 
and Jones, 
1998. 
Mouse Barx2 and 
Pax6 
Mouse L1  + Immunoglobulin CAM , 
modulates neuron-neuron and 
neuron-glia interactions 
Jones et al., 
1997; Meech et 
al., 1999; 
Simpson and 
Duce, 2002. 
Mouse Otx2 Mouse R-Cadherin + Ca2+ dependent cell adhesion, 
regionalization of the brain and 
regulation of cell intermixing 
Rhinn et al., 
1999. 
Mouse Pax6 Mouse R-Cadherin + as above Stoykova et al., 
1997. 
Xenopus gbx2 Xenopus  
N-Cadherin 
- Ca2+ dependent cell adhesion, 
implicated in neural tube 
morphogenesis 
King et al., 
1998. 
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Table 2.2  Examples of Hox gene regulation of cell adhesion molecules in non-
neuronal systems 
Hox gene Target Gene Transcriptional 
Activity 
System/Cell Type and 
Function 
References 
Human HOXD9/ 
mouse HNF1 
Chicken L-CAM  
 
+ 
Ca2+ dependent cell adhesion: 
Liver specific, contributes to 
the development of epithelial 
and parenchymal tissues in 
development 
Goomer et al., 
1994; Sorkin et 
al., 1993. 
Mouse 
Evx1/Pax6/Pax8 
Chicken/ 
mouse cytotactin 
(tenascin) 
 
+ 
Chicken embryonic fibroblast: 
ECM involved in processes 
such as counter adhesion and 
cell spreading, tissue 
patterning 
Jones et al., 
1992a; 
Chalepakis et al., 
1992; Copertino 
et al., 1995. 
Rat Prx1/ 
mouse Prx2 
Mouse tenascin  
+ 
Smooth muscle cells, 
implicated in vasculogenesis 
Jones et al., 
2001; Norris and 
Kern, 2001. 
Mouse Hoxa9 Mouse E-cadherin 
(L-CAM) 
 
+ 
Ca2+ dependent cell adhesion; 
involved in early T cell 
development; hematopoiesis  
Izon et al., 1998; 
reviewed by van 
Oosteveen et al., 
1999 
Mouse 
I-CAM1(CD54) 
Myeloid cells, hematopoiesis Mouse Hlx 
CD44 
 
 
_ Integral membrane CAM in T 
cells, involved in T cell 
activation, lymphopoiesis and 
cell migration 
Allen et al., 
1993; reviewed 
by van 
Oosteveen et al., 
1999. 
Human HOXD3 Ηuman αIIb33  
 
+ 
Integrin involved in cell 
adhesion of various tissues 
during embryogenesis 
including hematopoiesis  
Taniguchi et al., 
1995; reviewed 
by van 
Oosteveen et al., 
1999. 
Human OCT1 Human V-CAM1  
 
_ 
Immunoglobulin CAM, 
known as vascular cell 
adhesion molecule 1, found on 
vascular endothelial cells, 
involved in inflammation 
response 
 Schwachtgen et 
al., 1998; 
Iademarco et al., 
1993. 
Mouse Nkx2.3 Mouse MAdCAM1  
 
_ 
Immunoglobulin CAM, 
known as mucosal addressin 
CAM, found on endothelial 
cells, involved in leukocyte 
homing in lymphoid organ 
development 
Wang et al., 
2000. 
Human BARX2 Human Cadherin6  
 
+ 
Ca2+ dependent cell adhesion; 
found on ovarian surface 
epithelium, involved in tumor 
suppression in ovarian cancer 
cell lines  
Sellar et al., 
2001. 
Human α-2-
integrin 
Human HOXB4 
 
 
_ 
Found on neonatal 
keratinocytes, involved in 
regulation of cell proliferation 
Komuves et al., 
2002. 
 Human CD44    
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have been identified within their regulatory elements.  These proteins play an important 
role in nervous system development, where they may function as downstream effectors 
of Hox genes. 
The four main groups of cell adhesion molecules are: the immunoglobulin (Ig) 
related molecules, integrins, cadherins and selectins.  In addition to their involvement 
incell-cell/matrix adhesion these proteins are also involved in various signaling events 
that regulate processes such as cell growth, migration and differentiation (reviewed in 
Juliano, 2002).  N-CAM (neural cell adhesion molecule), which encodes an Ig related 
cell-cell adhesion molecule, is expressed at the earliest stage of neural tube formation 
and persists into adulthood in mice (reviewed in: Chuong, 1990; Edelman and Jones, 
1995; Edelman and Jones, 1998).  It is predominantly located in neurons where it is 
involved in neuronal development, plasticity and signaling pathways (reviewed in: Ronn 
et al., 1998; Kiss and Muller, 2001).  
Several negative and positive regulatory elements have been characterized within 
the promoter of N-CAM that were found to contain distinct Hox binding sites (HBS) 
capable of mediating transcription activity by several Hox genes, as well as the 
"dispersed" homeobox genes (Jones et al., 1992b, 1993; Holst et al., 1994; reviewed in 
Edelman and Jones, 1998).  These HBS sites represent Hox consensus sequences 
containing one or multiple canonical TAAT sites (for example, HBS-I 5' 
CCTAATTTTATTAA 3') flanked by varying sequences (Jones et al., 1993).  Hoxb9 
induces transcription by binding to HBS sequences within the N-CAM promoter, 
although cotransfection with Hoxb8 prevents this transactivation (Jones et al., 1992b; 
reviewed in Edelman and Jones, 1995).  Hoxc6, which displays overlapping expression 
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with N-CAM along the body axis (Chuong et al., 1990), also induces a positive 
regulatory effect on the promoter of N-CAM that is dependent not only on the presence 
of intact HBS sequences, but also on the neighboring elements (Jones et al., 1993; 
Boersma et al., 1999).  However, when taken out of context from its native promoter, 
these HBS sequences are insufficient in inducing transcription in vitro, although they 
appear to be required in vivo for proper specification of N-CAM expression along the 
dorsoventral axis of the developing spinal cord (Wang et al., 1996; reviewed in Edelman 
and Jones, 1998).  This observation, in addition to the apparent differential effects 
displayed by Hox genes on a common target (Jones et al., 1992b), indicate that cofactors 
may play an important role in determining specificity of Hox activity (Di Rocco et al., 
2001; Remacle et al., 2002; reviewed in Mann and Affolter, 1998).  
Neuroepithelial cells in general do not cross the boundaries between adjacent 
rhombomeres that subdivide the hindbrain (Fraser et al., 1990; Guthrie et al., 1993; 
Birgbauer and Fraser, 1994; Nittenberg et al., 1997).  This was believed to be due to 
segment-specific adhesiveness of cells within the hindbrain (Lumsden, 1990; Guthrie et 
al., 1993; Wingate and Lumsden, 1996; Nittenberg et al., 1997).  Interestingly, even and 
odd numbered rhombomeres display different functional adhesive properties (Wizemann 
and Lumsden, 1997).  Cadherins (Cad), which belong to the CAM family of proteins 
(reviewed in Redies, 1995) could be involved in the compartmentalization of cells 
(Inoue et al., 1997; Shen et al., 2000).  Unlike Ig related molecules such as N-CAM, 
Cads function in a Ca2+ dependent manner (reviewed in Redies, 1995).  The segregation 
of cells between adjacent rhombomeres is dependent on processes involving Ca2+ 
dependent molecules (Wizenmann and Lumsden, 1997).  
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R-Cadherin (R-cad, cad4) exhibits restricted expression in specific rhombomeres 
and in vitro cell aggregation assays show that R-cad+ cells segregate from R-cad – cells 
(Ganzler and Redies, 1995; Redies, 1995; Matsunami and Takeichi, 1995).  R-cad and 
cadherin 6 (cad6) display alternate expression patterns that delineates the odd and even 
numbered rhombomeres of mice, as well as the neighboring subdivisions of the brain 
within the telencephalon (Inoue et al., 1997, 2001).  Hence, the function of Cads may be 
a factor in the segregation of neuroepithelial cells of rhombomeric compartments.  
Many cads exhibit differential expression patterns throughout the developing 
CNS and experimental evidence implicate them in functioning as morphoregulatory 
molecules during embryogenesis (reviewed in: Redies, 2000; Tepass et al., 2000).  Also, 
several cads display segmentally restricted expression similar to that observed for Hox 
genes.  Hence, cads may be potential targets of Hox proteins, especially in consideration 
of their role(s) in rhombomere compartmentalization.  In wildtype embryos, Hoxa1 and 
cad6 exhibit overlapping spatiotemporal expression in early posterior hindbrain (Inoue 
et al., 1997).  Although a direct mode of action has not been determined, transgenic 
analysis reveals rhombomere and stage specific effects of Hoxa1-/- mutation on the 
expression of cad6 (Inoue et al., 1997).  Cad6 was also identified as a potential Hoxa1 
target using differential hybridization and subtractive gene screening (Shen et al., 2000).  
Thus, Hoxa1 may either directly or indirectly be involved in the regulation of cad6 in the 
posterior hindbrain. 
Another cell adhesion molecule that has been identified as a potential direct 
target of Hoxc8 is the β-amyloid precursor protein (APP) gene (Violette et al., 1992; 
Schubert et al., 1989; Breen et al., 1991; Wu et al., 1997).   APP is a transmembrane 
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protein similar to a cell-surface receptor.  APP and its derivatives (formed by secretase 
processing) are expressed in the developing CNS, where they have multiple functions 
and have been associated with pathological processes such as Alzheimer’s disease 
(reviewed in Dodart et al., 2000; Panegyres, 2001).  In addition to cell adhesion 
properties, APP is important for cell viability and neuroprotection (Goodman and 
Mattson, 1994; Perez et al., 1997; Nishimura et al., 2003).  APP is involved in the 
morphological and functional plasticity of nerve cells (reviewed in Dodart et al., 2000) 
and has also been implicated in cell signaling pathways (Russo et al., 2002; Mook-Jung 
and Saitoh, 1997; reviewed in Mattson and Furukawa, 1998).  In transfection studies, 
Hoxc8 exhibited repressor activity in a reporter system driven by the APP gene 
promoter, in addition to repression of endogenous APP expression (Violette et al., 1992).  
Although it has not been demonstrated in vivo, Hox proteins may directly regulate this 
response since there are at least 20 Hox binding sites present within the APP promoter.   
Osteopontin (OPN) is a secreted noncollagenous phosphoprotein component of 
the extracellular matrix (Oldberg et al., 1986), which exhibits adhesive properties 
through interactions with integrin adhesion molecules (Liaw et al., 1998).  Although 
OPN’s role in osteoblast differentiation and bone formation is well known, its role in the 
developing and adult nervous system has not been well characterized.  OPN is expressed 
in the developing notochord and hindbrain where it may contribute to CNS patterning 
(Thayer et al., 1995; Thayer and Schoenwolf, 1998).  However, it is not known whether 
OPN functions in the nervous system by targeting integrins as it does in osteoblast 
differentiation (Lee et al., 2001).  OPN exhibits neuron specific expression within the 
developing brainstem and adult brain (Shi et al., 1999; Lee et al., 2001) where it may 
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play a role in the differentiation and maturation of specific neuronal populations (Lee et 
al., 2001).  Hoxc8 and Hoxa9 mediated repression of OPN transcription in osteoblast 
precursor cells via a Hox binding element within its promoter (Shi et al., 1999, 2001). 
This repression may be antagonized or enhanced through interactions with various Smad 
signaling molecules, which mediate signaling in the TGFβ and BMP pathways (Bai et 
al., 2000; Yang et al., 2000; Shi et al., 2001).  Although the regulatory mechanisms 
controlling expression of OPN within the nervous system have not been determined, 
both Hoxc8 and Hoxa9 are present in the developing spinal cord where they may 
regulate OPN expression. 
2.9.2  Tumor Supressor Genes 
An additional target of Hoxc8 is mgl-1, whose function is not entirely understood 
but has been identified as a mammalian homolog of the Drosophila lethal (2) giant 
larvae, l(2)gl (Tomotsune et al., 1993).  Immunoprecipitation isolation of Hoxc8 bound 
DNA complexes from mouse spinal cords identified mgl-1 as a novel target that displays 
complementary expression patterns to Hoxc8 in the embryonic spinal cord, and may 
therefore be downregulated by Hoxc8 (Tomotsune et al., 1993).   
The l(2)gl gene is required for Drosophila development and a mutation of the 
gene results in a neoplastic overgrowth of the imaginal discs during embryogenesis 
(Bryant and Schmidt, 1990).  The l(2)gl gene functions by altering cell adhesiveness and 
is required for cell shape remodeling of epithelial cells and regulation of cell polarity 
(Manfruelli et al., 1996; Strand et al., 1994; reviewed in Humbert et al., 2003).  Both the 
Drosophila l(2)gl  and its human homolog have been shown to act as a component of the 
cytoskeletal network (Strand et al., 1994; Kalmes et al., 1996), where they function to 
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traffick proteins in signaling pathways in regulation of polarity and organization 
(Manfruelli et al., 1996; Plant et al., 2003; Yamanaka et al., 2003).  The role of the 
murine mgl-1 (also refered to as mlgl) in the regulation of cell polarity has also been 
studied, although it was not found to associate with the cytoskeletal network (Müsch et 
al., 2002).   
2.9.3  Cell Signaling 
There are several candidate downstream targets of Hox genes that are involved in 
signal transduction pathways regulating processes such as apoptosis, cell differentiation, 
cell proliferation and migration.  An important family of signaling molecules is the 
receptor tyrosine kinases (RTK), which are involved in the regulatory network that 
control multiple aspects of hindbrain development.  Upon ligand binding, the 
intracellular domain of these receptors is activated, resulting in autophosphorylation of 
specific tyrosine residues that subsequently initiates an intracellular signaling cascade 
(discussed in Taneja et al., 1996).   
Ephrin (Eph) receptors are an Ig CAM subfamily of the RTKs that are expressed 
much like Hox genes in characteristic rhombomeric specific patterns in the hindbrain 
(Taneja et al., 1996).  Eph receptors and their membrane bound ligands, ephrins, display 
complementary expression patterns during development (Gale et al., 1996), i.e. they are 
expressed in odd and even numbered rhombomeres in zebrafish embryos (Xu et al., 
1999).  This dynamic expression pattern implicates the Eph receptors and ephrins as 
being important factors in regulating embryonic patterning during development by 
maintaining cell restrictions (Gale et al., 1996; reviewed in: Coulthard et al., 2002; 
Tepass et al., 2002).  This is particularly evident in the developing hindbrain, where 
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bidirectional signaling mediated by both Eph receptors and their ligands inhibited 
intermixing of neuroepithelial cells at the rhombomeric boundaries (Mellitzer et al., 
1999; reviewed in Lumsden, 1999).  Although the precise function(s) of Eph receptors 
has not yet been determined, they are believed to restrict cell intermingling through 
repulsive cell-cell interactions much like cell adhesion molecules (reviewed in Xu et al., 
2000).  They have also been shown to regulate cell adhesion through interactions with 
integrin molecules in the regulation of the cytoskeleton (reviewed in Juliano, 2002).    
Hoxa1, Hoxb1 and the EphA2 receptor gene are all coordinately expressed in the 
primitive streak during gastrulation, where Hoxb1 and EphA2 expression is restricted to 
r4 (Chen and Ruley, 1998).  Additionally, several Hox-Pbx bipartite sites within an r4 
specific enhancer of EphA2 were identified that are capable of mediating transactivation 
only in the presence of HOXA1-Pbx1 and HOXB1-Pbx1 heterodimers (Chen and Ruley, 
1998).  Furthermore, Hoxa1/Hoxb1 double knockout mice exhibited decreased EphA2 
expression, providing additional evidence that EphA2 could be directly regulated by Hox 
transcription factors (Studer et al., 1998; Gavalas et al., 1998).   
Studies using Hoxa2 null mice revealed a rhombomere specific alteration in 
expression of another Eph family member, MDK1/EphA7 (Taneja et al., 1996).  These 
mice displayed a selective lack of MDK1 expression in r3, in addition to an alteration of 
its normal expression pattern in other rhombomeres.  Although direct regulation of 
MDK1 by Hoxa2 has not been determined, further examination of Eph receptor 
regulation in the developing hindbrain may result in the identification of several 
downstream targets of Hox genes. 
  45
 Another candidate target gene is the Purkinje cell-specific pcp-2(L7) gene, which 
is involved in modulating the G protein signaling pathway (Zhang et al., 2002; Redd et 
al., 2002).  Specifically, pcp-2 affects GDP binding of the alpha G proteins, Go and Gi 
(Luo and Denker, 1999; Natochin et al., 2001).  These heterotrimeric G proteins regulate 
both cellular and transcription machinery, and can activate various ion channels.  They 
induce transcription factor activity via signal transduction pathways such as the Src and 
Ras pathway, thereby directing cell processes specifically involved in embryogenesis 
(reviewed in Neves et al., 2002).  Several Hox consensus binding sites (5' TAAT 3') are 
present within the proximal promoter of the pcp-2 gene, which is comprised of a short 
regulatory element (L7ATE) found to be required for normal cerebellar expression 
(Sanlioglu-Crisman and Oberdick, 1997).  Most homeodomain proteins can bind these 
sites in vitro, however HOXA5 and HOXB7 were capable of specific synergistic 
transactivation of reporter genes mediated by the L7ATE in cell culture (Sanlioglu et al., 
1998).  Although HOXA5 and HOXB7 are not expressed in the developing cerebellum, 
both factors are enriched in adult Purkinje cells.  Transgenic analysis did however, 
indicate a negative regulatory effect on the pcp-2 gene by the homeobox protein 
Engrailed-2 (EN-2) (Oberdick et al., 1993).  Hence, a potential biphasic regulatory 
mechanism is in effect whereby expression of the pcp-2 gene is repressed in embryonic 
cerebellar Purkinje cells by the En proteins, followed by initiation and maintenance of 
expression postnatally by Hox proteins (Sanlioglu et al., 1998).  The function of pcp-2 in 
development is not well understood, although postnatally this regulatory molecule may 
play a role in synaptogenesis and dendritic growth within the cerebellum (Zhang et al., 
2002; Redd et al., 2002).  
  46
Rap1 is a member of the small GTPase Ras superfamily that is involved in signal 
transduction, which like Ras is active in its GTP bound form.  Although its function is 
not entirely understood, Rap1 is known to antagonize Ras signaling of the ERK/MAPK 
(extracellular signal regulated kinase/ mitogen activated protein kinase) pathway (Cook 
et al., 1993; Hu et al., 1997).  However, Rap1 is also involved in the activation of the 
MAPK pathway by regulating the activity of B-Raf (York et al., 1998).  In neuronal 
cells, consecutive stimulation of Ras and Rap1 results in a biphasic activation of the 
MAPK pathway (York et al., 1998; Bouschet et al., 2003).  Rap1 is involved in brain 
development, where it is believed to contribute to neuronal differentiation through the 
MAPK pathway (Bouschet et al., 2003).  It is also involved in the regulation of the 
cytoskeletal network through interactions with integrin (Ohba et al., 2001; reviewed in: 
Bos et al., 2001, 2003).  In mice, transient expression of Rap1 is observed within the 
developing CNS (Kehrer-Sawatzki et al., 2002) whereas in Xenopus, XRap1 displays 
restricted expression within the presumptive forebrain and midbrain during 
embryogenesis (Morsi El-Kadi et al., 2002).  Hoxb4 and XRap1 display complementary 
patterns of expression during embryogenesis and XRap1 was isolated as a putative 
Hoxb4 downstream target by differential display (Morsi El-Kadi et al., 2002).  In vivo, 
the repression of XRap1 transcription was mediated by DNA binding of Hoxb4 to the 
XRap1 regulatory sequence that is present within the 3´ UTR (Morsi El-Kadi et al., 
2002).  
2.9.4  Protease Inhibitors 
Proteases and their cognate inhibitors have highly diversified modes of action 
that regulate basic cellular processes.  Proteases can activate or degrade structural and/or 
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functional proteins involved in various signaling pathways regulating processes such as 
cellular communication, apoptosis, differentiation and cell growth (reviewed in: Seidah 
and Chretien, 1997; McFarlane, 2003; Marks and Berg, 1999; Ye and Fortini, 2000).  
Hence, proteases and their endogenous inhibitors play a role in regulating cellular 
mechanisms that are important for embryonic morphogenesis (discussed in: LeMosy et 
al., 1999; Ye and Fortini, 2000; Brachmann and Cagan, 2003).  
Members of the serpin family of serine protease inhibitors are found in a variety 
of tissues and organisms (reviewed in Gettins, 2002).  Serpins are expressed in the 
developing and adult brain and are believed to play a role in the development and 
plasticity of the nervous system (reviewed in: Turgeon and Houenou, 1997; Smirnova et 
al., 1994).  The serpin SPI3 was isolated in vivo as a candidate downstream target of 
Hoxb5.  It was identified by immunoprecipitation of Hoxb5 bound to DNA chromatin 
prepared from embryonic mice hindbrain tissue (Safaei, 1997).  Interestingly, 
overlapping domains of SPI3 and Hoxb5 expression were observed in the brain and the 
developing mouse embryo.  Furthermore, in vitro binding studies indicated that Hoxb5 
recognizes specific elements within the SPI3 promoter, although their transactivation 
potential was not evaluated.  Recently in the adult brain, SPI3 was found to interact with 
neuropsin, a serine protease that may be involved in synaptic plasticity (Kato et al., 
2001).  
2.9.5  Transcription Factors  
Perhaps the most characterized targets of Hox gene products are genes encoding 
transcription factors.  This is in part due to the high degree of Hox gene auto and 
crossregulation (Gould et al., 1997; Hooiveld et al., 1999; Jacobs et al., 1999; Kwan et 
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al., 2001; Manzanares et al., 2001; Maconochie et al., 1997; Packer et al., 1998; Pöpperl 
et al., 1995; Yau et al., 2002; Zhang et al., 1997a).  Regulatory interactions between the 
Hox proteins and other homeodomain encoding genes are also quite common, as has 
been observed in the regulation of Otx during development of the brain.  The Otx 
homeobox genes are vertebrate homologs of the Drosophila orthodenticle (otd), and 
their role in specification of the rostral CNS is well documented (reviewed in Simeone 
and Acampora, 2001).  The Otx family members exhibit spatially restricted expression in 
the forebrain and midbrain region at the cerebellar-r1 boundary, but are absent in the 
rhombomeric hindbrain where the anterior Hox genes are expressed (reviewed in 
Rubenstein and Puelles, 1994).  Hindbrain expansion occurs by induction of the anterior 
Hox genes coupled with severe repression of Otx expression in anterior brain structures 
indicating the presence of a crossregulatory mechanism (Simeone et al., 1995).  The 
regulatory pathway of both Otx and Hox gene transcription is responsive to RA 
gradients, which initiate Hox gene expression while at the same time repressing Otx 
expression. This results in mutually exclusive boundaries of expression for Otx2 and 
Hox in the developing brain (Guazzi et al., 1998).  It has been postulated that RA 
controls the restricted boundaries of expression of both the Hox and Otx genes by 
crossregulatory mechanisms, which would contribute to the mutually exclusive 
expression of the two gene families early on in brain development.  The 5´ flanking 
genomic sequence of Otx2 contains negative regulatory elements responsive to RA, and 
this same regulatory sequence was recognized differentially at multiple sites in vitro by 
the anterior Hox genes (HOXB1, HOXB2, HOXB3).  However, transactivation and not 
repression of Otx2 expression was observed in vitro in the presence of the anterior Hox 
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genes.  This activity did not extend to the more posterior Hox genes (HOXC6 and 
Hoxd8), whereas transactivation can be replicated with HOXD3.  Therefore, activation 
of Otx2 transcription appeared to be a characteristic of the Hox proteins in Hox paralogs 
1-3 (Guazzi et al., 1998).  Although the stability of Hox binding is dependent on the 
presence of nuclear cofactors, the identity of these factors has not been determined.  
Hence, Hox genes do not appear to fit the role of Otx repressors as previously believed, 
but perhaps function in conjunction with RA to refine the early developmental 
boundaries of Otx expression. 
The Iroquois (Irx) genes encode TALE homeodomain proteins and like the Hox 
genes are expressed in early development (Bosse et al., 2000; Cohen et al., 2000).  They 
function in establishing the midbrain-hindbrain boundary (Glavic et al., 2002) and in 
neuronal specification of cells within the neural tube (Briscoe et al., 2000).  Recently, 
the Irx5 homeobox gene was identified as a direct downstream target of Hoxb4 (Theokli 
et al., 2003).   In the developing murine CNS, Irx5 expression displayed dorsoventral 
patterning within the midbrain, hindbrain and along the spinal cord (Cohen et al., 2000).  
Irx5 and Hoxb4 display overlapping patterns of expression in the developing CNS in 
both mice and Xenopus (Graham et al., 1988; Wilkinson et al., 1989; Cohen et al., 2000; 
Theokli et al., 2003), and upregulation of Xenopus Irx5 transcription by Hoxb4 has been 
shown to be independent of protein synthesis and therefore likely involves a direct 
interaction (Theokli et al., 2003).  
The GATA2 and GATA3 genes are the only members of the GATA family of 
transcription factors expressed in the CNS (Kornhauser et al., 1994).  Both GATA2 and 
GATA3 have been implicated in specification of neural subtypes during development 
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(Karunaratne et al., 2002).  In the spinal cord and hindbrain these genes are expressed in 
spatially restricted domains similar to that of the Hox genes (Pata et al., 1999; 
Karunaratne et al., 2002).  GATA3 expression is particularly prominent in r4 (Nardelli et 
al., 1999; van Doorninck et al., 1999), exhibiting overlapping domains of expression 
with Hoxb1.  An analysis of GATA3 null mutant mice showed the presence of similar 
abnormalities to that of Hoxb1-/- mice, both demonstrating defects in r4-derived motor 
neurons.  Furthermore, Hoxb1 null mutants displayed a loss in expression of GATA2 and 
GATA3 in the ventral r4.  Hence, GATA3 appears to be a downstream effector of Hoxb1, 
although it is not known whether the mode of action for this regulation is direct (Pata et 
al., 1999).  It is interesting to note that many "dispersed" homeobox genes and some Hox 
genes are regulated by other GATA members in developmental systems other than the 
CNS (Vieille-Grosjean and Huber, 1995; Searcy et al., 1998).  Crossregulation between 
Hox and GATA genes may potentially play a role in the genetic pathways of Hox 
mediated morphogenesis. 
2.9.6 Norepinephrine Transporter Gene (NET)  
The norepinephrine transporter (NET) gene is expressed in the noradenergic 
neurons in many regions of the CNS and peripheral nervous system (PNS) (reviewed in: 
Hoffman et al., 1998; Amara, 1995; referenced in Kim et al., 2002), where it mediates 
norepinephrine reuptake into the presypnaptic nerve endings (Axelrod and Kopin, 1969). 
In early embryonic development NET is distributed in a wide range of neuronal and non-
neuronal tissues (Sieber-Blum and Ren, 2000). NET is believed to have additional 
functions such as specification of the neuronal norardrenergic phenotype, as well as the 
differentiation of neural crest stem cells into sympathetic neurons (Zhang and Sieber-
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Blum, 1992; Zhang et al., 1997b; Renn et al., 2001; Kim et al. 2002).  Hoxa5 has been 
shown to recognize a HBS sequence within the promoter of the human (h) NET gene in 
vitro, through which it transactivates expression of a reporter gene (Kim et al., 2002).  In 
vitro binding and transfection experiments indicated that this HBS sequence played a 
critical role in directing noradrenergic cell specific expression of hNET.  Hence, Hoxa5 
in addition to other factors may contribute to the specification of noradrenergic neurons 
within the CNS and PNS through regulation of the NET gene (Kim et al., 2002). 
2.10 Mechanisms of Auto, Cross, and ParaRegulation of Hox Genes in the             
Developing Mouse Hindbrain and Spinal Cord 
 
 Many of the potential direct targets initially identified for Hox proteins in both 
Drosophila and vertebrates were found to be Hox genes themselves.  Many auto and 
crossregulatory loops involved in controlling Hox gene expression of paralogs 1-4 in the 
developing hindbrain have been characterized.  In particular, rhombomere restricted 
expression of Hox genes driven by neuronal enhancers have been well characterized for 
the anterior Hox genes. 
2.10.1  Hoxb1 Autoregulatory Enhancer (b1-ARE) 
Experiments using transgenic animals initially indicated that both Hoxa1 and 
Hoxb1 function to specify r4 restricted expression of Hoxb1 early in development (7.5-
8.5 dpc.).  However, Hoxb1 is vital in the maintenance of this expression in later stages 
of development (Studer et al., 1996, 1998).  A highly conserved neuronal enhancer (b1-
ARE) was identified and found to consist of three Hox-Pbx bipartite consensus motifs 
(Knoepfler et al., 1996).  This b1-ARE was determined to be responsive to Hoxb1 
expression by transgenic analyses (Pöpperl et al., 1992, 1995), indicating the presence of 
a positive autoregulatory feedback mechanism for regulation of Hoxb1 expression in r4.  
  52
Transfection and in vitro binding experiments showed that although Hoxb1 is necessary 
to mediate b1-ARE activation, it alone is not sufficient for the initiation of transcription.  
Therefore, the activity of this neuronal enhancer is dependent on the presence of either 
cofactors of Hoxb1, or crossregulation by other Hox proteins.     
The DNA-binding selectivity of Hoxb1 for the r4 enhancer is determined by 
cooperative recognition of the b1-ARE by heterotrimeric complexes consisting of Pbx 
and Meis/Prep proteins (Pöpperl et al., 1995, Di Rocco et al., 1997; Berthelsen et al., 
1998a. b; Jacobs et al., 1999; Shanmugam et al., 1999; Fognani et al., 2002).  Both Prep1 
and Prep2 have been found to directly interact with the HOXB1-Pbx complex through 
association with Pbx, and did not require DNA binding by the Meis-related factors or 
direct interaction between the Hox and Meis protein (Berthelsen et al., 1998a, b; Fognani 
et al., 2002).  The effect of each Prep factor on the activity of HOXB1-Pbx1 is very 
different with regard to the b1-ARE.  The presence of Prep1 within the ternary complex 
stimulates transcription, and HOXB1 is an essential factor for activation by this complex 
(Figure 2.4) (Berthelsen et al., 1998).  In contrast, the presence of Prep2 has an 
inhibitory effect on b1-ARE directed expression by HOXB1-Pbx (Fognani et al., 2002).  
Whether this differential behavior of Prep proteins is due to distinct abilities in 
stabilizing Hox-Pbx complexes on DNA, or due to an absence of a transactivation 
domain is not yet clear (Fognani et al., 2002).  It is therefore apparent that the diversity 
of Hox gene function can be enhanced through protein-protein interactions with other 
proteins in a DNA specific manner. 
Meis1 has also been identified as a cofactor within timeric complexes involving 
Hoxb1, but in a DNA binding dependent mechanism (Jacobs et al., 1999).  A distal Meis 
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Figure 2.4  Hox, Pbx and Prep interaction on the b1-ARE 
Complexes of Hox/Pbx and Meis proteins that are involved in autoregulation of Hoxb1, 
crossregulation of Hoxb2, and the regulatory mechanism involved in controlling the R3 
Hox-Pbx site in the b1-ARE.  Ternary complex formation and HOXB1-Pbx interaction 
resulted in the activation of Hoxb1 transcription via the b1-ARE enhancer.  This activity 
is dependent on the DNA binding activity of both Hox and Pbx proteins, but not for 
Meis/Prep.  (Taken from Berthelsen et al., 1998a with permission: 
http://www.nature.com/) 
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site in relation to the Hox-Pbx recognition sequence present within the b1-ARE results in 
trimeric association of all three proteins (Figure 2.5).  For enhanced transcription to 
occur DNA binding by all three proteins must occur since a mutation in the Meis binding 
site phenocopies the effects of mutations in the Pbx-Hox site on reporter gene expression 
within the hindbrain.  The flexible amino terminal arms of the Meis and Pbx proteins 
interact, leaving their homeodomains relatively free to bind consensus sequences 
positioned in various configurations.  This is vital in enabling the Hox-Pbx heterodimer 
to fulfill the stringent half site requirements for DNA binding and association, while 
simultaneously permitting trimeric complex formation with Meis (Jacobs et al., 1999). 
In addition to autoregulation by Hoxb1, the b1-ARE is selectively activated and 
recognized in vitro only by members of Hox paralog groups 1 and 2 (HOXA1, HOXB1, 
HOXB2), reflecting their ability for differential recognition of enhancers through 
cooperative binding with modulatory proteins (Di Rocco et al., 1997).  Cooperative 
binding of these Hox paralogs with Pbx1/PBX1 to an intact bipartite consensus sequence 
within the b1-ARE is required for stable in vitro binding by Hox/HOX proteins, as well 
as transactivation (Pöpperl et al., 1995; Di Rocco et al., 1997).  This is also evident in 
vivo where Hoxa1 transgenic mice displayed ectopic patterns of Hoxb1 expression only 
in select regions of the hindbrain (r1/2), indicating that other components are required 
for permissiveness of the b1-ARE for pararegulatory control (Zhang et al., 1994).  
Genetic analyses suggest that Hoxa1 plays a role in activation of the r4 enhancer early 
on in development, although it is not exclusively required for initiation of Hoxb1 
expression nor is it involved in maintenance of this expression in later stages of 
development (Studer et al., 1998).  
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Figure 2.5 Trimeric interactions of homeobox proteins on hindbrain specific 
enhancers. 
Schematic representation taken from Jacobs et al. (1999) with permission 
(http://www.journals.asm.org/), which depicts the association of Hox, Pbx and Meis 
trimeric complexes on various enhancers.  Two contrasting proposals of trimeric 
complex formation: those in which the Meis/Prep protein is tethered to the DNA via 
protein-protein interactions, and the other involves DNA recognition by all 
components of the complex. 
 
 
 
 
 
 
 
M=Meis; Pr=Prep1; H=Hox; P=Pbx
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Further cell-specificity of the Hox gene function was observed when using mouse 
and human embryonic carcinoma (EC) cells in studying the transactivation potential of 
the b1-ARE (Di Rocco et al., 2001).  These cells are originally derived from germ cell 
tumors, retaining many characteristics of the primitive neuroectodermal cells, such as the 
potential for neuronal differentiation and activation of all Hox clusters upon retinoic acid 
treatment (discussed in Di Rocco et al., 2001).  Transactivation through the b1-ARE by 
both HOXA1 and HOXB1 proteins with PBX as a cofactor is in most cell types quite 
similar for both proteins.  In EC cells a differential ability in transactivation between 
these HOX proteins was observed, with HOXA1-PBX1 activation being definitively less 
efficient with regard to the b1-ARE and highly dependent on the presence of a 
SOX/OCT bipartite sequence (Di Rocco et al., 2001).  Therefore, the presence of cell 
specific/enriched factors that recognize this consensus must play a role in the 
stability/activity of the Hox-Pbx complex.  Accordingly, an analysis of transgenic mice 
has demonstrated that recruitment of these Sox and Oct proteins to the b1-ARE are 
necessary for efficient transactivation by Hoxa1.  Therefore, in vivo Hoxb1 is more 
readily capable of initiating and maintaining expression in the r4 via the b1-ARE relative 
to Hoxa1, and hence is absolutely necessary for maintaining r4 identity. 
A less consistent finding is the effect of the interaction of Hox proteins with 
histone acetyltransferases (HATs) and histone deactelyases (HDACs) as coregulators of 
transcription.  Both enzymes are chromatin modifiers, capable of enhancing repression 
or activation of transcription.  HATs establish local chromatin structure that is 
permissive for events leading up to transcription by acetylation of the NH2-terminal tails 
of histones within nucleosomes.  Conversely, deactylation of these tails by HDACs 
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results in stabilization of chromatin higher order folding.  This results in obstruction of 
access by the transcription machinery to their regulatory targets, resulting in repression 
of transcription (reviewed in Horn and Peterson, 2002).    
Hox-Pbx complexes can act as repressors or activators of transcription by 
association with corepressors and coactivators, implying that cell signaling is a direct 
determinant of Hox-Pbx function in embryonic patterning during development (Saleh et 
al., 2000).  Hoxb1-Pbx dimers have been shown to recruit HDACs to the b1-ARE 
resulting in repression of transcription.  Cell signaling due to aggregation of cells or by 
the protein kinase A (PKA) pathway switches activity of this complex to activation of 
transcription (Saleh et al., 2000).  Transcription can also be regulated by the cyclic AMP 
pathway, which has been shown to mediate these signaling effects via the PKA pathway 
and by a well-characterized HAT, CBP/p300.  The activation domain of Hoxd4 recruits 
CBP/p300 to its Hox-Pbx complex resulting in a shift from repression to activation 
(Figure 2.6) (Saleh et al., 2000).  This model is however disputed by others since 
representatives from all Hox paralog groups exhibited binding with CBP/p300, resulting 
in disruption of Hox-DNA binding (Shen et al., 2001).  Despite the presence of Pbx, 
addition of CBP/p300 to the Hox protein did not result in transcription of a reporter 
gene.  Also, a general mechanism of transcriptional repression is proposed whereby 
interactions of Hox proteins with CBP/p300 block the activity of these HATs, thus 
repressing transcription in a non-DNA dependent manner (Shen et al., 2001).  The 
previous findings of Hoxd4-Pbx interactions by Saleh et al. (2000) could not be 
duplicated, even though similar cell-types and genetic constructs were used in 
experimentation.  This is perhaps due in part to differences in orientation, number of, or 
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Figure 2.6  Model for activation and repression of transcription by Hox-Pbx 
Figure A: A schematic diagram shows how intramolecular contacts between the AD 
(activation domain) and homeodomain block access of other regulatory factors to the 
Hox protein.  Hox protein interacts with Pbx via the conserved hexapeptide motif 
disrupting intramolecular contacts to free the N-terminus domain to associate with other 
factors. Figure B: A model for activation and repression of transcription by Hox-Pbx 
complexes (taken from Saleh et al., 2000 with permission from American Society for 
Microbiology: http://www.journals.asm.org/).  Corepressors (HDAC) and coactivators 
(CBP) are able to interact with the AD and/or RD (repressor domain) of the Hox-Pbx 
dimer.  In response to PKA signaling, either an increase in coactivator function and/or 
decrease in corepressor activity occurs resulting in a shift from a net repression of 
transcription to a net ability to initiate activation. 
A
Represents the conserved 
hexapeptide motif  within the  
N-terminal arm of the homeodomain that 
mediates contact with Pbx. 
AD
The N-terminus with an activation 
domain for Hox proteins and a 
repression domain for Pbx. 
The homeodomain is depicted by a closed 
black box that is attached to the activation 
domain by its N-terminal arm 
 
B
HOX
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distance between bipartite sequences used for the studies that resulted in varying effects 
on transcription in each study.  Therefore, it is possible that in an enhancer and cell-
specific context, both types of HDAC-Hox interactions are possible. 
2.10.2  Hoxb2 Neuronal Enhancer (b2-r4) 
Expression analyses of transgenic mice for the labial class of Hox genes have 
identified an in vivo neuronal enhancer responsible for r4 expression of Hoxb2 that was 
activated by Hoxa1 and Hoxb1 proteins, but was not autoregulated (Maconochie et al., 
1997).  Although the Meis binding site within the b1-ARE was not found to be essential 
in vivo, the Hoxb2 enhancer absolutely requires Meis binding in addition to the Hox-Pbx 
heterodimer for initiation of Hoxb2 r4 specific expression by a ternary complex (Figure 
2.7) (Ferretti et al., 2000).  This is perhaps due to the presence of only a single Pbx-Hox 
(PH) and Pbx-Meis (PM) element in the b2-r4.  These elements have also been identified 
in several species (Scemama et al., 2002), where interference with either element 
resulted in the total abolishment of activity.  The presence of a single PH and PM 
element is contrary to the multiple PM and PH motifs found in the b1-ARE.  While the 
specific Meis family member involved in this regulatory complex has not been defined, 
both Prep1 and Meis1 were shown to interact with Pbx in the regulation of Hoxb2 
(Ferretti et al., 2000; Waskiewicz et al., 2001).  The Meis family of proteins potentially 
has two critical functions during vertebrate hindbrain patterning; that of a DNA bound 
Hox partner, and as a Pbx stabilizing factor.  Either Prep1 or Meis1 are candidates for 
Hoxa1 and Hoxb1 mediated regulation of Hoxb2, since both proteins are present in the 
hindbrain during critical developmental stages and their expression coincides with the 
Hox paralogs 1-4 during segmentation (Ferretti et al., 1999; Waskiewicz et al., 2001). 
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Figure 2.7  Schematic representation of homeodomain complexes on PH and PM 
sites. 
In figures A and B a single PH (Pbx-Hox) site is bound by Prep-Pbx dimers, which may 
hinder ternary complex formation with Hoxb1.  Removal of the HD (homeodomain) of 
Prep1 allows dimerization of Hoxb1 and Pbx (B).  In figure C, a Prep-Pbx dimer will 
preferentially form on the PH site (A & C), however in the presence of an additional PM 
(Pbx-Meis) site it is possible for Hoxb1 to displace the Meis factor from the PH site 
(figure D).  This results in ternary complex formation, where all three factors bind DNA 
(D). (Taken from Ferretti et al., 2000 with permission from The Company of Biologists 
Ltd., http://www.biologists.com/) 
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2.10.3  Hoxb3 Element IIIa 
Three major regulatory elements have been characterized that determine Hoxb3 
expression in the developing mouse hindbrain and spinal cord.  Each element has a 
specific effect on the expression of Hoxb3 within different domains of the neural tube 
(Kwan et al., 2001).  The first element is the Hoxb3 and Hoxb4 intergenic late neuronal 
enhancer that is responsible for directing expression up to the r6/r7 boundary (Morrison 
et al., 1997; Gould et al., 1997, 1998).  The second element, IIIa, involves 
auto/crossregulation of Hoxb3 expression at the r5/r6 boundary (Kwan et al., 2001; Yau 
et al., 2002) and the third element (IVa) involves kreisler dependent regulation of Hoxb3 
expression in r5 (Manzaneres et al., 1997, 1999a, b). 
In vivo, the Element IIIa was shown to direct expression of Hoxb3 to the r5/r6 
interface in the hindbrain and also the anterior spinal cord (Kwan et al., 2001).  The 
activity of this element was dependent on the presence of a minimal enhancer consisting 
of two consensus Hox binding sites (Yau et al., 2002).  These consensus sequences are 
recognized in vitro by Hoxb3 and Hoxb4, and mutation of the sequences indicated that 
they are required in vivo for Hoxb3 expression within the neural tube (Yau et al., 2002).  
Interestingly, neural crest cells migrating from the same neural domain of Hoxb3 
expression were not dependent on these homeodomain binding sequences (HBS) and 
hence require separate elements. 
2.10.4  Hoxb3 and Hoxb4 Late Neuronal Enhancer Element (Late NE) 
Both Hoxb3 and Hoxb4 share overlapping expression patterns, with a common 
rhombomeric boundary at r6/7 (Wilkinson et al., 1989).  In transgenic mice, this was 
shown to be controlled by an intronic neuronal enhancer present at the 3´ end of Hoxb4 
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(Gould et al., 1997).  The conserved element within this enhancer (CR3) is composed of 
a Hox-Pbx recognition site that is bidirectional in nature.  Additionally, no boundary or 
insulator elements have been identified within this enhancer; it is therefore not restricted 
in activity to only one Hox promoter.  In vitro DNA binding studies and analysis of 
transgenic mice demonstrated a regulatory requirement for multiple Hox proteins 
(including Hoxb4), with proteins from Hox paralog groups 4-6 displaying activation of 
transcription by the CR3 (Gould et al., 1997).  Analyses in mice using reporter gene 
assays have shown that the Late NE is able to impose an r6/7 boundary of expression for 
both Hoxb4, and also for Hoxb3 where it acts coordinately with its promoter. 
In transgenic mice, dissection of the regulatory regions that determine Hoxb4 
expression in the CNS indicated that the late NE was responsible for maintaining the 
r6/7 boundary of Hoxb3 expression during segmentation, although its expression is 
initiated by a pre-rhombomeric enhancer (Early NE) (Gould et al., 1998).  Therefore, the 
mechanism by which Hoxb4 expression is regulated during the establishment and 
maintenance phases is initially by induction of the Early NE via paraxial mesoderm 
signals.  Maintenance of Hoxb4 expression at the r6/7 boundary is mediated by auto and 
crossregulatory Hox feedback loops. 
Although an autoregulatory element for Hoxd4 that is positively regulated by 
Hoxd4 in EC cells has also been identified (Pöpperl and Featherstone, 1992; Zhang et 
al., 1997a), in vivo this Hox responsive element did not appear to be essential for 
neuronal specific expression (Morrison et al., 1997).  It is possible that this conserved 
autoregulatory enhancer might increase specificity or activity of the downstream 
mesodermal and neuronal enhancer; especially considering that this Hoxd4 ARE is also 
  63
found in humans and Xenopus.  Additionally, ectopic Hoxd4 expression in Xenopus 
resulted in autoregulatory transactivation (Hoovield et al., 1999).  Further studies are 
necessary to evaluate the precise role that autoregulation may play in the maintenance of 
Hoxd4 expression in hindbrain development. 
2.10.5  Hoxa2 Autoregulation, r2 Specific 3′ Enhancer 
 In later stages of development the expression of Hoxa2 within the rostral somites 
and in r2 of the hindbrain is directed by an enhancer sequence located at the 3′ end of 
Hoxa2 (Frasch et al., 1995; Ren et al., 2002).  Recently, a 10 bp Hox/Pbx binding 
element located within this enhancer was identified and is referred to as the E2-ARE 
(Lampe et al., 2004).  Hoxa2/Pbx1a/Prep1 mediated activation of the E2-ARE in vitro, 
and this activity was shown to require DNA binding by Hoxa2.  This enhancer sequence 
was also present in the zebrafish and human Hoxa2 gene (Lampe et al., 2004). 
2.10.6  Hoxa3 Conserved r5/r6 5′ Enhancer 
In r5-6, expression of Hoxa3 and Hoxb3 is initiated by the kreisler transcription 
factor but in later stages of development Hoxa3 expression is maintained by conserved 
auto/crossregulatory mechanisms (Manzanares et al., 2001).  The regulatory enhancer 
responsible for Hoxa3 expression consisted of two Hox-Pbx binding motifs, HOX/PBC-
A and HOX/PBC-B that were essential in vivo and in vitro for enhancer activity.  
Although these Hox-Pbx bipartite sites are similar to those identified in enhancers of 
Hoxb1/b2 and Hoxb4, the reporter genes under the control of HOX/PBC-A demonstrated 
a distinctive r5-6 expression pattern unlike the r6/7 and r4 expression pattern observed 
for studies using the b1-ARE and b2-r4 bipartite sequences.  Therefore, subtle 
differences in the bipartite sites can result in establishment of dramatically different 
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expression domains in vivo (Manzanares et al., 2001).  Hence, minor alterations in the 
binding motifs of various Hox responsive enhancers in vitro may represent a striking 
difference in selectivity/ability of these motifs to recruit cofactors to the transcription 
complex.  These protein-protein interactions are then ultimately responsible for 
determining restriction of target expression by Hox genes in a cell- and tissue-specific 
manner. 
Analogous to the Hox responsive elements involved in mediating Hoxb1 and 
Hoxb2 expression, a proximal Prep/Meis binding site is present relative to the 
HOX/PBC-B site of the Hoxa3 enhancer.  In vivo and in vitro studies have shown that of 
Hoxa3 regulation by trimeric complexes of Hox-Pbx-Meis/Prep proteins occurs through 
recognition of their binding sites found within the r5-6 enhancer.  All Hox paralogs in 
group 3, in conjunction with Pbx1, are capable of recognizing this enhancer in vitro.  In 
contrast to the Hoxb2 r4 enhancer, both the b1-ARE and the Hoxa3 element did not 
essentially require Meis/Prep binding for transactivation in vivo.  This is most likely a 
direct consequence of the presence of several HBS within the b1-ARE and Hoxa3 r5/r6 
enhancer, compared to the single Hox binding motif found in the Hoxb2 r4 enhancer 
(Ferretti et al., 2000; Manzanares et al., 2001).  
2.10.7  Hoxa4 Autoregulatory Region 
Potential Hox binding sites are present within both the promoter and intron of 
Hoxa4 (Behringer et al., 1993; Wu and Wolgemuth, 1993), with both regulatory regions 
exhibiting in vitro binding by Hoxa4 and the Drosophila transcription factor fishu tarazu 
(ftz) (Wu and Wolgemuth, 1993).  Although ftz mediated transactivation of reporter 
genes driven by the Hoxa4 consensus sequences from these regulatory regions, Hoxa4 
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itself was unable to activate transcription.  However, in vivo binding of Hoxa4 to the 
consensus sites did occur and resulted in disruption of ftz-potentiated transcription.  This 
inhibitory effect on ftz activity by Hoxa4 is dependent on DNA binding since it requires 
the presence of an intact homeodomain (Wu and Wolgemuth, 1993).  In the spinal 
ganglion and neural tube, the activity of this regulatory region was severly decreased in 
Hoxa4 null mutants.  Taken together, the results of both in vitro and in vivo studies 
indicate that Hoxa4 is unable to initiate its own expression (Wu and Wolgemuth, 1993).  
However, studies on the induction of Hoxa4 expression by RA indicated that an 
autoregulatory loop is required for maintenance of this expression in some areas of the 
CNS (Packer et al., 1998).  It is therefore possible that Hoxa4 potentially plays a role in 
maintenance but not initiation of its expression, although further studies using transgenic 
mice are necessary to determine the mechanism underlying the activity of these 
elements. 
Other instances of potential cross/para/autoregulation have been observed 
(Friedman-Einat et al., 1996; Vigano et al., 1998), but not in the context of their role in 
vivo during development.  Nevertheless, these studies do contribute to information 
concerning the functional cooperativity of Hox proteins with other factors, and their 
importance in the transcription activity of a particular complex.  Domain-swapping 
experiments have demonstrated the necessity of performing experiments in a 
biologically relevant system.  Specifically, these proteins should be studied in the 
appropriate context; in their native conformation on a natural homeodomain target and in 
the presence of appropriate cofactors.  Otherwise it is highly likely that the activity of a 
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Hox protein will be misinterpreted due to the highly specialized manner in which they 
appear to function. 
2.11  Conclusion 
 Many common characteristics are observed for the Hox genes, such as their 
conserved structure, organization and the presence of spatial and temporal restricted 
patterns of expression during embryogenesis.  In addition, interaction of Hox proteins 
with their cofactors, such as Pbx and Meis, is conserved in several species.  Little 
information exists regarding the interactions of Hox proteins with their cofactors on 
downstream targets.  However, their coordinated actions in various auto and 
crossregulatory mechanisms have been well described.  It is therefore likely that various 
cofactors play an important role in contributing to the actions of Hox proteins in the 
regulation of specific molecular pathways.   
Hox genes are expressed in a variety of embryonic tissues and are known to 
function in developmental processes such as limb morphogenesis and skeletogenesis.  In 
the early neural tube, Hox expression is highly restricted, particularly within the 
rhombomeric boundaries of the hindbrain.  The role of Hox genes as critical 
morphogenetic regulators in the development of the vertebrate hindbrain is well 
documented.  Analyses using Hox mutants have determined that Hox genes have 
important roles in the specification of neuronal networks within the developing spinal 
cord and hindbrain, but this has not clearly defined their role in determining 
rhombomeric identity.  
Deciphering the precise genetic pathways of individual Hox genes by disrupting 
their function in vivo has not been entirely successful due to functional redundancy. 
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Understanding the precise regulatory mechanisms through which Hox genes achieve 
morphological control during development will require the identification of their 
downstream target genes.  Hox genes are believed to be required for segmentation of the 
hindbrain and specification of rhombomeric identity; hence they may regulate genes 
involved in processes such as cell migration and differentiation.  Therefore, their 
involvement in directing expression of various cell adhesion molecules and Ephrin 
receptors is not surprising, implicating Hox genes in the formation of rhombomeric 
boundaries within the hindbrain.  Characterization of Hox targets, such as signaling 
molecules and transcription factors, may facilitate identification of the signal 
transduction pathways through which Hox genes act as effectors in the specification and 
differentiation of neuronal cell populations.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  68
 
 
3. MATERIALS AND METHODS 
3.1  Protein Purification   
The full-length Hoxa2 cDNA sequence (Nazarali et al., 1992; Tan et al., 1992) 
was previously subcloned into the pFLAG-2 vector (Sigma/Kodak) at the EcoR I and 
Xho I sites downstream of the FLAG epitope coding region. E.coli strain XL1-Blue 
supercompetent (Stratagene) was used for protein expression (Hao et al., 1999). 
Expression was induced in cultures with isopropyl-β-thiogalactoside (IPTG) as per 
Kumar and Nazarali (2001).  FLAG-Hoxa2 recombinant protein was extracted as 
inclusion bodies from bacteria using the method of Hoey (1990) and described in Kumar 
and Nazarali (2001).  In brief, the protein from inclusion bodies was extracted by 
dissolution in equal volumes of HEMGN buffer containing [100 mM KCl, 25 mM 
HEPES (pH 7.6), 0.1 mM EDTA (pH 8.0), 12.5 mM MgCl2, 10% glycerol, 0.1% v/v 
Nonidet P-40, 0.1 mM PMSF, 0.1 mM sodium metabisulfite] and 8 M guanidine-HCl for 
30 min at 4oC.  After centrifugation at 87,000 g for 30 min (4oC), the supernatant was 
dialyzed against HEMGN in decreasing concentrations of guanidine-HCl (1 X in 1 M 
guanidine-HCl, 1 X in 0.1 M guanidine-HCl, and 2 X in HEMGN alone).  Insoluble 
material was removed by centrifugation and the supernatant was utilized for subsequent 
purification by affinity chromatography with columns containing anti-FLAG M2 
antibody affinity gel (Sigma).  Purified recombinant Hoxa2 protein was eluted with 0.1 
M glycine (pH 3.5) and then neutralized with 1 M Tris (pH 8.0).   
Recombinant Hoxa2 protein was also isolated as soluble protein with B-PerTM 
reagent (Pierce).   Briefly, 40 ml of bacterial culture (OD600 of 1.5-3.0) was harvested 
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and pelleted by centrifugation.  Pellets were resuspended in 5 ml of B-PerTM reagent and 
incubated for 20 min at room temperature.  The supernatant containing soluble proteins 
was isolated by centrifugation at 27,000 g for 15 min.  Protein samples were dialyzed 
against PBS with 0.1 mM PMSF.  Recombinant Hoxa2 protein was partially purified by 
salting out the protein from the soluble protein extract with 30% ammonium sulphate.  
The protein was then dialyzed against PBS.  Protein samples were concentrated by 
centrifugation through Centricon-30 filters (Millipore-Amicon).  All protein samples 
were analyzed on 10-12% SDS-PAGE gels for purity and identified by Western Blot 
analysis. 
3.2  Antibody Purification  
A 17 amino acid oligopeptide (J3 peptide) from the coding sequence of the 
Hoxa2 protein was previously used to generate Hoxa2 peptide specific polyclonal 
antiserum (B579) in rabbits (Hao et al., 1999).  HiTrap protein A columns (Amersham 
Pharmacia Biotech) were used to purify IgG antibodies from the Hoxa2 antisera.  B579 
antiserum was diluted (1:2) in 20 mM NaH2PO4 (pH 7.0) and applied to the column.  
The IgG antibodies were eluted with 0.1 M Citric Acid (pH 4.0) and then neutralized 
with 1 M Tris (pH 8.0).  The eluant was dialyzed against 0.1 M HEPES (pH 8.0) and 
quantified using the DC Protein Assay (BioRad). 
 Antibodies specific for Hoxa2 were purified from B579 antiserum using affinity 
chromatography.  Both purified and partially pure recombinant Hoxa2 protein (as 
described above) were conjugated to AffiGel 10 affinity support (BioRad) in coupling 
buffer [PBS containing 80 mM CaCl2] for 4 hr at 4oC.  The remaining active ester sites 
were blocked with 0.1 M Tris (pH 8.0) and the matrix was used to prepare an affinity 
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column.  The B579 antiserum was heat inactivated at 56oC for 30 min and then diluted 
1:2 in wash buffer [50 mM Tris (pH 7.5)].  The column was washed with alternating 
solutions of wash buffer alone or wash buffer containing 0.5 M NaCl.  Hoxa2 specific 
antibodies were eluted with 0.1 M glycine and neutralized with 0.1 M triethylamine (pH 
11.5).  Antibodies were dialyzed against 0.1 M HEPES (pH 8.0).  Eluants were tested by 
electrophoresis on 12% SDS-PAGE gels and subsequent western blot analysis. 
3.3  Western Blot Analysis   
Both 10 and 12% SDS-PAGE gels were used to separate proteins according to 
the manufacturer’s protocol (Invitrogen).  The protein was transferred and immobilized 
onto a PVDF membrane (NEN Dupont) by using the Xcell II Blot Module (Invitrogen) 
for wet transfer in 1 X transfer buffer containing 12 mM Tris, 96 mM glycine and 20% 
methanol, for 2 hr at 30 V/200 mAmp.  Blocking of the membrane was performed in 3% 
skim milk (PBS) at 4°C for 16 hr.  For detection of the Hoxa2 protein, the membrane 
was incubated for 2 hr at room temperature with the rabbit anti-Hoxa2 antiserum (B579) 
at a dilution of 1:5000 in 3% skim milk/PBS.  The membrane was washed 3 X 20 
minutes with PBS/0.8% Tween-20 and incubated for 1 hr at room temperature with the 
horse radish peroxidase (HRP) conjugated secondary goat anti-rabbit antibody, diluted 
1:3000 in 3% skim milk (PBS).  The membrane was then washed for 2 hr, 6 X in 
PBS/0.8% Tween-20.  For detection of FLAG-Hoxa2 recombinant protein a 1:3000 
dilution of mouse anti-FLAG M2 primary antibody (Eastman Kodak, New Haven, CT) 
was used, followed by 3 X 10 min washes.  A 1:1500 dilution of HRP conjugated goat 
anti-mouse IgG was used as the secondary antibody and the membrane was washed 3 X 
for 20 min in PBS/0.08% Tween-20.  Visualization of proteins was performed by a 
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chemiluminescence reaction (PerkinElmer Life Sciences, Inc.) as per manufacturer’s 
instructions, followed by exposure of the membrane to Kodak X-OMAT Blue XB-1 film 
for 5 sec to1 min. 
3.4  Chromatin Preparation and Immunoprecipitation  
All mice used in experiments were obtained from the Animal Resource Center, 
Saskatoon, SK and embryos dissected as described in section C of Manipulating the 
Mouse Embryo (2nd Ed.).  Day twelve (E12) and day eighteen (E18) gestational embryos 
were removed from CD-1 mice and staged as per Kaufman (1992) and Theiler (1989).  
The spinal cord and surrounding tissue was removed from the embryos and fixed in 4% 
paraformaldehyde.  Nuclear extracts were prepared from the tissues according to the 
method of Rosenberg (1996).  In summary, tissues were washed and resuspended in 
hypotonic buffer A [10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 
0.5 mM PMSF, and 0.5 µg/ml each of leupeptin, pepstatin A, antipain, aprotinin].  The 
sample was homogenized and pelleted to collect the nuclear pellet.  Nuclei were 
sonicated in binding buffer [10 mM NaH2PO4 (pH 7.0), 10 mM KCl, 2 mM MgCl2, 0.5 
mM EDTA, 0.5 mM PMSF, 15 µg/ml aprotinin, 5 µg/ml leupeptin, 5 µg/ml antipain, and 
2 µg/ml pepstatin A) and centrifuged at 8,000 g for 10 min to collect the supernatant.  
Chromatin preparations were digested with 1500 U of Hae III for 1 hr at 37oC.  Hoxa2 
protein-DNA complexes were isolated from the digested chromatin by affinity 
chromatography using an AffiGel10 column conjugated with IgG purified antibodies 
from anti-Hoxa2 rabbit polyclonal antiserum (described above).  The column was 
washed three times with high salt buffer [0.1 mM NaH2PO4 (pH 7.5), 1 M NaCl] 
followed by low salt buffer [0.1 mM NaH2PO4 (pH 7.0)].  Target sequences were eluted 
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with 3 M NaSCN and dialyzed against 10 mM NaPO4 (pH 7.0).  Protein was removed 
from the target sequences by digestion with 0.1 mg/ml proteinase K, 50 mM Tris (pH 
8.0), 100 mM EDTA and 0.3% SDS for 8 hrs at 37oC.  DNA was extracted by phenol-
chloroform, precipitated, and purified using NAP-5 columns (Amersham Pharmacia 
Biotech).  Klenow enzyme was used to blunt end the DNA before ligation into the Sma I 
site of pBluescript SKII+ (Stratagene).   
Target DNA sequences of Hoxa2 were also isolated from E18 hindbrain and 
spinal cord chromatin preparations using a modified immunoprecipitation method 
previously utilized in isolating in vivo target genes for Hoxc8 and Hoxb5 (Tomotsune et 
al., 1993; Safaei, 1997).  E18 hindbrains, spinal cords and surrounding tissues were 
isolated as previously described.  Chromatin was prepared from the tissues by 
homogenization in binding buffer and sonication, as described by Safaei (1997).  The 
chromatin containing supernatant was digested with 104 U of Hae III for 2 hr at 37oC, 
followed by DNase I (10 U) digestion at 4oC for 5 min and the reactions were stopped 
with 2.5 mM EGTA.  Hoxa2-DNA complexes were immunoprecipitated from E18 
mouse hindbrain and spinal cord chromatin preparations by affinity chromatography 
using purified anti-Hoxa2 antibodies conjugated to AffiGel10 matrix (Pharmacia 
Biotech).  DNA was eluted from the column as previously described and treated with 0.1 
mg/ml proteinase K in 10 mM Tris, 5 mM EDTA and 0.5% SDS for 16 hr at 37oC. 
Samples were extracted with phenol-chloroform followed by passage through NAP-5 
columns.  The resulting DNA was cleaved with Sma I prior to subcloning into 
pBluescript SKII+.  DH5α E.coli cells were used for transformation with plasmids and 
subsequent DNA isolation.  Target sequences were sequenced by dideoxy-chain 
  73
termination method (Sanger et al., 1977) using Sequenase-Version 2.0 (U.S. 
Biochemical Corp.) and also at the DNA Technologies Unit, NRC-Plant Biotechnology 
Institute, Saskatoon, SK. 
3.5  In vitro translation of Hoxa2 transcript 
 The TNT Coupled Wheat Germ Extract System (Promega) was used to produce 
in vitro Hoxa2 protein from the Hoxa2 cDNA using the T3 promoter of the pBluescript 
SKII+-Hoxa2 plasmid (Hao et al., 1999) as per the manufacturer’s instructions.  In short, 
Hoxa2 was produced from 1 µg of circular plasmid in 25 µl of wheat germ extract with 1 
µl of T3 polymerase incubated for 60 min at 30oC. 
3.6  Electromobility Shift Assays (EMSAs)  
Nuclear extracts (NE) were prepared from whole E12 mouse tissue, and also 
from the spinal cord and hindbrain tissue of E18 and P1 mice.  For extraction of nuclear 
protein from E12 and E18 mice, the method described in Thompson et al. (1998) was 
used.  Briefly, embryos were homogenized in PBS, pelleted and resuspended in cell lysis 
buffer [10 mM HEPES (pH 7.0), 3 mM MgCl2, 40 mM KCl, 0.5 mM PMSF, 1 mM 
DTT, 5% glycerol, 1% protease inhibitor cocktail (Sigma), and 0.2% Nonidet P-40].  
Cells were lysed for 10 min at 4oC and the nuclei pelleted by centrifugation in 
microcentrifuge at 5,000 rpm for 5 min.  Nuclei were resuspended in extraction buffer 
[20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 0.42 KCl, 0.2 mM EDTA, 1 mM DTT, 0.5 
mM PMSF, 25% glycerol] and incubated for 1 hr at 4oC on an orbitron shaker.  
Supernatant was collected after centrifugation and dialyzed against a solution of 20 mM 
HEPES (pH 7.9), 1.5 mM MgCl2, 0.42 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM 
PMSF, and 20% glycerol.   
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For extraction of NE from hindbrain and spinal cord tissue of P1 mice a method 
provided by Alan Bateson (personal communication) was used for extraction of nuclei.  
In short, tissues from Hoxa2-/- and wildtype C57BL/6J mice (obtained from Gendron-
Maguire et al., 1993) were homogenized in 0.25 mL of ice-cold sucrose buffer [0.25 M 
sucrose, 15 mM Tris-HCl (pH 7.9), 60 mM KCl, 15 mM NaCl, 5 mM EDTA (pH 8.0), 1 
mM DTT, 0.5 mM PMSF, and 1% protease inhibitor cocktail (Sigma)].  The volume of 
the homogenate was increased to 0.75 mL with sucrose buffer and centrifuged at 2,000 g 
for 10 min at 4oC.  Pellets were resuspended in 0.4 mL of wash buffer [10 mM HEPES 
(pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 1 mM DTT, 0.5 mM PMSF, and 1% of protease 
inhibitor cocktail], pelleted at 4,000 g for 10 min (4oC) and then incubated for 1 hr on ice 
in 20 mM HEPES (pH 7.9), 0.75 mM MgCl2, 10 mM EDTA (pH 8.0), 0.5 mM KCl, 
12.5% glycerol, 1 mM DTT, 0.5 mM PMSF, and 1% protease inhibitor cocktail.  The 
supernatant was collected after centrifugation at 14,000 g for 30 min at 4oC.  All nuclear 
extracts were aliquoted and stored at –70oC. 
DNA probes for all of the Hoxa2 target sequences were produced by digestion of 
pBluescriptSKII+ containing target sequences with Xho I and Xba I and labeling with 
[α32P]dATP using Klenow enzyme.  Binding reactions were performed in 30 µl of 
binding buffer [10 mM HEPES (pH 7.9), 1 mM MgCl2, 60 mM KCl, 0.5 mM EDTA, 1 
mM DTT, 10% glycerol] with 2 µg of polydI-dC, 2 µg nuclear extract (unless indicated 
otherwise) and 50,000 cpm of probe at room temperature for 20 min.  Reactions for 
supershift assays were performed as described above, with the addition of B579 
antiserum.  Control reactions were performed using an equal amount of non-immune 
rabbit antiserum.  Nuclear extracts were incubated for 20 min (4oC) with antisera prior to 
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addition of probe.  All competition reactions involved the addition of 100 X 
concentration of unlabelled target sequence.  Samples were electrophoresed on 6% to 
8% TBE and Tris-Glycine gels, dried for 2 hr and exposed to Kodak X-OMAT film at –
70oC. 
3.7  DNase I Footprinting   
A modified protocol of Spiro and McMurray (1999) was utilized for thermal 
cycle sequencing of target sequences for footprinting assays.  Forward and Reverse 
primers for pBluescript SKII+ were labeled with γ32P using T4 kinase in sequencing 
reactions.  Template DNA was sequenced using universal primer (5′  
GTAAAACGACGGCCAGT 3 ′) and reverse primer (5 ′  
GGAAACAGCTATGACCATG 3 ′),  2 U Taq DNA polymerase (Invitrogen) and 
dNTP/ddNTP mix (reaction mix A: 450 µM ddATP, 15 µM dATP, 50 µM each dCTP, 
dGTP,dTTP; reaction mix C: 125 µM ddCTP, 15 µM dATP, 18 µM dCTP, 50 µM each 
dGTP, dTTP; reaction mix G: 125 µM ddGTP, 15 µM dATP, 18 µM dGTP, 50 µM each 
dCTP, dGTP; reaction mix T: 300 µM ddTTP, 15 µM dATP, 18 µM dTTP, 50 µM each 
dCTP, dGTP).  Reactions were incubated for 2 min at 95oC followed by 20 cycles of 
95oC for 30 sec, 58oC for 15 sec, and 72oC for 40 sec.  The procedure of Leblanc and 
Moss (2000) was used for DNase I footprinting of the target sequences.  Varying 
amounts of NE taken from E12, E18 and P1 mice were used in the footprinting 
reactions.  Protein was incubated with T4 kinase labeled γ32P DNA probes (5 X 104 cpm) 
in 50 µl binding buffer [20% glycerol, 0.2 mM EDTA, 1 mM DTT, 20 mM HEPES (pH 
7.9), 60 mM KCl] with 2 µg of polydI-dC overnight at 4oC or at room temperature for 2 
hr.  Samples were treated in the presence of 5 mM MgCl2 and 0.25 mM CaCl2 for 2 min 
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with 5 X 10-4 to 5 X 10-3 U of DNase I for control reactions and 2 X 10-3 to 8 X 10-2 U 
for DNA-protein reactions.  DNA fragments were ethanol precipitated for several hours 
at –20oC, and DNA pellets were dissolved in formamide loading buffer (90% v/v 
deionized formamide, 0.025% w/v xylene cyanol, 0.025% w/v bromophenol blue).  
Reactions were visualized by electrophoresis on 6% denaturing sequencing gels and 
exposed to Kodak X-OMAT film at –70oC.   
3.8  Southwestern Blot Analysis  
A method outlined by Papavassiliou (2001), which entails performing a 
southwestern blot followed by nuclease footprinting of the sequences while bound to the 
membrane was used.  In brief, approximately 20 µg of NE (per lane) from E18 mice was 
separated by electrophoresis on 12% SDS-PAGE gels.  Proteins were transferred and 
immobilized onto PVDF membranes (NEN Dupont).  The membrane was washed with 
SW renaturation buffer [25 mM HEPES (pH 7.5), 50 mM KCl, 6.25 mM MgCl2, 1 mM 
DTT, 10% glycerol, 0.1% Nonidet P-40, and 0.2 mM PMSF].  Blocking of the 
membrane was performed overnight in SW renaturation buffer containing 3% milk or 
5% BSA.  Blots were probed for 4 hr with γ32P ATP labeled DNA at either the 5′ end on 
the sense or antisense strand in SW binding/wash buffer [12.5 mM HEPES (pH 7.5), 50 
mM KCl, 6.25 mM MgCl2, 0.5 mM DTT, 2% PVP, 10% glycerol, 0.05% Nonidet P-40, 
and 0.2 mM PMSF].  Excess probe was removed by multiple washes with SW wash 
buffer, and the blots were subsequently exposed to Kodak X-OMAT film for 3 hr.     
3.9  Tail Genomic DNA Isolation and Mouse Genotyping   
Tail tissue was excised from both embryonic (CD-1) and P1 (C57BL/6J) mice, 
and genomic DNA was extracted using a simplified protocol of Laird (1991).  Briefly, 
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tails were digested in lysis buffer [10 mM Tris-HCl (pH 8.5), 0.05 M EDTA, 1%SDS, 
0.5 M NaCl and 2 mg/ml Proteinase K] for 3 to 5 hr at 55oC.  Genomic DNA was 
precipitated and quantified using UV spectrophotometry, and approximately 1 µg of 
DNA used for subsequent PCR analysis.  For identification of wildtype and Hoxa2+/- 
mice, PCR amplification of a 330 bp fragment of the Hoxa2 gene was performed using 
primers wt-5 (5 ′  GTTGGAACTGACCTCCTCTTG 3 ′) and wt-6 (5 ′  
GGGTCCGAGCAGGGTTATTCC 3 ′) (Gendron-Maguire et al., 1993).  For 
identification of homozygous knockout Hoxa2 mice, PCR was performed using DNA 
primers KO-1 (5 ′  GTTGGTGTACGCGGTTCTCAG 3 ′) and NEO-1 (5 ′  
TCGCCTTCTATCGCCTTCTTG 3 ′) resulting in a 380 bp fragment amplification 
of the Neomycin sequence (Gendron-Maguire et al., 1993).  PCR conditions were as 
follows: 94°C for 3 min followed by 30 cycles at 94°C for 45 sec, 59°C for 30 sec and 
72°C for 1 min.  Samples were incubated for 10 min at 72°C for elongation and 
terminated at 4oC.  DNA fragments were visualized by electrophoresis on a 1% agarose 
gel, and Hoxa2-/- mice were identified by the presence of a 380 bp band and the absence 
of a 330 bp fragment. 
3.10  RNA Isolation and RT-PCR Analyses  
Embryos at stages E10, 12, 14, 16, and 18 were removed and homogenized in 
TRI Reagent (Sigma) for RNA extraction according to the manufacturer’s instructions.  
Also, hindbrain and spinal cord tissues were removed from P1 Hoxa2+/+, Hoxa2+/-, and 
Hoxa2-/- mice (C57BL/6J) for RNA extraction.  Mouse genotyping was performed by 
PCR analysis as described above.  RNA was stored in ethanol at –70oC, and dissolved in 
water immediately before use. Quantification of RNA was performed by UV 
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spectrophotometry at 260 nm.  DNA was digested in 1 µg of RNA sample with 1 U 
DNase I (Sigma) at room temperature for 15 min.  The digestion was terminated by the 
addition of stop buffer (2.5 mM EDTA) and heating at 70oC for 10 min.  Reverse 
transcription reactions were performed in a volume of 20 µl using 1 µg of DNase I 
treated RNA with 200 U of Superscript II RNase H- Reverse Transcriptase (Invitrogen) 
and 2.5 µM of random nonamers (Sigma).  Subsequent cDNA amplification was 
performed using 2 µl of RT product and 2 U Taq DNA polymerase (Invitrogen), unless 
otherwise specified.  PCR conditions and primer sequences used for individual genes are 
described below.   
In all RT-PCR analyses amplification of the mouse β actin gene, using primers 5′ 
GGCATCGGATGGACTCCG 3′ and 5′ GCTGGAAGGTGGACAGCGA 3′ (Remacle et 
al., 2002) for amplification of a 612 bp fragment, was utilized as an internal control.  For 
multiplex PCR amplification of the RT reactions from the P1 Hoxa2 wildtype and 
mutant hindbrain and spinal cord tissue, β actin primers were used at a concentration of 
0.1 µM while the gene specific primer concentration was 0.5 µM.   
Tasp fragment amplification from RT reactions was performed using touchdown 
PCR as follows:  10 cycles of 95oC for 45 sec, 68oC for 1 min, and 76oC for 1 min, 
followed by 20 cycles of 94oC for 45 sec, 62oC for 1 min, and 76oC for 1 min, and a final 
extension step at 78oC for 10 min.  PCR amplification of the Tasp fragment from the RT 
reactions was quantitated through imaging by a gel doc system (BioRad), followed by 
analysis using the pixel density function of the Quantity 1 program (BioRad). 
Dyrk4 was amplified by RT-PCR using 2 µl of RT samples with 0.2 µM β actin 
primers and 0.5 µM Dryk4 primers for embryonic RNA samples.  Amplification of 
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Dyrk4 for RT reactions on adult and P1 RNA extract was performed as described above 
using 4 µl of RT reactions.  RNA samples were tested for contaminating DNA by PCR 
amplification of DNase I treated RNA.  PCR samples were incubated as follows: 95oC 
for 5 min and 30 cycles of 95oC for 45 sec, 62oC for 1 min, 72oC for 45 sec and an 
elongation step at 72oC for 10 min. 
3.11  Amplification of Tasp and Dyrk4 Probes   
All RT reactions used for the production of probes utilized RNA isolated from 
E18 embryos and P1 mice.  A Tasp DNA probe was produced by PCR amplification of 
RT product using primers 5′ CCAACCCAGACTTTCCAGCG 3′ and 5′ 
AGCTGAAATTAAGGGTCA 3′ corresponding to position 1361 and 1770 of the 
9530081K03RIKEN clone sequence (NCBI Accession# AK035194).  PCR conditions 
consisted of an initial denaturation step at 95oC for 5 min, followed by 30 cycles of 95oC 
for 45 sec, 60oC for 1 min, 72oC for 45 sec and an elongation step at 72oC for 10 min.  
PCR products were purified by micron filters (Millipore) and subcloned into pBluescript 
SKII+ at the Xho I and Xba I sites.  Automated DNA sequence analysis at the Saskatoon 
Cancer Research Unit, University of Saskatchewan verified the nucleotide sequence. 
 PCR amplification of Dyrk4 from 1 µg mouse tail genomic DNA with primers 5′ 
GGGCTCGAGAGATGAGGCTACCAA 3′ and 5′ GGGTCTAGACACGATGGGTGG 
TAAGATG 3′ was performed as described above, with the exception of the annealing 
step which was performed at 62oC for 1 min.  The resulting 229 bp product was 
subcloned into pBluescript SKII+ at the Xho I and Xba I sites.  The insert was verified as 
corresponding to positions 1738-1967 within the mouse Dyrk4 cDNA sequence 
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(Ensemble–EMI/Sanger Institute, Transcript ID: ENSMUST00000032495) by DNA 
sequencing. 
3.12  Southern Hybridization   
RT-PCR products were visualized by electrophoresis on 1% agarose gels, 
followed by capillary transfer using GeneScreen Plus (NEN Dupont) as described by the 
manufacturer.  DNA probes were produced by digestion with Xho I and Xba I, followed 
by termini fill-in with the Large Fragment of DNA Polymerase I (Klenow Fragment) 
(Invitrogen).  DNA fragments were labeled with 20 µCi of [α32P]dCTP and 0.5 U of 
Klenow fragment for 30 min at 4oC, and the reactions were terminated by phenol 
extraction.  Membranes were hybridized with 2.5 x 106 cpm of α32P Klenow labeled 
DNA probes in QuickHyb solution (Stratagene) as per the manufacturer’s instructions.  
The membrane was washed 1 X in 2 X SSC/0.1% SDS at room temperature and 3 X in 
0.1 X SSC/0.1% SDS at 65oC.  Blots were exposed to Kodak X-OMAT AR film 
overnight at -70oC. 
3.13  Cell Culture, Transient Transfection and Luciferase Assays  
HeLa cells are a human cervical carcinomal cell line that is commonly used in 
transcient transfections.  The HeLa cells were maintained in Glutamax Dulbecco's 
modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin (Invitrogen) in a 37oC/5% CO2 atmosphere.  Cells were 
transfected at approximately 50-70% confluency using the calcium phosphate method of 
N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES)-buffered saline, as 
previously described by Greaves and O'Hare (1989).   
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Potential Hoxa2 target sequences, corresponding to the intronic regions of Tasp 
and Dyrk4 previously isolated by immunoprecipitation were digested from pBluescript 
SKII+ at the BamH I and Sal I sites and ligated into the pGL3-Promoter vector 
(Promega) downstream of the luciferase coding region.  The resulting reporter plasmid, 
as well as the pGFP, pcDNA3, pRSV-Hoxa2, and pCMV-RL vectors were used to 
transform DH5α E.coli cells.  All DNA for use in transfection was isolated using the 
Endofree Plasmid Maxi Kit (Qiagen).  DNA concentrations were quantified by three 
methods: spectrophotometry at 260 nm, by ethidium bromide spot testing and agarose 
electrophoresis.  Efficiency of transfection was assessed by cotransfection with 0.1 µg of 
pGFP. 
DNA concentrations of all transfections were supplemented to a total of 5 µg 
with pcDNA3 vector, and performed in 6-well plates.  Cells were incubated for 48 hr 
and then washed with PBS prior to harvesting for luciferase assays as per manufacturer’s 
instructions (Promega).  In brief, cells were incubated with 500 µl of Passive Lysis 
Buffer (Promega) for 15 min at room temperature, and then subjected to 3 rapid freeze 
thaw cycles.  Luciferase assays were performed using the Dual-Luciferase Reporter 
Assay System (Promega), where 20 µl of the cell lysate was added to 100 µl of 
Luciferase assay reagent AR II and luminescence was measured for the firefly luciferase.  
Activity of the Renilla luciferase reporter was subsequently measured by the addition of 
100 µl of Stop and Glo reagent. 
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3.14  Transient Transfection of Hoxa2 in Cell Culture and Expression Analysis 
of Dryk4 and Tasp   
HeLa cells were transfected in 100 mm plates with 0, 0.05, 0.10, 0.25, 0.50, 1, 
and 2 µg of pRSV-Hoxa2 supplemented with pcDNA3 to a total of 6 µg of DNA/plate 
using 50 µl of Polyfect Reagent (Qiagen).  Cells were washed 1 X with PBS and 
transfection efficiency was assessed by cotransfection of cells with a Green Fluorescent 
Protein (GFP) encoding plasmid and visualized by fluorescence microscopy.  Harvesting 
of cells for RNA and protein extraction was performed using 1 ml of TRI reagent 
(Sigma) as per the manufacturer’s instructions.  RNA was stored as a pellet in 75% 
RNase free ethanol at –20oC.  Subsequent to use in RT-PCR analysis, RNA was 
dissolved in water and quantified as previously described.   
Analysis of Dyrk4 and Tasp expression in HeLa cells was performed using two-
step RT-PCR as described above.  Protein was extracted simultaneously with RNA and 
stored as a pellet in 100% ethanol at –20oC.  Solubilization of the protein was performed 
by dissolving in 0.1% SDS followed by heating at 45oC and sonication for 60 min (Bath 
Sonicator 5200; Branson Ultrasonics, Danbury, CT).  After determination of protein 
concentrations (Lowry et al., 1951), samples were aliquoted and stored at –20oC for 
western blot analysis. 
3.15  Statistical Methods 
Differences in the RT-PCR analysis of target gene expression in Hoxa2 wildtype 
and mutant embryonic tissue was assessed using a one-tailed t-test.  The transfection 
data was analyzed using a one-way ANOVA, and all analyses were performed using 
GraphPad Prism 4.0 software (GraphPad Software, Inc.). 
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4. RESULTS 
4.1  Purification of Recombinant Hoxa2 in E.coli using the pFLAG system for 
Affinity Purification of Hoxa2 Specific Antibody from Polyclonal Antisera 
 
Recombinant Hoxa2 protein (~ 41 kDa) was expressed in E.coli using the 
pFLAG-2 expression vector (Appendix I).  The predicted molecular weight of Hoxa2 is 
40,793 Da and when expressed in bacterial cultures it is observed as a protein migrating 
at approximately 39-41 kDa by SDS-PAGE analysis.  Differences in the observed 
migration on SDS-PAGE may be in part due to variations in the different molecular 
weight markers.  Also, the migration of Hoxa2 may have been altered due to its acidic 
nature (pI 5.53).  
Optimization of Hoxa2 expression had been previously conducted for isolation of 
inclusion bodies.  IPTG induction of protein expression was performed for 16 hr at 37oC 
for the production of high levels of insoluble recombinant Hoxa2 protein.  Upon 
sonication and treatment with lysozyme, the protein was extracted from the cellular 
debris by isolation of inclusion bodies with Guanidine-HCl [4 M final concentration] 
(Figure 4.1).  Afterwards the protein was renatured by dialysis, at which point a 
significant amount of protein was lost due to precipitation.  This protein precipitant was 
also used for extraction of protein by the addition of Triton X-100 and 0.1 M Guanidine-
HCl.  Both the dialyzed protein and the solublized protein precipitant were used for 
purification of Hoxa2 using affinity chromotagraphy with the anti-FLAG M2 antibody 
(Figure 4.2, lane 8).  Although affinity chromatography with anti-FLAG antibodies 
resulted in a highly pure protein product, the yield for each elution from 1 ml of affinity  
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Figure 4.1  Purification of insoluble recombinant Hoxa2 in E.coli 
Figure A:  Protein samples from a 16 hr IPTG induction of E.coli cultures 
containing the pFLAG-Hoxa2 plasmid were analyzed by 12% SDS-PAGE, 
followed by coomassie blue staining.  Lane 1: crude bacterial pellet from 
pFLAG-Hoxa2 E.coli cultures; Lane 2: empty; Lane 3: Supernatant of bacterial 
sonicate; Lane 4: Pellet after sonication; Lane 5: Bacterial pellet after extraction 
with 4 M guanidine-HCl; Lane 6: Supernatant after extraction with 4 guanidine-
HCl; Lane 7: Protein precipitant after dialysis; Lane 8: empty; Lane 9: Gibco-
BRL Pre-stained Ladder, the 38 kDa protein marker is indicated by the arrow. 
 
Figure B:  Western Blot analysis using anti-Hoxa2 polyclonal antibodies of the 
protein samples from a 16 hr IPTG induction of E.coli cultures containing the 
pFLAG-Hoxa2 cultures.  Lanes correspond to those of the coomassie blue SDS-
PAGE gel.  Recombinant Hoxa2 is mainly present in the pellet after sonication, 
and is extracted with Guandine-HCl in subsequent steps. 
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Figure 4.2  Purification of recombinant Hoxa2 from inclusion bodies 
Figure A: Recombinant Hoxa2 extracted and purified from induced bacterial 
cultures resolved by 12% SDS-PAGE, followed by coomassie staining.  Lane 1: 
Gibco-BRL Seeblue protein marker; Lane 2: crude bacterial pellet after IPTG 
induction; Lane 3: Supernatant after sonication of bacterial culture; Lane 4 and 5: 
Guanidine-HCl extraction of inclusion bodies from bacterial pellet; Lane 6; 
bacterial pellet after guanidine-HCl extraction; Lane 7: insoluble protein 
precipitant after dialysis; Lane 8: anti-FLAG affinity chromatography 
purification of recombinant FLAG-Hoxa2 protein which migrates as a 41 kDa 
protein. 
 
Figure B: Western Blot analysis of the above protein samples using anti-FLAG 
M2 antibody corresponding to the lanes in the coomassie stained gel shown 
above. 
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column is low, at approximately 30-50 µg.  A total yield of approximately 100 µg of 
purified Hoxa2 protein was obtained from 1 L of induced culture, as determined by 
BioRad Protein Assay.   
 Hoxa2 protein was partially purified by extraction of inclusion bodies, followed 
by ammonium sulphate precipitation.  Recombinant Hoxa2 precipitates upon the 
addition of 30-80% ammonium sulphate.  The minimal amount of coprecipitation of 
Hoxa2 with bacterial proteins is at 30% ammonium sulphate (Figure 4.3).
Extraction of recombinant FLAG-Hoxa2 protein in the form of soluble protein 
was performed by optimization of IPTG induction to 4 hr at 37oC, followed by 
disruption of the bacterial cells using B-PerTM Reagent (Figure 4.4).  Increasing the 
induction time results in the presence of Hoxa2 as insoluble protein, while a reduction in 
induction temperature yields very low amounts of recombinant protein.  Hoxa2 protein 
was then partially purified by precipitation with ammonium sulphate and collection of 
the 0-30% ammonium sulphate protein fraction. 
 Both purified FLAG-Hoxa2 and ammonium sulphate precipitated proteins were 
dialyzed for renaturation and then combined.  Protein samples were concentrated by 
centrifugation through a Centricon-30 filter (Figure 4.5).  Protein samples were analyzed 
by Circular Dichroism for verification of the presence of alpha-helical structures (Figure 
4.6).  The partially purified protein sample consisted of approximately 30% alpha helical 
structure with the remaining 70% consisting of mainly beta-turn (type II) and random 
unordered structures, followed by the presence of some beta-sheets (Appendix II). 
 Approximately 20 mg of partially purified Hoxa2 protein was conjugated per ml 
of AffiGel (BioRad) matrix.  Conjugation of protein to the matrix was determined by  
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Figure 4.3 Ammonium sulphate precipitation of recombinant Hoxa2 protein from 
bacterial protein extract 
Figure A: SDS-PAGE analysis of protein samples from E.coli induced for recombinant 
Hoxa2 expression precipitated with ammonium sulphate at a concentration of 20, 40 and 
60%.  
Figure B: SDS-PAGE analysis of 0-30% ammonium sulphate precipitant fraction of 
protein from bacterial cultures induced for recombinant Hoxa2 expression (lane 2), 
remaining protein in bacterial extract after precipitation (lane 3), and bacterial extract 
before precipitation (lane 4). Prestained protein ladder (Gibco-Brl) was used as a 
standard for estimation of molecular weight (lane 1).  Western Blot using anti-FLAG 
M2 antibody showed that Hoxa2 (~ 40 kDa) coprecipitates with other proteins in 30% 
ammonium sulphate (Figure C).  
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Figure 4.4  Expression of recombinant Hoxa2 in E.coli as soluble protein 
Figures A and B, as well as C and D are true alignments according to migration of 
molecular weight markers. 
Figure A:  SDS-PAGE analysis of the supernatant from bacterial suspensions in B-PerTM 
reagent for recombinant Hoxa2 protein induced cultures at 37oC for 2 hr (lane 3), 3 hr 
(lane 4), 4 hr (lane 5), and 6 hr (lane 6).  (Figure B) Western blot analysis with anti-
Hoxa2 polyclonal antisera identify recombinant Hoxa2 protein (lane 2).  Migration of 
Hoxa2 on the coomassie stained gel is shown by a black arrow. 
Figure C:  SDS-PAGE analysis of B-PerTM extracted recombinant Hoxa2 protein 
induced at 37oC for 4 hr.  (Figure D) Western Blot analysis with anti-FLAG M2 
antibody showed that Hoxa2 is present as soluble protein within the supernatant 
following disruption of bacterial cell by B-PerTM reagent (lane 2) and not as inclusion 
bodies within the cellular debris (lane 3). 
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Figure 4.5  Concentration of partially purified recombinant Hoxa2 protein 
Several batches of B-PerTM extracted soluble Hoxa2 protein fractions were partially 
purified with ammonium sulphate precipitation and then combined with FLAG affinity 
purified recombinant Hoxa2 protein extracted from E.coli as inclusion bodies.  Fractions 
were combined, dialyzed to remove ammonium sulphate and concentrated using a 
Centricon-30 filter.  Purity of the protein samples from separate batches of purification 
was assessed by 12% SDS-PAGE and Coomassie Blue Staining (above, lanes 2, 4, 6, 8).  
Recombinant Hoxa2 ran slightly above the 36 kDa band of the Gibco-BRL Seeblue 
Marker (lane 1). 
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Figure 4.6  Circular Dichroism (CD) Scan of partially purified recombinant Hoxa2 
CD Spectra of the FLAG affinity purified Hoxa2 combined with the 30% ammonium 
sulphate precipitated protein fraction.  The samples were dialyzed in PBS buffer and 
then concentrated before analysis.  Protein samples analyzed in PBS (red line) displayed 
a CD spectrum indicating the presence of alpha helical structures, which is improved by 
dissolution in 50% 2,2,2-trifluoroethanol (TFE).  The presence of the FLAG epitope did 
not appear to dramatically affect folding of the recombinant Hoxa2 (Bottom). 
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measuring absorbance at 280 nm and by western blot analysis.  Affinity chromatography 
was used to purify anti-Hoxa2 specific antibodies from polyclonal Hoxa2 antiserum, and 
the specificity of purified antibody was determined by immunohistochemistry on mouse 
embryonic tissue, peptide inhibition studies and ELISA (Hao et al., 1999; Wolf et al., 
2001). 
Approximately 3 mg of Hoxa2 antibodies were conjugated to AffiGel (BioRad) 
matrix for isolation of chromatin preparations from the hindbrain and spinal cord tissue 
of E18 embryos.  Hoxa2-DNA complexes were isolated by immunoprecipitation, and 
putative targets were subcloned into the Sma I site of pBluescript SKII+ (Appendix III). 
4.2  Cloning and Identification of Putative Hoxa2 Target Sequences 
 Hoxa2 expression within the CNS begins as early as E10 and continues 
throughout development into adulthood, with the highest levels of expression observed 
at E12.  Therefore, we attempted to isolate the downstream target gene(s) of Hoxa2 at 
the E12 stage utilizing an immunoprecipitation method and affinity purified IgG 
antibodies from Hoxa2 antiserum.  The DNA isolated by this method was contaminated 
with EDTA precipitation and was therefore purified for ligation.  The clones isolated 
from ligations were short DNA sequences (<100 bp), and hence too small for use in 
target gene identification.  The experiment was repeated using chromatin preparations 
isolated from E18 embryos with the number of dialysis steps of the eluted DNA 
increased to ensure removal of 3 M NaSCN and thereby alleviate difficulties observed 
with precipitation.  However, precipitation persisted and the resulting DNA did not yield 
transformants. 
  92
 Although expression of Hoxa2 is highest at E12, due to availability of embryonic 
tissue the chromatin preparation was isolated from E18 CNS tissue.  Also, use of older 
stage embryos was advantageous because it allows for the use of a more specific subset 
of CNS tissue for chromatin isolation.  Therefore, target sequences of Hoxa2 were 
isolated from E18 spinal cord and hindbrain chromatin preparations utilizing a 
modification of the immunoprecipitation method utilized by Safaei (1997).  Samples 
were digested with proteinase K in the presence of a decreased concentration of EDTA, 
and then isolated after column purification. The resulting DNA was devoid of 
precipitant.  Thirteen clones were isolated using this method, of which seven were >50 
bp in length.  Identification of target genes by screening either Genomic libraries or 
DNA databases is less efficient using shorter sequences.  The seven clones ranging in 
size from ~ 70-280 bp were sequenced (Figure 4.7). 
All target sequences were analyzed by BLAST query against various GenBank 
databases (Altschul et al., 1990).  Sequences for clones 2, 3, 4, 8 and 12 were found to 
have alignment with mouse trace sequences present in the Trace Archive database at the 
NIH NCBI GenBank website.  Trace sequences (500–1000 bp in length) were used to 
screen various EST databases to identify potential target genes. The most significant 
alignment observed was with clone 8 and the E.coli deoxyguanosine triphosphate 
triphosphohydrolase (dgt) gene, having 98% identity.  Clone 8 also aligned with several 
mouse trace sequences (500–1000 bp).  Trace sequences exhibited 95–98% identity with 
the dgt gene but did not produce hits using BLAST for screening of the mouse or human 
genome, or any EST databases.  Clone 4 also displayed high identity (94%) to E.coli  
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>clone 1 (222 bp) 
GTCGTCGTGCCAGCGAAATCTGGCCCAGGTGGTCGCTCCACAGCCGGGCATT
GCAAGCTCATGAAGTCCCGCACCCAGCACGCGCGGGTCGGCCGGCAGCGGC
TTGCAGCAAGCGCCTGCGTGCGCGGGATGCGCAGGTTGAACATCGCCGCGA
TGATGTAGAGCAGCACCATGGCCGCGATCGCCGCCTCGGGCGGGGTGTCGA
TGCCGGTGTCGATGCCC 
 
>clone 2 (103 bp) 
CCAGTCTGCTTAGACTCAGCAGACACAGGCTGGCAAAGTCCCTGGAAACAG
CAGCCACAGCCATGCTTTCCCAAATACTATAGAACAAAACCAGGCATCATGG 
 
>clone 3  (272 bp) 
CGYGCACGCGTCGCCTGCGAGACCATGGTCAAGACCGGTGTTGCCATCGTGG
CCGGTGAAATCACCACCAGCGCCTGGATCGACCTGGAAGCACTGACCCGCA
AGGTCATCACGGACATCGGCTTACGACAGCTCGACGTCGGCTTGACGGCGGC
GCCACCTGCGGCGTGCTGAASACTGATCCGGCAAGCAGTCACCGTACATTGC
CCAGGGCGTGGATCGCAAGAAGCCGGAAGAAATGGGTGCCTGGCGACCCAG
GGCCTGATGTTCGG 
 
>clone 4  (103 bp) 
CCAGAGAAAACCGGTAATACGCCGGACGGTCGTCGCCGCCGGAACACCGTT
CGCGCCGGGCGCTAACCCCGATGCATGGTCTTTGACCGCAAAGGTGCCGTGG 
 
>clone 5  (76 bp) 
GTGCACGGCATGTCGGTGATCCAGTGGGGTGCACGGGAACGGCATCGGTAT
CGCCATCCAGGGCGACGAACACGCG 
 
>clone 8  (142 bp) 
CCTATGTCGAGGCTTCAGTAAATTACCGTCAGATTCTCCTGAGTTTCCGCTAT
GGGAATATTATTACCGTTGCCGCCTGCTGCAGGATTATATCAGCGGTATGAC
CGCCTCTATGCGTGGGATGAATACCGACGTCTGATGG 
 
>clone 12  (218 bp) 
CCATCGGCAGCCCCTTTGCCCTGCAGAACACCGTGACAACGGGTATTGTCAG
CACTGCCCAGCGGGATGGCAAGGAGCTGGGTCTCCGGGACTCAGACATGGA
CTATATCCAGACCGATGCCATCATCAATGTGAGTGCTGTGGGGAAGGCTGAC
CTCAGCAACTTTGGACCAGCTTGTGCCCTGTCCTATCATACAACACACCACC
ATCTAGGAAGG 
 
Figure 4.7  Putative Hoxa2 Target Sequences isolated by immunoprecipitation 
The potential Hoxa2 target sequences were isolated by immunoprecipitation using E18 
hindbrain and spinal cord preparations.  Clone 2 was identified as the mouse homologue 
of the human DYRK4.  Clone12 showed 99% identity with the Toll-associated serine 
protease (Tasp) gene, which is the mouse homolog of the human HTRA3 gene.   
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sequences, but not within a coding region.  Trace sequences aligning with clone 12 
exhibited significant identity (99%) with a mouse RIKEN cDNA gene referred to as toll-
associated serine protease (Tasp).  However, the full-length gene sequence of Tasp was 
not available at that time. 
BLAST queries were later performed using the Ensemble Mouse Genome 
Database (EBI/Sanger Institute) rather than the NCBI megaBLAST search. Clone 12 
displayed alignment with Tasp in the area spanning the latter (100 bp) half of exon 4 and 
the first ~ 200 bp of the fifth intronic sequence and is flanked by Hae III enzyme 
recognition sites.  Tasp is a serine protease belonging to the HTRA family of genes, 
whose transcript is 1380 bp in length and consists of 9 exons (Figure 4.8).   
Clone 2 was identified by BLAST alignment as the murine homolog of the human 
Dual specificity tyrosine kinase 4 (Dyrk4) gene located on chromosome 6.  The Dyrk4 
cDNA is 1794 bp in length and consists of 15 exonic sequences (Figure 4.8).  Clone 2 
aligns within 3' end intronic sequences and is also flanked by Hae III restriction sites 
within the intron sequence. 
4.3  In Vitro DNA Binding of Hoxa2 to the Target DNA 
Initial attempts to study in vitro DNA binding were performed using recombinant 
FLAG-Hoxa2 protein isolated as soluble protein from E.coli.  The use of bacterial 
protein extracts resulted in weak binding of Hoxa2 to clone 2 (Figure 4.9), but shift 
bands for the remaining target sequences aggregated in the wells and did not separate 
during electrophoresis (clones 1, 3-5, 8 and 12).  The shift complex observed in lane 2 
formed a faint supershift band (SS) upon addition of the anti-Hoxa2 antibodies (lane 4), 
although most of the shift complex (S) appeared to remain unbound by the antibodies.  
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Figure 4.8  Schematic representation of the murine Tasp and Dyrk4 genes 
Exonic sequences are indicated by closed black boxes, intronic sequences are 
represented by the black line running between the closed boxes, and the UTRs by open 
boxes.  Schematic representation of the 32.95 kb Tasp (Top) genomic sequence present 
on mouse chromosome 5, direction of transcription is indicated by the black arrow.  
Clone 12 displayed 99% identity with the 4th exonic and 5th intronic sequence (indicated 
by red box).  Schematic representation of the two potential transcripts for the murine 
homolog of the DYRK4 gene (Bottom) present on mouse chromosome 6, direction of 
transcription is indicated by the black arrow.  Clone 2 displayed 100% identity with the 
intronic sequences present in both Dyrk4 transcripts (indicated by red boxes). 
 
Tasp  
Dyrk4 
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Figure 4.9  EMSA analysis of clone 2 using recombinant Hoxa2 protein 
Figure A: The clone 2 target sequence was incubated with 10 µg of bacterial protein 
extract from FLAG-Hoxa2 expressing E.coli (lane 2-4).  The addition of anti-Hoxd1 
antibody (Wolf et al, 2001) did not affect shift band formation (S) (lane 3), while the 
addition of anti-Hoxa2 antibodies resulted in a small supershift (SS) (lane 4).   
 
Figure B: The band shift formed by incubation of clone 2 with crude recombinant 
FLAG-Hoxa2 protein extract (lane 7), is inhibited by the addition of 100 X unlabelled 
clone 2 sequence to the binding reaction (lane 6).  Migration of the labeled unbound 
probe is shown in lanes 1 and 5. 
 
 
 
 
 
 
Free probe 
S 
SS 
A B 
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This may have resulted from an insufficient amount of antibody present in the SS 
reactions for binding to high levels of recombinant Hoxa2 protein in the bacterial 
extract.  Alternatively, some of the shift complex (S) may have been formed by bacterial 
factors (lane 2) that are unaffected by Hoxa2 antibodies.  Addition of anti-Hoxd1 
polyclonal antiserum (Wolf et al., 2001) demonstrated that SS was not due to binding of 
clone 2 by serum factors (lane 3). 
In vitro binding of Hoxa2 with the isolated target sequences was further studied 
by electrophoretic mobility shift assays (EMSA) using nuclear extracts (NE).  Binding 
reactions using nuclear protein from E12 whole embryos resulted in the formation of 
multiple shift complexes with clones 4, 5, 3, 12 and 2 (Figure 4.10 A, B, C, D, and E 
respectively).  For clones 4 and 5 (Figure 4.10 A and B) nuclear complexes formed three 
shift bands (Sa, Sb, and Sc).  Supershift assays using anti-Hoxa2 antibodies 
demonstrated an absence in the third shift band (Sc), resulting in the formation of a 
supershift (SS).  EMSAs for clones 3 and 12 (Figure 4.10 C and D) displayed two shift 
bands upon addition of NE (lane 2, Sa and Sb).  Formation of the high molecular weight 
shift band (Sa) was inhibited by incubation with anti-Hoxa2 antibodies and a supershift 
complex (SS) was formed by binding of anti-Hoxa2 antibodies to the low molecular 
weight shift complex (Sb) (lane 3).  It is possible that more shift bands were present for 
clone 12 (Figure 4.10 D, lane 2) that were not resolved by electrophoresis due to an 
excess of nuclear protein present in the binding reaction.  Binding of nuclear protein 
with target 2 resulted in the formation of one shift complex (S) (Figure 4.10 E, lane 2).  
The binding complex did not form a supershift band upon the addition of anti-Hoxa2 
antibodies; instead it displayed the formation of a lower molecular weight shift band 
  98
Figure 4.10  EMSAs for the Hoxa2 target sequences using E12 NE 
EMSA analysis of target sequences from clone 4 (A), clone 5 (B), clone 3 (C), clone 12 
(D) and clone 2 (E).  Binding reactions for each target sequence were performed with 10 
µg of E12 NE (lanes 2-5, A-E).  Migration of unbound target sequences can be observed 
in lane 1 of A-E.  The addition of anti-Hoxa2 polyclonal antiserum resulted in the 
formation of a supershift band (lane 3, A-D).  Incubation of binding reactions with non-
immune rabbit serum did not affect shift formation (lane 4, A-E).  Competition reactions 
using 100 X unlabelled probe resulted in inhibition of shift band formation (lane 5, A-
D).  In figure E, addition of anti-Hoxa2 antiserum resulted in the formation of a lower 
molecular weight shift complex rather than a supershift (lane 3, black arrow) that was 
not observed in the presence of non-immune rabbit serum (lane 4).  Abbreviations:  
Nuclear Extract (NE), Shift band (S), Supershift band (SS), anti-Hoxa2 antiserum (Ab), 
rabbit antiserum (As), Competition (Comp), free probe (fp). 
  99
(Figure 4.10 E, lane 3, black arrow).  Also, clone 2 displayed less competition at 100 X 
unlabelled probe than the other target sequences (Figure 4.10 A-E, lane 5).  Clone 1 was 
not analyzed for binding with E12 NE, and clone 8 did not show binding with any 
Hoxa2 containing nuclear complexes with E12 NE. 
Factors present in NE isolated from E18 hindbrain and spinal cord tissue also 
demonstrated binding to target sequences (Figure 4.11).  Clone 8 exhibited two shift 
bands upon binding with E18 NE (Figure 4.11 A, lanes 1-3) that migrated in close 
proximity to one another.  Addition of anti-Hoxa2 resulted in the appearance of two shift 
bands (Figure 4.11 A, lane 4) that were likely due to DNA binding by factors present 
within the antisera, since they are also observed in the presence of control antisera 
(Figure 4.11 A, lane 5).  The high molecular weight shift complex seen in lanes 1-3 was 
unaffected by the control antiserum (lane 5), but was not observed in the presence of 
Hoxa2 antibodies (lane 4).  Due to poorly resolved shift bands, in lane 5 it is difficult to 
assess whether the lower molecular weight shift band from lane 1 was affected by the 
addition of the Hoxa2 antibodies.  However, this band was clearly seen in the control 
antisera and did not migrate at a much larger molecular weight in lane 5, making it 
unlikely to be formed by a supershift.  It is possible that anti-Hoxa2 antibody mediated 
inhibition of DNA binding by the higher molecular weight complex resulted in an 
increase in binding by the lower molecular weight complex and therefore a larger shift 
band was observed in lane 5.  Although competition assays showed that both shift bands 
were specific for the target sequence, it is likely that Hoxa2 was only involved in DNA 
binding of the top shift band.  As seen for clone 8, binding by E18 nuclear factors to 
clone 5 resulted in the formation of similar shift bands (Figure 4.11 B).  The high 
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Figure 4.11  EMSA analysis of potential Hoxa2 target sequences using E18 
hindbrain and spinal cord NE   
In vitro binding studies using E18 NE was performed on: clone 8 (A), clone 5 (B), clone 
2 (C), clone 4 (D), clone 12 (E), and clone 1 (F).  Shift bands are indicated by black 
arrows. 
 
Figure A:  Clone 8 was incubated with decreasing amounts of NE at 15 µg (lane 1), 10 
µg (lane 2), and 5 µg (lane 3); 15 µg of NE was incubated with 4 µg of anti-Hoxa2 
polyclonal antiserum (lane 4), and non-immune rabbit serum (lane 5), as well as 100 X 
unlabelled probe for competition assay (lane 6). 
 
Figure B:  Clone 5 was incubated with decreasing amounts of NE as well, at a 
concentration of 10 µg (lane 1) and 5 µg (lane 2).  Supershift assays were performed by 
incubating 10 µg of NE with 2 µg (lane 3) and 4 µg (lane 4) of anti-Hoxa2 antiserum.  
Corresponding amounts of non-immune serum were also used (lane 5 and lane 6, 
respectively).  Competition was performed at 100 X (lane 7). 
 
Figure C:  Clone 2 was incubated with NE at 15 µg (lane 1), 10 µg (lane 2), and 5 µg 
(lane 3); 15 µg of NE was incubated with 4 µg (lane 4) and 2 µg (lane 5) of anti-Hoxa2 
polyclonal antiserum, 4 µg of control serum (lane 6), and 100 X unlabelled probe (lane 
7). 
 
Figure D:  Shift bands appeared upon binding of clone 4 to 2 µg and 4 µg of NE (lane 1 
and 2, respectively).  Supershift assays were performed on 4 µg of NE by incubation with 
2 and 4 µg of anti-Hoxa2 antiserum (lanes 3 and 4 respectively), or corresponding 
amounts of non-immune serum (lanes 5 and 6).  Competition of the 4 µg NE binding 
reaction with 100 X unlabelled probe is shown in lane 7. 
 
Figure E:  Binding reations for clone 12 were performed with 0, 2 and 5 µg of NE (lanes 
1, 2, and 3 respectively).  Protein DNA complexes were unaffected by the addition of 
rabbit antiserum (lane 4), but shift bands were inhibited upon incubation with 2 and 4 µg 
of anti-Hoxa2 antiserum (lanes 5 and 6); competition was performed at 25 X and 50 X 
unlabelled probe concentrations (lanes 7 and 8). 
 
Figure F:  Clone 1 binding reactions with 0, 2, 4 and 8 µg of NE protein (lanes 1, 2, 3 and 
4 respectively) resulted in large unresolved shift bands.  The addition of 2 and 4 µg of 
anti-Hoxa2 antiserum resulted in removal of some of the protein complexes involved in 
binding, thereby increasing resolution of the remaining shift bands (lanes 5 and 6).  
Incubation with corresponding amounts of non-immune rabbit serum resulted in an 
overload of protein in the wells at the top of the gel (lanes 7 and 8).  Competition using 
25 X and 50 X unlabelled probe resulted in a reduction in the intensity of the bands in 
lane 1 but is not sufficient in blocking binding entirely (lane 9 and 10). 
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Figure 4.11  EMSAs for potential Hoxa2 target sequences using E18 hindbrain and 
spinal cord NE 
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molecular weight shift band from lane 1 was not seen in the presence of anti-Hoxa2 
antibodies, while binding by the lower molecular weight protein complex was unaffected 
(lane 3 and 4). 
Binding reactions performed for the clone 2 target sequence resulted in the 
formation of three shift bands (Figure 4.11 C, lanes 1 and 2).  The top two shift bands 
migrated in close proximity to one another and were poorly resolved, but could be 
observed upon addition of Hoxa2 antibodies (lane 5).  However, formation of these shift 
bands was inhibited by the addition of a higher amount of Hoxa2 antibodies (lane 4).  
The lower molecular weight shift complex was absent in the presence of both antibody 
concentrations (lanes 4 and 5).  Smearing of the bands in lanes 1 and 2, which is also 
observed upon the addition of rabbit serum (lane 6), was likely due to protein 
degradation of the nuclear extract. 
Although three different protein complexes exhibited binding to clone 4 (Figure
4.11 D, lanes 1 and 2), competition assays demonstrated that the highest shift band was 
due to non-specific DNA binding by NE factors (lane 7).  Supershift assays indicated 
that the lowest molecular weight complex involved Hoxa2 (lanes 3 and 4), but the larger 
molecular weight shift band was unaffected by the addition of anti-Hoxa2 antibodies. 
Nuclear factors produced three band shifts in the presence of clone 12 (Figure 
4.11 E, lanes 3 and 4), but incubation of binding reactions with Hoxa2 antibodies 
inhibited only the top two shift bands (lanes 5 and 6).  Competition of all protein 
complexes bound to clone 12 occured with the addition of 25 and 50 X unlabelled probe.  
The same binding reactions performed with clone 1 (Figure 4.11 F, lanes 2-4) resulted in 
large smeared shift bands.  This may have been due to: an overload of nuclear protein 
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required for binding to this particular target sequence, aggregation of multiple protein 
complexes on the target sequence, the presence of multiple binding sites in close 
proximity resulting in bands with very similar migration rates, and the use of an excess 
amount of radiolabelled probe.  Upon the addition of increasing amounts of Hoxa2 
antibody (lanes 5 and 6), the upper portion of the shift band from lanes 2-4 was removed 
and a sharper, lower molecular weight shift band remained.  Incubation of the binding 
reactions with control antiserum (lanes 7 and 8) resulted in protein overload at the top of 
the gel, indicating large aggregates of serum protein combined with NE factor binding to 
the probe.  Although there is a slight decrease in intensity of the shift band, competition 
at 25 and 50 X concentrations of unlabelled probe did not completely block binding to 
the target sequence (lanes 9 and 10).   
In vitro binding analyses were also performed by EMSAs using P1 hindbrain and 
spinal cord NE of both Hoxa2-/- and Hoxa2+/+ mice.  These revealed a difference in the 
binding complexes observed in the presence and absence of Hoxa2 protein for clone 1 
(Figure 4.12 A and B).  In wildtype mice, three shift bands were observed (Sa, Sb, and 
Sc) with clone 1 (Figure 4.12 A, lanes 1-3), while only one prominent shift was 
observed in the binding reactions with the mutant NE (Figure 4.12 B, lane 2).  Supershift 
assays suggested that the lower molecular weight complexes (Sb and Sc) involved 
Hoxa2 activity (Figure 4.12 A, lane 4).   
Hoxa2 protein synthesized in vitro with wheat germ extract (Figure 4.12 C and 
D) was also used for DNA binding analysis (Figure 4.12 A, lane 5).  Expression of 
Hoxa2 in vitro resulted in the production of two protein bands, at 42 kDa and 48 kDa 
(Figure 4.12 C).  The migration of the in vitro translated protein differed from that of the 
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Figure 4.12  EMSA analysis of clone 1 using P1 NE and in vitro translated Hoxa2 
EMSA analysis for clone 1 was performed using NE isolated from P1 hindbrain and 
spinal cord tissue of Hoxa2+/+ (Figure A) and -/- mice (Figure B).  Incubation with 5, 
10, and 15 µg of wildtype NE resulted in shift bands (Sa, Sb, and Sc) (Figure A, lanes 1, 
2 and 3 respectively).  Supershift of Sb and Sc occured with addition of Hoxa2 antisera 
to the binding reactions containing 10 µg of NE (lane 4).  In vitro translated Hoxa2 
protein bound to the target sequence and displayed faster mobility than complexes 
formed by NE (lane 5, Figure A).  Competition resulted in the removal of the shift band 
for in vitro translated Hoxa2 (lane 6) and for NE shift bands Sb and Sc (Figure A, lane 
7).  Binding of nuclear factors to the target sequence also occurred in mutant NE (Figure 
B, lanes 1 and 2,) and was unaffected by the addition of Hoxa2 antibodies (Figure B, 
lane 3).  Western Blot was performed using anti-Hoxa2 polyclonal antisera and Hoxa2 
protein translated in vitro by wheat germ extract (Promega) (Figure C and D).  In vitro 
translated Hoxa2 protein resolved by 12% SDS-PAGE (Figure C, lanes 1 and 2) 
appeared to migrate as a 42 kDa (black arrow) and a 48 kDa (arrowhead) protein, in 
comparison with Hoxa2 protein present in E12 nuclear extract which appeared to be ~ 38 
kDa (lane 3).  (Figure D) Analysis using 10% SDS-PAGE showed that the Hoxa2 
protein bands (lane 1) did not appear in the wheat germ extract containing no Hoxa2 
cDNA (lane 2). 
Abbreviations:  Nuclear Extract (NE), anti-Hoxa2 Antibodies (Ab), free probe (fp), in 
vitro translated Hoxa2 (IV), nonspecific binding (NS), Supershift (SS). 
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Hoxa2 present in NE (Figure 4.12 C), which appeared to migrate as a 38 kDa protein.  
However, electrophoresis using gels with an increasing percentage of acrylamide and in 
the presence of multiple protein markers showed that Hoxa2 protein appeared to be 38-
48 kDa.  The appearance of a reduced mobility of in vitro translated Hoxa2 may have 
occured as a result of its high acidity (pI 5.53), which is known to alter migration of 
proteins in 1D electrophoresis (Hames, 1990).  It may also have been due to pH 
differences between the nuclear extraction buffer and the wheat germ extract, or the use 
of prestained markers that sometimes migrated slower than their estimated molecular 
weight due to the presence of chromophores.  The appearance of a doublet for in vitro 
translated Hoxa2 may have been due to proteolytic cleavage of the protein product in 
vitro or post-translational modifications such as phosphorylation. 
A single shift band was observed for clone 12 (Figure 4.13, lanes 5 and 6) that 
was distinct from complexes formed by binding with mutant NE (Figure 4.13, lane 8).  
Although anti-Hoxa2 antibodies did not remove the shift band entirely, the intensity of 
binding was reduced indicating inhibition of Hoxa2 binding (Figure 4.13, lane 7).  
Binding analyses using null mutant NE and in vitro translated Hoxa2 protein was only 
performed with clones 1 and 12. 
DNase I footprinting was performed to isolate the specific Hoxa2 DNA binding 
site within the target sequences and to confirm Hoxa2 recognition of the target 
sequences.  Protein from P1 and E18 hindbrain/spinal cord NE were not stable in 
binding DNA, resulting in a lack of protection.  Therefore, NE isolated from E12 whole 
embryos was used in footprinting analysis due to a high level of Hoxa2 expression at this 
time in development (Figure 4.14).  Although some protection in the presence of NE was  
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Figure 4.13  EMSA analysis of clone 12 using P1 Hoxa2 wildtype and mutant NE 
In vitro translated Hoxa2 protein (3 µl) bound the target sequence (lane 2) and was 
inactivated by anti-Hoxa2 antibodies (Ab) (lane 3).  Migration of the unbound probe (fp) 
is shown in lane 1.  Competition reactions for in vitro translated Hoxa2 protein (lane 9), 
and NE (lane 10) using 100 X unlabelled clone 12.  Increasing concentrations of 
wildtype NE at 5, 10, 15 µg appeared to produce shift bands with the target sequence 
(lanes 4, 5, and 6 respectively), and binding of these complexes was reduced upon 
addition of Hoxa2 antisera (lane 7).  Hoxa2 mutant NE also displayed shift bands that 
appeared to migrate at a different rate than those present in the wildtype NE (lane 8).  
All supershift assays were performed using 10 µg of NE and 2 µg of Hoxa2 antibodies.  
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Figure 4.14 DNase I footprinting analysis of clone 2 
Left:  Thermocycle sequencing was used as a DNA ladder for footprinting reactions 
(lanes 1-4, GATC respectively).  The probe was digested with increasing concentration 
of DNase I in the absence of protein (lanes 5 and 6).  Binding reactions using 20 µg of 
E12 NE were digested with increasing concentrations of DNase I (0.002-0.08 U) in lanes 
7 –11, respectively.   
Right: Enlargement of footprinting sites A: 5′ TACCGTAGTACC 3′, and B: 5′ 
GACCGTTTCAGGGA 3′ 
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observed using clone 2 (sites A and B), the footprints did not display a clear consensus 
sequence.  Nor can any firm conclusions be drawn as to a specific Hoxa2 binding site 
until purified recombinant Hoxa2 protein is used in footprinting reations. A database 
search for potential transcription factor binding sites using TESS (Transcriptional 
Element Search System; www.cbil.upenn.edu/tess/) did  not reveal any known 
transcription binding sites similar to site A or B (Figure 4.15).  The only characterized 
Hoxa2 binding site (Lampe et al., 2004), a Pbx bipartite consensus sequence, 5′ 
T/AGATT/GA/GAT/AG/CG/T/A 3′, could not be found within the clone 2 or 12 sequence by 
ClustalW alignment.  TESS analysis demonstrated the presence of multiple binding sites 
within clone 12 for the Drosophila factor Zeste (Figure 4.16 A), and a Zeste binding site 
flanking site B in clone 2 (Table 4.1 and 4.2).  A search for homeobox binding sites of 
Clone 12 revealed the presence of a Thyroid Transcription Factor (TTF-1) binding site 
(Figure 4.16 B), but no previously characterized homeobox binding sites were found 
within the clone 2 sequence.  Although both clone 2 and 12 exhibited multiple binding 
sites for the Glucocorticoid Receptor (GR), ClustalW alignment of the two clones 
revealed few similarities between their sequences. 
To identify the specific Hoxa2 binding site a method utilizing DNase I 
footprinting coupled with Southwestern Blotting (SW) was performed (Figure 4.17).  In 
this approach DNase I footprinting reactions were performed on probes using protein 
that was immobilized on a membrane, with the position of Hoxa2 determined by 
concurrent immunoblotting.  Although Hoxa2 demonstrated binding to target sequences 
2 and 12 (Figures 4.17 A and B, respectively), low binding capacity of the probe to the 
immobilized protein made it difficult to isolate DNA subsequent to DNAse I treatment.  
 
 
Figure 4.15  TESS analysis of clone 2 target sequence 
TESS analysis of potential transcription factor binding sites for clone 2 did not reveal any known homeobox binding sites.  
Sites of protection from the DNase I footprinting for clone 2 are shown boxed.  DNA binding sites are shown by dotted lines, 
followed by the transcription factor name.  The GR and Zeste binding sites flank site B, while site A overlaps with a myogenin 
binding site.  Tabular results of the TESS analysis are shown in Table 4.1. 
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Figure 4.16  TESS analysis of clone 12 target sequence 
 
Figure A:  TESS analysis of the clone 12 sequence for potential binding sites for 
the vertebrate class of transcription factors.  Similarities between the TESS 
analyses of clone 12 and clone 2 was the presence of GR and Zeste binding sites.  
A search for the presence of homeobox binding sites revealed the presence of a 
potential TTF-1 binding site (Figure B).  The TTF-1 transcription factor belongs 
to the NK2 class of homeodomain proteins, and its binding site has been 
characterized as 5′ CAAG 3′. 
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Table 4.1  Tabular results for analysis of clone 2 by TESS 
Tabular results of TESS using the TRANSFAC 5.0 database for clone 2, corresponding 
with Figure 4.16.  The transcription factors have been classified as either vertebrate or 
invertebrate.  The binding site for Zeste, a Drosophila transcription factor, is also present 
in clone 12.  Glucocorticoid Receptor binding sites are also present in both clones 2 and 
12.  The start site of the binding site is shown under Beginning and Length refers to the 
length of the transcription factor binding site.  For the transcription factor binding site 
sequence: W represents nucleotides A and T, R represents A and G, K represents G and 
T, and Y represents C and T. 
 
Factor Classification Beginning Length Sequence 
Zeste Invertebrate 13 6 GACTCA 
GR Vertebrate 22 6 GACACA 
KBF1 Vertebrate 32 11 GGgAAAGTCCC 
HNF-4 Vertebrate 32 12 KGCWARGKYCaY
NF-kappa B Vertebrate 33 10 GgAAAGTCCC 
IL-6 RE-BP Vertebrate 42 6 CTGGAA 
C/EBPbeta Vertebrate 42 7 CTGGRAA 
NF-1 Vertebrate 66 6 CTTTCC 
Ik-1, Ik-2 Vertebrate 68 6 TTCCCA 
TBP Vertebrate 76 7 TACTATA 
GR Vertebrate 82 6 AGAACA 
myogenin Vertebrate 91 7 CCAGGCA 
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Table 4.2  Tabular results for analysis of clone 12 by TESS  
The results of the analysis of clone 12 by TESS in Figure 4.17 A and B have been 
arranged by position within the sequence, name of the transcription factor and 
classification. Beg indicates the start site of the binding site and Length refers to the 
length of the transcription factor binding site that overlaps with the in clone 12 sequence.  
For the sequences of the transcription factor binding site Y represents C and T. 
 
 
Factor Classification Beg Length Sequence 
TCF-1alpha Vertebrate 13 6 CCTTTG 
Tf-LF1 Vertebrate 13 10 CCTTTGaCCT 
TTF-1 Vertebrate 18 9 GCNCTNNAG 
GR Vertebrate 25 6 AGAACA 
USF Vertebrate 32 6 CGTGAC 
c-Myb Vertebrate 37 6 CAACGG 
NF-S Vertebrate 47 7 YGTCAGC 
Sp-1 Vertebrate 55 6 CTGCCC 
RPF1 Vertebrate 88 7 GGGACTC 
Zeste Invertebrate 90 6 GACTCA 
myc-CF1 Vertebrate 97 6 ACATGG 
NF-1 Vertebrate 100 14 TGGANNNNATCCAa 
Sp1 Vertebrate 108 10 ATCCAGcCCG 
Zeste Invertebrate 133 6 TGAGTG 
AML1 Vertebrate 140 6 TGTGGG 
AP-2alphaA Vertebrate 142 6 TGGGGA 
c-Ets-2 Vertebrate 144 6 GGGAAG 
120-kDa CRE-
binding protein 
Vertebrate 150 11 GCTGACgTCAG 
RITA-1 Invertebrate 151 10 CTGACgTCAG 
CREM tau alpha Vertebrate 151 11 CTGACgTCAGC 
PPAR Vertebrate 152 6 TGACCT 
ER Vertebrate 152 6 TGACCT 
URTF, CREB Vertebrate 152 8 TGACCTCA 
RAR-alpha1 Vertebrate 168 17 GGACCANNNNTGaCCT 
HES-1 Vertebrate 175 6 CTTGTG 
GR Vertebrate 177 6 TGTGCC 
GR Vertebrate 184 6 TGTCCT 
GATA-1 Vertebrate 187 8 CCTATCAT 
GR Vertebrate 195 6 ACAACA 
C/EBPalph Vertebrate 196 10 CAAaACACCA 
NF-1 (-like 
proteins) 
Vertebrate 200 7 ACACCAC 
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Figure 4.17  Analysis of DNA binding by P1 NE to clone 2 and 12 using 
Southwestern Blot technique 
Southwestern Blots (SW) of probe 12 (Figure A) and 2 (Figure B and C) using NE 
isolated from hindbrains and spinal cord of P1 mice.  All lanes contained NE at 20 µg 
protein/lane.  Two SWs were performed for probe 2, the first blot was performed using 
milk as a blocking agent (Figure B) and the second SW was blocked with Bovine Serum 
Albumin (Figure C).  Hoxa2 was identified by concurrent immunoblotting with anti-
Hoxa2 polylconal antiserum.  In addition to other nuclear factors, Hoxa2 protein (~ 42 
kDa) bound to both target sequences.  However, its binding activity for probe 2 appeared 
to be increased when BSA was used as a blocking agent rather than milk.  Bands 
corresponding to the position of Hoxa2 were excised for DNase I footprinting but were 
too weak for visualization by autoradiography. 
 
 
 
 
 
~ 42 kDa 
  115
It is apparent however that multiple proteins in addition to Hoxa2 were capable of 
recognizing the target sequences.  The activity of some of these factors may have been 
affected by phosphorylation (Figure 4.17 C).  Although recognition of the potential 
target sequences by Hoxa2 has been demonstrated, the specific binding site and the 
cofactors by which this is mediated were not evident.  Transcription factor database 
analyses of the remaining clones revealed multiple binding sites such as GATA-2, GATA-
3, Oct1, and CdxA.  GATA-2, GATA-3, and Oct1 all have been implicated in neural 
development, and CdxA is known to be involved in spinal cord development.   
4.4  Luciferase Assays of Hoxa2 mediated Regulatory Activity on the Target 
Sequences from Clones 2 (Dyrk4) and 12 (Tasp) in HeLa cells. 
 The putative Hoxa2 target sequences in clones 2 and 12 are present within 
intronic sequences rather than a promoter region.  Hence, the target sequences were 
subcloned into the pGL3 Promoter vector (Promega) (Appendix IV), expression from 
which is regulated by an SV40 minimal promoter.  HeLa cells were found to 
endogenously express the human HOXA2 (see section 4.5), which displays 94.44% 
identity with the mouse Hoxa2 protein.  Cotransfection with a Hoxa2 expressing plasmid 
under the control of the RSV promoter was performed to assess whether overexpression 
of Hoxa2 affected the regulation of the target sequences.   
Although the initial transfection efficiency assessed by cotransfection with GFP 
was found to be ~ 60-80%, the luciferase activity in pGL3 transfected cells was 
considerably low.  Hence, transfections with 1, 2 and 3 µg amounts of pGL3 plasmid 
were assayed with the internal control vector at the recommended ratio of 50:1.  
Increasing reporter plasmid concentrations did not substantially increase the basal 
luciferase activity of the pGL3 vector.  Therefore, transfections of the pGL3 Promoter 
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vector containing the Tasp intronic element from clone 12 (pGL3-c12, Figure 4.18) and 
the reporter vector with the Dyrk4 intronic element from clone 2 (pGL3-c2, Figure 4.19) 
were performed using 2 µg:40 ng amounts of pGL3 to pCMV-RL (Renilla luciferase). 
The use of an internal control at the recommended amount of 50:1 for the 
reporter to control vector (Figure 4.18 D and 4.19 D) resulted in the appearance of 
‘trans’ effects between the reporter plasmid and pCMV-RL, where Renilla luciferase 
activity increased from 1,000-3,000 relative light units in pGL3 transfections, to ≥10,000 
units in pGL3-c2 transfections and 5,000–9,000 units in pGL3-c12.  ‘Trans’ effects are 
sometimes observed when either the control or reporter vector contains very strong 
promoter/enhancer activity.  The activity of a strong promoter affects the ability of the 
promoter/enhancer of the cotransfected vector to direct transcription (Promega, Dual-
Luciferase Reporter Assay System Technical Manual).  This increase in activity of the 
internal control aberrantly reduced the ratio of firefly/Renilla luciferase activity, 
resulting in the alteration of transfection data.  Therefore, varying amounts of reporter to 
internal control vector were assayed for both pGL3-c2 and pGL3-c12 for optimization of 
the assay (Figure A, B, C in 4.18 and 4.19).  However, less than 4 ng of internal control 
vector could not be used since Renilla luciferase activity became too low for 
measurement.  An increase in the ratio of reporter:control from 125:1 to 1000:1 
alleviated the problem of inflated Renilla luciferase values.  Although transfection using 
a ratio of 4 µg reporter plasmid to 4 ng of control plasmid decreased the appearance of 
‘trans’ effects, it resulted in a high degree of variability in firefly luciferase activity of 
the control when cotransfected with pRSV-Hoxa2.  The inhibition in luciferase activity  
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Figure 4.18  Luciferase assay of transfections using pGL3-c12 
Transfection of the pGL3-c12 representing the intronic element of the murine Tasp.  
Firefly luciferase activity was normalized with Renilla luciferase activity (pGL3-
12/pCMV-RL = Luc Activity), and is shown as a ratio to the control pGL3 luciferase 
activity (Luc Activity/pGL3 activity).  Ratios of internal control to reporter vector are 
1:125 (Figure A), 1:250 (Figure B), 1:1000 (Figure C), 1:50 (Figure D).  Cotransfection 
with increasing concentrations of pRSV-Hoxa2 showed a trend of decreasing firefly 
luciferase activity for the pGL3-c12.  Error bars represent the range, with n=2. 
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Figure 4.19  Luciferase assay of transfections with various concentrations of pGL3-
c2: pCMV-RL and pRSV-Hoxa2 
Transfection of the pGL3-c2, containing the target element from the intron of the murine 
Dyrk4 homolog.  Firefly luciferase activity was normalized with Renilla luciferase 
activity, and is shown as a ratio to the control pGL3 luciferase activity.  Transfection of 
the pCMV-Renilla (RL) internal control vector to reporter plasmid at dilutions of 1:125 
(Figure A), 1:250 (Figure B), 1:500 (Figure C), and 1:50 (Figure D).  Cotransfection 
with increasing concentrations of pRSV-Hoxa2 showed a trend of increasing luciferase 
activity.  Error bars represents the range, with n=2. 
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of the pGL3-c12 vector was not statistically significant as calculated by a one-way 
ANOVA test.   
The p values for the luciferase assays of transfections using 1, 2 and 4 µg of 
pGL3-c12 were p= 0.104, 0.087 and 0.059, respectively (Appendix V, VI and VII) and 
therefore were not statistically significant.  However, cotransfection of the pGL3 
Promoter vector containing the Tasp intronic element from clone 12 (pGL3-c12) at 
various reporter:internal control concentrations all displayed a trend in decreasing firefly 
luciferase activity with increasing amounts of Hoxa2 (Figure 4.18 A, B, C, and D). 
For the mouse Dyrk4 intronic sequence, transfection data with pGL3-c2 indicated 
a trend in increased firefly luciferase activity after overexpression of Hoxa2.  However, 
the p value as calculated by one-way ANOVA for transfections with 1 and 2 µg of 
pGL3-c2 (Figure 4.19 B and D) were 0.18 and 0.12, respectively (Appendix VIII and 
IX) and therefore did not demonstrate a statistically significant difference.  
4.5  Dryk4 and Tasp Expression in the Developing Mouse 
 
 Although Expression sequence tags (ESTs) have been isolated for Dyrk4 and 
Tasp from various mouse tissues, their specific developmental expression patterns have 
not been studied.  RT-PCR analyses of both genes showed that they are expressed from 
E10–18 as well in the adult and P1 hindbrain and spinal cord.  Hoxa2 has previously 
been demonstrated to be present at these stages of development, and in the adult CNS 
(Hao et al., 1999). 
 The expression of the murine homolog of DYRK4 during embryonic 
development at stages E10, 12, 14, 16 and 18 (Figure 4.20 A, lanes 1, 2, 3, 4 and 5 
respectively) was analyzed by RT-PCR amplification of a 229 bp fragment from within 
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Figure 4.20  Expression of the mouse Dyrk4 in embryonic and adult mouse tissue 
Figure A: RT-PCR analysis of embryonic Dyrk4 expression at stages E10 (lane 1), E12 
(lane 2), E14 (lane 3), E16 (lane 4), E18 (lane 5).  Figure B: A 229 bp Dyrk4 fragment 
was amplified by PCR using RNA samples from (middle) the adult mouse forebrain 
(lane 1), hindbrain (lane 2), and spinal cord (lane 3), and the sequence verified by 
Southern blot analysis (bottom).  Expression of Dyrk4 was observed in both Hoxa2 
wildtype (lane 4) and mutant (lane 5) hindbrain and spinal cord tissue.  
A
B 
β actin 
Dyrk4  
β actin 
Dyrk4  
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the 15th exon.  Levels of the mRNA for the Dyrk4 homolog appear to be abundant at 
E12, coinciding with one of the developmental stages (E10-12) at which Hoxa2 has the 
highest levels of expression during embryogenesis (Tan et al., 1992; Wolf et al., 2001).  
Low levels of Dyrk4 mRNA were also present within the mouse adult forebrain, 
hindbrain and spinal cord (Figure 4.20 B, lanes 1, 2 and 3 respectively).  Analysis of 
Dyrk4 expression by RT-PCR amplification using RNA isolated from P1 hindbrain and 
spinal cord tissue of Hoxa2 wildtype and mutant mice showed the presence of the Dyrk4 
in both genotypes (Figure 4.20 B, lanes 4 and 5).  It was difficult to determine the 
change in levels of mRNA for the Hoxa2 mutant, therefore further quantitative analysis 
of multiple litters is required. 
Analysis of Tasp expression was performed by RT-PCR amplification of a 429 
bp fragment spanning the 3′ end of exon 8, into exon 9, including a portion of the 3′ 
UTR.  Due to the presence of a serine protease and an IGFBP (Insulin Growth Factor 
Binding Protein) encoding sequence, this region is the only area of the Tasp sequence 
that does not bear significant overlap with any other serine protease or IGFBP.  Tasp 
mRNA is detected at embryonic stages E10-E18 (Figure 4.21 A and B), as well as in the 
adult mouse forebrain, hindbrain and spinal cord (Figure 4.21 C).  Expression of Tasp is 
also present in the hindbrain and spinal cord of P1 mice (Figure 4.21 C).  The absence of 
Hoxa2 expression does not appear to have an all or none effect on Tasp mRNA levels in 
that it is gene expression is not entirely turned on or off.  However, Tasp expression 
within the hindbrain and spinal cord of Hoxa2 mutant mice appears to be slightly higher 
than in wildtype mice (Figure 4.21 C and 4.22 A, B, C). 
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Figure 4.21  RT-PCR analysis of Tasp expression in embryonic and adult mouse 
Figure A: RT-PCR amplification of RNA extracted from whole embryonic mouse tissue 
from stages E10 (lane 1), E12 (lane 2), E14 (lane 3), E16 (lane 4) and E18 (lane 5).  
β actin (top) was coamplified with the 429 bp Tasp sequence (middle).  Southern blot 
hybridization was subsequently performed with the Tasp probe (bottom) for validation of 
the RT-PCR product. 
Figure B: PCR amplification using Tasp primers and an 18S primer:competimer mix for 
mouse E10 (lane 1), E12 (lane 2), E14 (lane 3), E16 (lane 4) and E18 (lane 5) RNA 
samples. 
Figure C: RT-PCR analysis of Tasp expression in the adult mouse forebrain (lane 1), 
hindbrain (lane 2), and spinal cord (lane 3).  Tasp was also expressed in P1 mouse 
hindbrain and spinal cord tissue (middle, lanes 4-6), in both Hoxa2 mutant (lane 4) and 
wildtype mice (lanes 5 and 6).  Analyses of Tasp by RT-PCR showed expression in both 
the adult mouse forebrain and hindbrain (middle, lanes 1 and 2) but not in the spinal 
cord.  However, southern blot analysis showed the presence of low levels of Tasp in the 
spinal cord as well (bottom, lane 3).   
 
 
 
 
 -/-   +/+   +/+ 
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Figure 4.22  Tasp expression in P1 Hoxa2 mutant and wildtype mice  
Tasp expression was analyzed by RT-PCR using RNA from both Hoxa2 mutant and 
wildtype hindbrain and spinal cord tissue.  Amplification of Tasp by RT-PCR is shown 
for litters 4 (Figure A), 7 (Figure B), and 2 (Figure C).  Tasp was coamplificated with β 
actin as an internal control.  PCR amplification of the RT reactions was performed using 
two different concentrations of β actin primers, 0.1 µM (left, Figure A, B and C) and 0.2 
µM (right, Figure A, B, and C).  Agarose gels were subsequently used for density 
measurements for normalization of Tasp expression values with β actin (Figure 4.23). 
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Tasp expression in Hoxa2 mutant and wildtype mice was analyzed by comparing 
density measurements of RT-PCR products separated by gel electrophoresis 
(Figure4.23).  RT-PCRs performed using 0.2 µM concentration of β actin primer were 
analyzed with a densitometer (Figure 4.23).  Three litters were assessed for Tasp 
expression in Hoxa2 mutant mice and their wildtype littermates.  Normalized density 
measurements for Tasp were plotted for individual litters (Figure 4.23 B, C and D) and 
also as total mutant versus wildtype (Figure 4.23 A).  Overall, there appeared to be a 
trend of increasing Tasp expression in the absence of Hoxa2 (Figure 4.23 A).  However, 
the degree of change in Tasp expression was variable between litters. 
A normality test for equal variance indicates that the data follow a Gaussian 
distribution.  Statistical analysis using a one-tailed unpaired t-test (assuming equal 
variance) shows that the differences in Tasp expression between Hoxa2 mutant to 
wildtype mice are significantly different (p=0.03). 
4.6  RT-PCR Analyses of Tasp Expression during Overexpression of Hoxa2 in 
HeLa cells 
 
 The human HOXA2 displays over 94% identity with the murine Hoxa2 protein, 
and has within its C-terminal sequence the J3 peptide that was used for the production of 
anti-Hoxa2 polyclonal antiserum (Hao et al., 1999).  HeLa cells, which endogenously 
express HOXA2, were used for overexpression of murine Hoxa2 by transfection with 
pRSV-Hoxa2 (Figure 4.24 A and B).  Western Blot analysis of protein extracted from 
HeLa cell culture showed Hoxa2 migration at the 62 kDa molecular weight as opposed 
to 42 kDa in nuclear cell extract from murine P1 tissues (Figure 4.24 C, lanes 2-5) and 
whole cell mouse embryonic protein (Hao et al., 1999).  However, protein
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Figure 4.23  Analysis of normalized Tasp expression in Hoxa2 wildtype and mutant 
mice 
Density measurements of Tasp RT-PCR were normalized to β actin amplified with 0.2 
µM β actin primer, corresponding to samples observed in Figure 4.22 A, B and C 
(right). In total, three litters were analyzed for Tasp expression changes in the hindbrain 
and spinal cord tissue of mutants as compared with their wildtype littermates (Figure B, 
C, and D).  In figure A, changes in Tasp expression for mutants compared with wildtype 
are shown by comparing the total values for all litters.  All PCR reactions were 
performed in duplicate.  A one-tailed t-test shows that expression of Tasp in Hoxa2 
mutant mice is significantly higher (*p<0.05) than in Hoxa2 wildtype mice.  Error bars 
represent SD, with an n=4 for wildtype and n=7 for mutant for the combined litter. 
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Figure 4.24  Hoxa2 expression in HeLa cells transfected with pRSV-Hoxa2 
Figure A: Western Blot analysis using anti-Hoxa2 antibodies on 20 µg protein extract 
from HeLa cells transfected with pRSV-Hoxa2 at concentrations of 0, 0.05, 0.25, 0.5 µg 
(lanes 1, 2, 3, 4 and 5 respectively).  Figure B: Western Blot analysis using 10 µg of 
protein extracted from HeLa cells transfected with 0, 1, 2 µg of pRSV-Hoxa2 (lanes 1, 
2, and 3 respectively).  Expression of Hoxa2 in a mammalian system displayed the 
presence of a doublet of protein bands with very similar molecular weights that were 
difficult to distinguish with higher amounts of Hoxa2.  Western Blot analysis of Hoxa2 
protein present in 20 µg of nuclear extract from the hindbrain, spinal cord, heart and 
lung tissue of P1 mice (Figure C, lanes 2, 3, 4 and 5 respectively) showed Hoxa2 at the 
expected 42 kDa size.  However, whole cell protein extracted from the P1 eye appeared 
to be 62 kDa (Figure C, lane 1). 
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extract from murine P1 eyes also displayed migration of Hoxa2 at 62 kDa (Figure 4.24 
C, lane 1).  Also, at lower concentrations two protein bands with very similar molecular 
weights were observed when Hoxa2 was expressed in mammalian cells (Figure 4.24 B, 
lane 1).    
The predicted human ortholog of the mouse Tasp gene is HTRA3 (Accession 
number, gi:24475740 NCBI/Entrez), which displays over 87% identity with the coding 
sequence of the mouse Tasp gene.  The gene specific primers for the mouse Tasp gene 
anneal at positions 1328-1747 of the human HTRA3, resulting in amplification of a 419
bp fragment (Figure 4.25). HeLa cells endogenously expressed HTRA3, and 
overexpression of Hoxa2 in HeLa cells with transfections of 0, 0.05, 0.25, and 0.5 µg of 
pRSV-Hoxa2 did not have any effect on HTRA3 expression when normalized to β actin.  
Transfection with 1 and 2 µg of pRSV-Hoxa2 showed a slight decrease in HTRA3 
expression (Figure 4.26), although differences in expression when assessed by one-way 
ANOVA test are not significant (p=0.32). 
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Figure 4.25  RT-PCR analysis of Tasp expression in pRSV-Hoxa2 transfected HeLa 
cells 
An analysis of Tasp expression using RT-PCR was performed on RNA from HeLa cells 
transfected with pRSV-Hoxa2.  PCR amplification of the human HTRA3 using mouse 
Tasp specific primers results in a 419 bp fragment.  Figure A: Overexpression of Hoxa2 
in HeLa cells did not show a significant change in human HTRA3 (Tasp) expression in 
cells transfected with 0, 0.05, 0.25, 0.5 µg (Figure A, lanes 1, 2, 3, 4 and 5, 
respectively).  Figure B: Transfections using higher concentrations of pRSV-Hoxa2 at 0, 
1, 2 µg (lanes 1, 2, and 3, respectively), also did not significantly affect Tasp expression. 
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Figure 4.26  Effects of Hoxa2 overexpression in HeLa on Tasp mRNA levels 
Expression of Tasp from RT-PCR was normalized with β actin for HeLa cells 
transfected with 0, 1, 2 µg of pRSV-Hoxa2.  Analyses were performed for two 
independent transfections in triplicate using 0.2 and 0.1 µM of β actin primer (top and 
bottom respectively).  Analysis using a one-way ANOVA showed that overexpression of 
Hoxa2 did not significantly alter Tasp expression in HeLa cells, p>0.05 for all three 
groups.  Error bars represent SD. 
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5. DISCUSSION 
Hoxa2 is expressed throughout development from E10 into adulthood and may play 
a role in dorsoventral patterning (Hao et al., 1999).  Isolation of in vivo downstream 
targets of Hoxa2 by immunoprecipitation from chromatin preparations of E18 spinal 
cord and hindbrain tissue would be helpful in identifying putative target genes through 
which Hoxa2 may specify dorsoventral patterning.   
5.1  Limitations of Study 
Chromatin immunopreciptiation (ChIP) has become a more popular method of 
studing DNA binding factors in vivo.  The advantage of using this system is the ability to 
study previously unknown genes that are targets of transcription factors.  The targets are 
isolated in the presence of regulatory cofactors and thereby reflecting their true in vivo 
environment.  Also, this approach allows for identification of direct downstream targets 
in previously uncharacterized pathways.  It is of importance to note that several 
improvements of this method have been established since its use in this study.  It has 
been found that optimization of protein-DNA crosslinking is dependent on the 
anatomical region of the tissue, the developmental stage, cell number and the protein 
factor that is being analyzed (Kurdistani and Grunstein, 2003; Wells and Farnham, 2002; 
Zhou et al., 2004).  Also, digestion of chromatin DNA is now mostly performed using 
sonication since DNase I digestion is more difficult to control.  Before 
immunoprecipitation is performed, sonication is optimized for the production of 
genomic fragments that are 200-1000 bp in length.  Also, chromatin preparations are 
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precleared with Protein A, BSA or sonicated DNA from calf thymus or salmon sperm to 
reduce non-specific binding.  Controls are sometimes performed that consist of either 
immunoprecipitation using no antibody, or chromatin extracted from tissues where the 
transcription factor is not present. 
The efficiency of target gene isolation is also dependent on a variety of factors, 
namely the use of high affinity antibodies.  In some instances researchers have purified 
polyclonal antibodies multiple times to ensure high affinity (Weinmann and Farnham, 
2002).  Also, the use of antibodies produced against whole protein rather than a peptide 
region may be advantageous in that some protein-protein interactions within the 
transcription complex may mask the antigenic region thereby preventing 
immunoprecipitation.  Therefore, antibodies recognizing multiple epitopes may increase 
the number of protein-DNA complexes recognized.  Chromatin preparations are 
sometimes enriched by performing multiple consecutive immunoprecipitations.  
Specificity can also be increased by using excess antibody with decreasing amounts of 
chromatin preparation so that non-specific binding by antibodies is not caused by an 
excess of protein.  The use of cultured cells for chromatin extract rather than embryonic 
tissue may also simplify interpretation of target gene function, although these targets 
would be in vitro and not in vivo.   
5.2  Hoxa2 Protein Expression and Purification of Hoxa2 antibodies 
Expression of recombinant protein in bacterial cultures commonly results in the 
formation of inclusion bodies due to misfolding of the recombinant protein within the 
bacterial cell.  The advantage of extracting recombinant protein in the form of inclusion 
bodies is that high yields of the expressed protein can be separated from most bacterial 
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cytoplasmic proteins by centrifugation.  Recombinant FLAG-Hoxa2 protein was isolated 
from bacterial cell extract in the form of inclusion bodies by solubilization with 
guanidine-HCl.  One disadvantage of inclusion body purification is that the expressed 
protein is denatured and may therefore be biologically inactive.  As the B579 antibody 
was produced by an immune reaction to the J3 peptide present within the C-terminal end 
of the homeodomain (Hao et al., 1999), it was not necessary for the recombinant Hoxa2 
to be properly folded for affinity purification of Hoxa2 specific antibodies.  However, 
dialysis prior to affinity purification of the protein was necessary due to incompatibility 
of the anti-FLAG M2 antibody with guanidine-HCl.   
Although purification of recombinant Hoxa2 protein using the FLAG system 
resulted in very pure protein, the yield of protein was insufficient for use in purification 
of Hoxa2 specific antibodies.  Therefore ammonium sulphate precipitation was utilized 
to increase the amount of recombinant protein isolated.  Salting out of protein is a 
common procedure for concentrating protein in fractions or as a partial purification step.  
The 0-30% ammonium sulphate protein fraction was used to partially purify the 
recombinant Hoxa2 protein.  As the concentration of salt in solution increases more 
proteins become insoluble, therefore partial purification of Hoxa2 was performed at a 
lower salt concentration.   
The final protein mixture of ammonium sulphate precipitated and FLAG purified 
Hoxa2 was further purified by centrifugation with a Centricon-30, to exclude proteins 
with a molecular weight lower than 30 kDa.  Analysis of the Hoxa2 protein mixture by a 
CD scan indicated that ~ 30% of the proteins in this solution exhibited an alpha-helical 
structure.  Hoxa2 consists of a helix-turn-helix motif within the homeodomain sequence 
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and as well as unordered structures within the N- and C-terminal sequences.  Therefore 
the partially purified recombinant Hoxa2 should exhibit mostly alpha helical, type I turn 
and unordered structures.  However, alpha helical proteins are present in many bacterial 
proteins and therefore CD analysis does not accurately reflect the percentage of Hoxa2 
present within the solution.  Also, addition of the helical inducer TFE increased the 
percentage of alpha-helical structures indicating that a lack of alpha helical structures 
present was due to improper renaturation after purification rather than contamination. 
To minimize the amount of contaminating serum proteins present in the Hoxa2 
polyclonal antiserum, Protein A sepharose was used to isolate the IgG antibodies.  
Cross-reactivity of the B579 antiserum to bacterial proteins was not observed when 
tested against Hoxd1 expressing E.coli cultures in western blot analysis (Appendix X).  
Also, immunohistochemistry using mouse embryonic tissue sections indicated that the 
subsequent purification of the IgG specific Hoxa2 polyclonal serum using partially 
purified recombinant Hoxa2 resulted in isolation of Hoxa2 specific antibodies (Wolf et 
al., 2001). 
5.3  Chromatin Immunoprecipitation of Hoxa2-DNA Target Sequences and 
Identification of potential Hoxa2 Target Genes 
Immunoprecipitation of E12 chromatin for the identification of Hoxa2 targets 
would be advantageous since Hoxa2 embryonic expression is particularly high at this 
time point.  Also, specification of the rhombomeric segments in the hindbrain occurs 
early on in development (~ E10) and Hoxa2 is the most anteriorly expressed Hox gene 
within these rhombomeres at this stage (see section 2.6).  Immunoprecipitation of 
Hoxa2-DNA targets from chromatin using the method described by Safaei (1997) 
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resulted in contamination with a precipitant and poor yield in transformants after 
cloning.  Although target sequences were isolated, all clones were less than 100 bp in 
length.  Contamination of the DNA was likely a result of high concentrations of EDTA 
used for proteinase K removal of protein from the target sequences, described by Safaei 
(1997) as a working concentration of 0.1 M EDTA.  Several washes with 70% ethanol 
did not remove the precipitant.  It is unlikely that contamination was due to a carry over 
of salts as increased dialysis following immunoprecipitation did not alleviate the 
contamination, and any salts present in the sample would have been removed by 
washing the DNA pellet in 70% ethanol.  To remove contaminants, samples were 
dissolved in water and purifed by buffer exchange using Sephadex G-25.  However, the 
subsequent DNA sample contained EDTA after precipitation with ethanol, albeit at 
lower levels.  High levels of EDTA do not affect proteinase K activity (Invitrogen); but 
instead protect DNA against nuclease activity.  However, EDTA can chelate Mg2+ which 
is required for subsequent enzyme reactions such as ligation for cloning.  This resulted in 
isolation of only a few clones from the immunoprecipitation.  Subsequent 
immunoprecipitation with E18 hindbrain and spinal cord chromatin preparations, 
performed with reduced amounts of EDTA (10 mM), resulted in the isolation of seven 
potential target sequences.  Although anteroposterior specification of hindbrain and 
spinal cord segmentation is complete at E18, expression and mutant analysis of Hoxa2 
indicates that Hoxa2 may specify dorsoventral patterning at E18-P1 (Davenne et al., 
1999; Hao et al., 1999).  More specifically, in later stages of development Hoxa2 is 
likely involved in the specification of neuronal phenotypes within the CNS (Hao et al., 
1999; Ohnemus et al., 2001).  Therefore, potential target sequences isolated at this 
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developmental stage may reflect more of a cell specific role for Hoxa2 in differentiation 
rather than functioning as a global selector gene controlling morphology as is observed 
with earlier stages of development. 
Clone 8 was found to display  an identity of 99% with the E.coli dgt gene but this 
information did not provide insight into identification of a potential murine target gene.  
The dgt gene encodes a dGTPase enzyme involved in the DNA repair pathway, where it 
is responsible for dephosphorylating dGTP to deoxyguanosine and tripolyphosphate 
(Nakai et al, 1990).  Some human and rodent dGTPases have been isolated that are 
homologs of the MutT and MutY enzymes; however they do not bear any significant 
identity with the dgt gene.  Conservation of this sequence from bacteria to mice is 
suggestive of an evolutionarily conserved element so it is possible that this sequence 
represents a mitochondrial sequence.  However, screening of human mitochondrial DNA 
databases, as well as other species, yielded no results.  Also, clone 4 aligns with several 
E.coli genomic sequences but did not produce high identity (98%) with any vertebrate 
sequences.  Although both clones 4 and 8 were shown to align with various Trace 
Archive Sequences, these did not appear to be mapped within the present build (v.32) of 
the mouse genome.  It is possible that clones 4 and 8 are a result of contamination of the 
immunoprecipitation with bacterial DNA.  Hoxa2 protein may have promiscuously 
bound these E.coli sequences which both consist of the in vitro Antp homeodomain 5' 
TAAT 3' site, in particular clone 8 has several of these sites present.  Carry-over of 
bacterial sequences may have occured by accidental elution of Hoxa2 protein with 
Hoxa2 specific antibodies from the AffiGel matrix when purifying the B579 antiserum.  
The presence of these sequences within the Trace Archive may be due to partial 
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sequencing of the ends of BAC clones used for Whole Genome Shotgun sequencing of 
the mouse genome.   
Clones 1, 3 and 5 showed no alignments to E.coli sequences and therefore were not 
due to contamination.  However, using BLAST alignment only low identitiy (<70%) was 
observed with multiple mouse sequences in the Ensembl Genome database.  These 
sequences may represent areas of the mouse genome that have not yet been assembled, 
and may be identifiable in subsequent builds of the mouse genome.  Hence, screening a 
genomic library with the immunoprecipitated target sequences may have been 
advantageous because it would allow for the isolation of larger genomic fragments that 
may facilitate identification of the target genes and is not reliant on the amount of 
information available through the Mouse Genome Browser. 
BLAST queries of the Ensemble database identified two of the isolated clones as 
partial intronic sequences of the murine homolog of the human DYRK4 gene and the 
murine homolog of the human HTRA3, also known as Tasp.  Both target genes identified 
for clone 2 and clone 12 belong to superfamilies that are known to be involved in CNS 
development.  It was expected that as a transcription factor Hoxa2 would bind to 
promoter sequences for regulation of transcription and therefore sequences isolated by 
this method would identify putative promoters.  There are however many examples of 
homeodomain proteins acting on regulatory elements within intronic sequences to 
specify expression within tissues particularly in the CNS (Cvekl et al., 1995; Haerry and 
Gehring, 1997; Lonigro et al., 2001; Lou et al., 1995; Zhu et al., 2004). 
The novel gene that was identified from clone 2 is dual specificity tyrosine 
phosphorylation regulated kinase 4 (Dyrk4) (as predicted by Ensemble pipeline 
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analysis), which belongs to a protein family consisting of 6 murine members (Becker et 
al., 1998).  These proteins are so named for their activity in autophosphorylation of 
tyrosine residues, resulting in their activation and subsequent phosphorylation of other 
target proteins.  The pipeline analysis involves the use of a GeneWise or GenScan 
prediction followed by confirmation of the exons by comparison to protein, cDNA and 
EST databases.  The Dyrk protein family, including several homeodomain interacting 
protein kinases referred to as HIPK proteins was identified as a group of co-repressors 
for homeodomain transcription factors.  Using Nkx1.2 homeoprotein as bait, a yeast 
two-hybrid screen isolated HIPK2 as a potential cofactor that differentially interacted 
with homeoproteins, and in the case of Nkx1.2 repressed its transcriptional activity (Kim 
et al, 1998).  These cofactors were identified as proteins that affect the function of 
homeodomain proteins by phosphorylation.  The human DYRK4 has been implicated in 
neuronal differentiation in retinoic acid induced postmitotic neurons, although the 
mechanism through which this occurs has not been studied (Leypoldt et al, 2001).  The 
Dyrk4 gene is the least characterized kinase of the family and its expression and function 
has not been widely studied.  However, recently a large body of research on the function 
of kinase activity for Dyrk family members has emerged.  Dyrk1a is expressed in the 
embryonic and adult cerebellum, brainstem motor nuclei and spinal cord and its 
mutation is associated with impaired motor dysfunction (Becker et al., 1998; Martinez 
de Lagran et al., 2004; Guimera et al., 1996, 1999; Marti et al., 2003; Song et al., 1996).  
Also, the expression analysis of Dyrk1a coupled with its position within the so called 
Down Syndrome Critical Region of human chromosome 21 has implicated it as playing 
a role in Down Syndrome (reviewed in Hammerle et al., 2003).  Dyrk1b has three 
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different isoforms which are expressed in a variety of mouse tissues and in several 
carcinomas (Leder et al., 2003).  Phosphorylation by Dyrk1a and 1b affects a variety of 
functions through activation of transcription (Lim et al., 2002 a, b), and was implicated 
in the regulation of epithelial cell migration (Zhu et al., 2003).  They are also involved in 
the post-translational turnover of cell-cycle regulators (Ewton et al., 2003; de Graaf et 
al., 2004).  DYRK2 was shown to phosphorylate factors involved in transcription and is 
overexpressed in several adenocarcinomas (Campbell and Proud, 2002; Miller et al., 
2003).  Apoptosis is modulated in part by kinase activity on the CRE (cAMP Response 
Element) and CREB (CRE binding protein) pathways by DYRK3 during erythropoiesis 
(Li et al., 2002).  Although both DYRK2 and DYRK3 are localized within the 
cytoplasm, DYRK1 and its isoforms function within the nucleus.  The murine Dyrk4 
protein consists of a bipartite nuclear localization signal and is therefore likely a nuclear 
protein as well (Ensemble Mouse Genome Database; EBI/Sanger Institute).   
All of the DYRK family members are implicated in serine and tyrosine 
phophorylation.  Dyrk4 also has the conserved serine/threonine and protein kinase 
domain present within all family members, and therefore likely functions in a similar 
manner in phosphorylation of its targets.  The substrate specificities for several of the 
DYRK family members have been determined.  Although there were some differences in 
specificities for various family members, those investigated required the presence of an 
arginine amino acid on the N-terminal side of their target residue (Campbell and Proud, 
2002).  Also, several DYRK family members are capable of targeting the same substrate 
(Campbell and Proud, 2002). 
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The RIKEN institute, which first identified the Tasp cDNA sequence, has 
designated the name of the murine homolog of HTRA3 as Tasp but no experimental 
evidence to date suggests that it is related to any of the Drosophila proteins involved in 
cleavage of the Toll ligand Spätzle.  Also, the HTRA family of proteins is highly 
conserved in humans, rat and mice, but there is no evidence of their homology to 
Drosophila serine proteases.  The Drosophila Toll transmembrane receptor is well 
known for its important role in dorsoventral patterning of the Drosophila embryo. Its 
function is dependent on binding with its ligand Spätzle, which is a secreted protein that 
requires activation by a serine protease cascade requiring several protease factors.  
Activation of Toll results in the initiation of a signaling pathway, which in turn 
transports the factor Dorsal into the nucleus and hence induces polarization of the 
embryo (reviewed in: Stathopoulos and Levine, 2002; Armstrong et al., 1998). 
The serine protease superfamily consists of a large number of different proteins 
that function in varying roles.  HtrA2, or Omi, is a mitochondrial specific protease 
related to cellular stress response, and was shown in mice to cause the neuromuscular 
disorder of motor neuron degeneration 2 (Gray et al., 2000; Jones et al., 2003).  The 
human HTRA1 has been studied in cartilage cells where it was found to potentially play 
a role in the regulation of cell growth, and its overexpression in various cell types caused 
inhibition of cell growth and proliferation (Hu et al., 1998; Baldi et al., 2002).  Tasp and 
HtrA1 have been found to be upregulated in the mouse uterus during placentation and 
pregnancy, and low levels of a potential alternative transcript of Tasp were also observed 
(Nie et al., 2003; de Luca et al., 2004).  The probable human counterpart of Tasp 
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displayed high expression in human tissues such as the adult brain and heart, with low 
expression found in numerous other tissues (Nie et al., 2003).     
The Tasp protein does have several proteolytic domains and there are multiple 
Toll-like receptors identified in the murine system, however no evidence of Toll receptor 
involvement in murine embryogenesis has been observed.  Also, the activity of Tasp is 
further complicated by the presence of several different overlapping protein domains 
such as: HtrA/DegQ protease, a kazal-type serine protease inhibitor, serine protease V8, 
a trypsin-family serine protease, PDZ/DHR/GLGF domain, as well as a bipartite nuclear 
localization signal (for a list of abbreviations see pg xiv-xviii).  Recently the murine 
Tasp, or HtrA3, was found to bind to similar TGFβ signaling protein targets as those 
previously identified for HtrA1, and also inhibited signaling of BMP-4,-2, and TGFβ1 
(Tocharus et al., 2004).  The specific role of Tasp regulated TGF signaling in embryonic 
development has not been identified, and whether these signaling pathways are 
controlled by Tasp in vivo has not been shown.  Although pathways downstream of TGF 
signaling have been shown to regulate the actions of Dorsal in Xenopus and contribute to 
dorsoventral patterning during early development of Xenopus and zebrafish, this has not 
been demonstrated in mice (Shimizu et al., 2000; Takebayashi-Suzuki et al., 2003).  
However, TGF signaling along with homeobox genes mediate vertebrate asymmetric 
gene expression along the left-right axis during murine embryogenesis (reviewed in 
Hackett, 2002).  It is important to note that although HtrA1 and HtrA3/Tasp have very 
similar protein domains and appear to recognize similar signaling targets, only 
HtrA3/Tasp has a nuclear localization signal.  Therefore, HtrA3/Tasp may have a more 
specific nuclear function in vivo that is different from the secreted HtrA1 and perhaps is 
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more similar to HtrA2, which has been shown to aggregate in the nucleus during cellular 
response, where it mediates apoptosis (Gray et al., 2000; Fahrenkog et al., 2004).   
Both the Dyrk4 and Tasp genes are quite long (>30 kb) and the isolated target 
sequences are present within introns that are closer to the 3' end of the gene.  It is 
possible that these intronic sequences are not involved in regulation of the gene they are 
present in but instead regulate genes positioned up or downstream of Tasp and Dyrk4.  
This is unlikely for the Tasp gene since the closest adjacent gene is >30 kb in distance.  
Although there have been examples of very long range regulatory sequences that act >50 
kb away (Crisponi et al., 2004; Carter et al., 2002), and there are no examples of 
vertebrate homeodomain proteins acting over such a long-range in regulation of 
transcription.  Also, most examples to date of distal enhancer-promoter interactions 
describe regulation of genes that reside within gene clusters or are linked, and most 
consist of highly conserved sequences present in multiple species (Calhoun and Levine, 
2003).  Interestingly, the specific genes flanking Dyrk4 and Tasp are conserved in 
various species (chicken, rat and human).  Also, in some cases the interchromosomal 
distance between adjacent genes is also conserved.  However, BLAST and ClustalW 
analysis show that neither target sequence from the introns of either gene is present 
within the human or rat homologs.  Dyrk4 is flanked by two genes encoding protein 
kinase A anchoring protein 3 and RAD51 associated protein, which are situated ~16 and 
34 kb away respectively from the Dyrk4 intronic sequence recognized by Hoxa2.  If no 
regulatory effect is observed with Hoxa2 on these target genes, then methods such as 
FISH and RNA TRAP could be utilized to further study possible long-range activity of 
these sequences (reviewed in: Dekker, 2003; Carter et al., 2002). 
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There have also been examples of intronic enhancers regulating other genes by 
acting as a distal promoter for downstream genes and for alternative transcripts within a 
gene (Molina et al., 1993; Nakayama et al., 2001; Schausi et al., 2003; Tiffoche et al., 
2001; Wijesuriya et al., 1999).  Promoter analysis of both sequences using ProScan 
Version 1.7 (BMIS, CIT, NIH: http://bimas.cit.nih.gov/molbio/proscan/) did not reveal 
putative eukaryotic Pol II promoter sequences.  Exonic sequences have also been shown 
to influence regulation of transcription (Dirksen et al., 2003; Yanicostas and Lepesant, 
1990; Wang et al., 2002 a, b), and part of the chromatin immunoprecipitated sequence 
for Tasp included the exonic region.  Therefore, it may be possible that elements within 
the adjacent exonic sequences are involved in transcriptional regulation as well. 
Several Dyrk family members encode alternative transcripts, and the human 
DYRK4 has two potential transcripts of 12 and 13 exons (Ensemble Mouse Genome 
Database; EBI/Sanger Institute).  Also, Tasp has been shown to encode an alternative 
transcript present in the uterus.  Therefore, the possibility that Hoxa2 is involved in 
regulation of alternative transcripts should be examined.  Although the occurrence of 
intronic enhancer regulated alternative splicing has been well documented (Dirksen et 
al., 2003; Scamborova et al., 2004 and referenced therein), homeobox genes have not 
been implicated in this type of transcriptional regulation.  It would be interesting to 
investigate whether Hoxa2 plays a role in differential regulation of cell or tissue specific 
transcripts. 
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5.4  In Vitro DNA Binding Analyses of the Immunoprecipitated Target 
Sequences 
It should be noted that in vitro binding analyses of the immunoprecipitated clones 
was performed prior to determining the identity of the target sequences since the mouse 
genome database was incomplete at that time.  Only clone 12 had been identified as a 
potential RIKEN clone by partial overlap with its sequence and the cDNA, however the 
genomic sequence was not available at that time.  In addition, classification of the target 
gene was difficult to determine due to the high homology between the serine protease 
family members.  Hence, analysis of in vitro binding of Hoxa2 to the potential target 
sequences was performed on all isolated clones.  Both clones 4 and 8 showed binding by 
Hoxa2 in vitro, this is likely due to the presence of several TAAT sites within these 
sequences resulting in promiscuous binding of Hoxa2 (Ekker et al., 1994).   
Analyses of in vitro DNA binding of the target sequences indicated that various 
nuclear factors present in E12 and E18 tissues are able to recognize and bind to these 
sequences.  Supershift assays indicated that Hoxa2 was present in protein complexes 
binding to the target sequences.  E12 NE supershift assays and in vitro binding with 
recombinant Hoxa2 demonstrated binding of Hoxa2 with clone 2 (Dyrk4), albeit with 
low affinity (Figure 4.9 and 4.10 E).  Southwestern blot analyses indicated that the 
phosphorylation state of Hoxa2 may be important in its ability to recognize the Dyrk4 
intronic element, and therefore EMSAs using in vitro translated Hoxa2 protein may have 
been more appropriate.  DNA binding analysis using recombinant Hoxa2 protein may 
also indicate that in the context of the Dyrk4 target sequence, Hoxa2 requires the 
presence of stabilizing nuclear cofactors for high affinity DNA binding.  Also, the 
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addition of B579 antiserum resulted in a downshift rather than a supershift with E12 NE 
(Figure 4.10 E).  It is possible that removal of Hoxa2 from the binding complex does not 
affect the ability of other transcription factors to recognize the Dyrk4 element and 
therefore Hoxa2 itself may be a cofactor rather than the primary nuclear factor binding 
to the DNA.  Binding using E18 NE was also observed for clone 2, although resolution 
of the shift band makes it difficult to determine the number of transcription factors 
involved. 
Clone 12 was bound by nuclear factors present in E12 NE, and supershift assays 
also indicated that Hoxa2 was involved in recognition of this sequence (Figure 4.10 D).  
It is possible that multiple shift complexes with similar molecular weights were bound to 
clone 12.  It would therefore be optimal to perform EMSAs with electrophoresis on a 
larger gel apparatus so that increased separation can occur.  Alternatively, decreasing 
amounts of NE could be used to determine which complex has the highest affinity for 
this target.  Binding with varying amounts of E18 NE showed that three shift bands were 
present, and supershift assays demonstrated that two of these complexes involved Hoxa2 
activity (Figure 4.11 E).  It is possible that some of the complexes present for E12 and 
E18 NE were the same.  However, it has been hypothesized by researchers that 
homeodomain protein activity is regulated by the presence of cell and tissue restricted 
expression of various cofactors, which in turn increase the specificity of their target 
sequences (see Section 2.3; Chariot et al., 1999a; Vigano et al., 1998).  Binding by E18 
NE would more accurately reflect the activity of Hoxa2 on Tasp since ChIP was 
performed on CNS tissue from this developmental stage.  The use of in vitro translated 
Hoxa2 in EMSAs with clone 12 demonstrated that Hoxa2 is capable of binding to this 
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target in the absence of cofactors (Figure 4.13).  It would be interesting to determine 
whether one or both the 42 or 48 kDa in vitro translated Hoxa2 protein were active in 
binding to the target sequence.  Binding analyses of Hoxa2-/- NE indicated that although 
Hoxa2 is required for binding of some protein complexes to clone 12, it is neither 
present nor required in all complexes involved in binding these DNA sequences.  It is 
possible that one of the protein complexes observed for the mutant NE involved activity 
of Hoxb2 or another homeodomain that is capable of functionally compensating for 
Hoxa2.  Also, expression of Tasp is observed in a variety of tissues throughout 
development and into adulthood, and expression of Hoxa2 has not been observed in 
several of these tissues.  It is likely that Tasp is co-regulated by multiple transcription 
pathways and plays an important role in the cell. 
In vitro binding analysis of clones 1, 3 and 5 was also performed.  Clone 1 
demonstrated binding with nuclear factors present in E18 NE, but it was difficult to 
assess how many shift complexes Hoxa2 was involved in (Figure 4.11 F).  Analysis 
using P1 NE from Hoxa2+/+ and -/- mice showed two shift complexes that involved 
Hoxa2 recognition of clone 1 (Figure 4.12).  However, there are larger molecular weight 
complexes present in mutant NE that were capable of binding to clone 1 in the absence 
of Hoxa2.  Binding with in vitro translated Hoxa2 indicated that recognition of clone 1 
by Hoxa2 was direct rather than through protein-protein interactions (Figure 4.12).  As 
both clones 1 and 12 are longer sequences (>200 bp) it is possible that multiple protein 
complexes recognized these targets due to the presence of several transcription binding 
sites.  It is therefore not surprising that Hoxa2 was not involved in recognition of these 
targets for all of shift complexes that were observed by EMSA.  Binding analysis of 
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clone 3 was performed using E12 NE (Figure 4.11 C), where two shift complexes 
containing Hoxa2 were observed.  EMSA performed on clone 3 with E18 NE resulted in 
unresolved shift bands retained at the top of the gel (Appendix XI).  Clone 3, which is 
the longest sequence isolated by ChIP, is 272 bp in length.  Hence, the presence of a 
large number of binding sites within this sequence may have resulted in an aggregation 
of large amounts of nuclear protein with the probe making separation of shift bands 
difficult by electrophoresis.  In vitro binding analysis of clone 1 may yield better results 
with in vitro translated Hoxa2 rather than NE.  Clone 5 demonstrated binding by both 
E12 and E18 NE (Figure 4.10 B and Figure 4.11 B).  Although multiple shift complexes 
were formed by nuclear factors with clone 5, Hoxa2 was involved in only one shift 
complex for both E12 and E18 NE. 
EMSA is generally performed utilizing probes that range from 30-100 bp for 
formation of distinct shift bands (Laniel et al., 2001).  DNA binding analyses of these 
target sequences, in particular those targets >100 bp, with NE would be optimal using 
several shorter (~50 bp) overlapping probes for each target.  Binding by nuclear factors 
and resolution of shift bands for these shorter sequences may enhance their stability 
during electrophoresis and the use of shorter sequences would also identify the putative 
Hoxa2 binding element.  DNA binding analyses using in vitro translated Hoxa2 protein 
could determine whether these targets are recognized by Hoxa2 through direct 
recognition of binding site or through protein-protein interactions.  Most examples of 
homeodomain recognition involve direct interactions with a DNA binding element.  
However, there have been examples where DNA recognition by a homeodomain is not 
necessary and the regulatory effect of the Hox protein is solely mediated via protein 
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interactions (Catron et al., 1995; Hussain and Habener, 1999; Suzuki et al., 2003).  
However, full-length homeobox proteins, particularly those within the 3' end of the 
cluster, have been shown to display low stability and specificity when binding DNA in 
vitro (Shen et al., 1996).  Hence, EMSAs using recombinant and in vitro translated 
Hoxa2 may not be feasible for different target sequences, as was observed when 
attempting to perform EMSA with recombinant Hoxa2 with the majority of isolated 
target sequences.  Difficulty in using recombinant Hoxa2 for in vitro binding analysis is 
likely due to protein aggregation.  This is a common problem during expression of 
proteins resulting in decreased solubility and stability of the protein.  Previous 
expression of recombinant Hoxa2 has shown this to be a problem, therefore utilizing 
recombinant Hoxa2 for in vitro binding experiments would require optimization of 
conditions to maximize solubility and stability after purification (Bondos and Bicknell, 
2003).  Also, purification of the recombinant Hoxa2 may be necessary to remove 
prokaryotic homeodomain factors that may compete by recognition of similar DNA 
binding sites or through conserved protein-protein interactions (Kant et al., 2002).  
Recent attempts by collegues in our research group at purifying soluble forms of GST-
Hoxa2 show strong interactions with bacterial factors, which could potentially result in 
decreased DNA binding activity.  
To help determine the specific binding element recognized by Hoxa2, DNaseI 
footprinting of clone 2 (Dyrk4) was performed.  Although DNA footprinting analysis 
was attempted with clone 12 (Tasp) (Appendix XII), protection of sites greater than 4 bp 
was not observed.  This is likely due to an insufficient amount of nuclear factors bound 
to the probe or unstable DNA binding.  DNA binding analysis using EMSA is generally 
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more sensitive for detecting DNA-protein interactions unlike DNA footprinting which 
requires binding of all or most of the probe for protection to be evident.  P1 and E18 NE 
were unable to provide protection for DNA footprinting of clone 2.  Although Hoxa2 
expression is present at these stages within the CNS, levels of protein are not as high as 
E12.  Therefore, E12 NE was utilized because levels of Hoxa2 expression are highest at 
this development stage in several different tissues.  Footprinting analysis using E12 NE 
revealed some protection at two sites within clone 2 (Figure 4.14).  These sites do not 
resemble the typical homeobox TAAT site, however they may represent a half binding 
site for Hoxa2 with various cofactors.  It is also possible that binding of Hoxa2 was too 
unstable for protection and these sites represent other factors involved in regulating 
Dyrk4.  Problems associated with a lack of protection against DNase I may be alleviated 
by: using purified Hoxa2 protein rather than NE, or isolation of NE from cell cultures 
overexpressing Hoxa2.  
Analysis of clone 2 using TESS did not reveal previously characterized 
homeodomain binding sites (Figure 4.15).  It should be noted that almost all of the 
characterized in vivo binding sites for Hox proteins have been determined from auto and 
crossregulatory target genes involving the Pbx and Meis family of cofactors.  These 
mechanisms and sequences appear to be highly conserved in early development, and 
may not reflect the DNA binding ability of Hox proteins with other types of cofactors at 
later stages of development.  Site B from DNA footprinting is adjacent to both a Zeste 
and Glucocorticoid Receptor (GR) binding site.  It partially overlaps with Hepatocyte 
Nuclear Factor-4 (HNF4) binding sites as well as NFκB and KBF1 sites.  Members of 
the HNF steroid/thyroid receptor superfamily have important functions in liver and gut 
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development, but they are not known to play a role in the CNS (Taraviras et al., 1994).  
NFκB (Nuclear Factor kappa B) is a ubiquitously expressed transcription factor also 
found within the murine brain that dimerizes with various factors such as KBF1 to 
regulate transcription in response to various signaling pathways (Bakalkin et al., 1993).  
The only cooperative interaction documented for homeobox genes and NFκB is with the 
intestine specific homeodomain Cdx1, which is not a member of the Hox gene cluster 
(Kim et al., 2004).  Both clone 2 and 12 have Zeste and GR binding sites present, and 
clone 12 has a binding site for the nonclustered TTF1 homeodomain (Figure 4.16).  It is 
interesting that a TTF1 binding site is present within the Tasp intronic sequence in that it 
may represent possible regulatory interactions between homeobox factors on the same 
target sequence.   
Zeste is a self-aggregating Drosophila transcription factor that is involved in 
transvection (reviewed in Duncan, 2002).  Transvection is a term coined by E.B. Lewis 
in 1954 to describe the actions of an enhancer acting in trans between homologous 
chromosomes (referenced in Duncan, 2002).  This phenomenon is common in 
Drosophila and has been observed for many genes within the homeotic complex.  At 
present there are no proteins identified in vertebrates that exhibit an analogous function 
to that of the Zeste factor, and transvection has only been implicated in regulation of the 
β-globin locus (Ashe et al., 1997).  Analysis of the structural and functional properties of 
the Zeste DNA binding domain indicates that it is most related to the Myb and 
homeodomain structures (Mohrmann et al., 2002).  Although Zeste binding sites have 
been previously identified in the murine Pax8 promoter, the activity of this site has not 
been determined (Okladnova et al., 1997). 
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Site A from clone 2 overlaps with a binding site for Myogenin, which is an early 
cell differentiation marker.  Myogenin is a member of the myogenic bHLH family of 
transcription factors that are involved in skeletal muscle cell specification (reviewed in 
Kablar and Rudnicki, 2000).  Some family members are expressed during development 
in the CNS where they function to inhibit neuronal differentiation (Delfini and Duprez, 
2004; Kablar, 2002).  All myogenic bHLH factors consisting of an E2a domain display a 
highly conserved N-terminal motif through which cooperative binding to DNA with the 
homeodomain heterodimers Pbx-Meis2/Prep1 may occur (Knoepfler et al., 1999).  In 
vitro binding experiments have shown that Pbx-Meis/Prep1 sites flank the Myogenin 
binding site within E-box elements (Funk and Wright, 1992), and these sites are bound 
by Pbx-Meis cooperatively with all four Myogenin family members (Knoepfler et al., 
1999).  It is possible that Hoxa2 interacts with Myogenin in a manner similar to that of 
Pbx, or it is possible that Hoxa2 competes with Myogenin for binding to Pbx and Meis. 
An interesting example of variability in the DNA binding specificities for 
homeodomain proteins, with regard to cell or tissue specific expression of a target gene, 
is the TTF1 homeodomain.  This transcription factor is essential for thyroid and lung 
development, and is well characterized with respect to its structure and DNA binding 
specificity to the consensus sequence 5' CAAG 3' (Damante et al., 1994; Tell et al., 
1998).  More recently its role in specification of the rostral brain regions during early 
development has been shown, and TTF1 is required for CNS specific transcriptional 
activation of a neuroepithelial marker gene nestin (Lonigro et al., 2001).  The CNS 
specific regulation of nestin is mediated by an intronic element where TTF1 does not 
recognize its canonical consensus sequence.  Instead, transcription is activated through a 
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binding site resembling a nuclear hormone/cAMP response element that is very different 
from the typical TTF1 binding site.  This sequence is essential for forebrain specific 
expression of nestin mediated by DNA binding of TTF1 in vivo, even though it is 
flanked by two 5' CAAG 3' motifs.  Also, analysis of Hoxb2 DNA binding in the 
regulation of Otx2 demonstrates that it recognized a 5' ACTT 3' repetitive sequence that 
does not resemble the typical Hox consensus sequence (Guazzi et al., 1998). Therefore, 
homeodomain proteins are capable of recognizing entirely different sequences in 
specific cell types, even in the presence of a typical binding site. 
The Glucocorticoid Receptors have been known to mediate a transcriptional 
response by either binding to the Glucocorticoid Response Element (GRE), or through 
protein-protein interactions with transcription factors bound to DNA (reviewed in 
Almawi and Melemedjian, 2002).  The only known regulatory interaction between GR 
and homeodomain proteins is between the ubiqitiously expressed Oct1, Pbx and Pit1 
(Nalda et al., 1997; Subramaniam et al., 1997, 1998).  The mechanism of this regulation 
involves competition for DNA binding of the same target element within a promoter 
sequence.  Expression of the DNA binding domain of the GR is able to block the activity 
of Pbx-Oct1, or Pit1 on the target sequence resulting in repression of transcription. 
The in vitro Hoxa3 half site present within clone 12 (Figure 4.16) that was 
identified by Patch analysis using TRANSFAC5.0 may not be of significance.  This site 
was found to display intermediate affinity for Hoxa3 and was identified by in vitro 
binding selection to random oligomers rather than an actual in vivo target gene (Catron 
et al., 1993). 
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ClustalW alignment (service at European Bioinformatics Institute: 
http://www.ebi.ac.uk/clustalW) was used to identify if a Hoxa2 consensus binding site 
was present in all targets.  Alignment of all seven clones did not reveal any clear 
consensus sites, and alignment using only clone 2 and 12 also did not yield any 
consensus sites greater than 4 bp in length.  However, a comparison of the Hox-Pbx 
consensus site identified by Lampe et al. (2004) with each clone reveals the presence of 
5 sites displaying some similarity with the bipartite sequence (Figure 5.1).  Although a 
clear 10 bp consensus sequence is cannot be found, there is a core sequence present in all 
five sites consisting of 5′ CCATCT/A 3′ that may represent a novel Hoxa2 in vivo 
binding site.  It is interesting to note that the core CCATC sequence is also present in 
clone 2 adjacent to the myogenin binding site within site A (Figure 4.15).  It is possible 
that this is a bipartite sequence recognized by Hoxa2 and myogenin.  The recognition of 
clone 2 and 12 is likely mediated through different DNA binding sites due to cooperative 
binding with specific cofactors for each target gene, this would then potentially involve 
distinct binding elements.  It is common for the core binding sequence to be conserved 
in DNA recognition by homeodomain proteins in vitro, with variability of the 3 
nucleotides flanking the core (Liberzon et al., 2004). 
5.5  Regulatory Activity of the Dyrk4 and Tasp Intronic Sequences in Cell 
Culture 
Luciferase assays for the activity of clone 2 and clone 12 in transient transfection 
of HeLa cells indicated that there is a trend of inhibition of transcription by Hoxa2 for 
clone 12 (Tasp) (Figure 4.18).  For clone 2 (Dyrk4), Hoxa2 functions as an enhancer of 
transcription (Figure 4.19).  The presence of the Tasp intronic element increased CMV 
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Hoxa2-Pbx bipartite consensus sequence (Lampe et al., 2004): 
T/A/C G/C A/T T A/C A/C ATC A/T 
Alignment of potential Hox-Pbx sites in clone 12: 
GGTGGCCATCG 
CCTTGCCATCC
CGATGCCATCA 
CTGTCCTATCA 
CACCACCATCT 
 
 
Figure 5.1  Alignment of sites present in clone 12 that display some similarity with 
the Hoxa2-Pbx bipartite sequence. 
All sites are shown in a 5′ to 3′ orientation.  Five sites with some similarity to the Hox-
Pbx sequence are aligned above.  Grey boxes indicate the presence of a consensus 
nucleotide from the Hox-Pbx binding sequence within the clone 12 site.  Overlap of the 
five sites found within clone 12 show that although the exact Hoxa2-Pbx site is not 
found, there are multiple sites that are similar with the bipartite consensus sequence.  
Alignment of these sites shows a 6 bp consensus site of CCATC A/T.  
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regulated expression of luciferase, but increasing concentrations of Hoxa2 resulted in a 
decrease in luciferase activity.  Hoxa2 appeared to mediate an opposing effect on the 
Dryk4 intronic sequence, where cotransfection with Hoxa2 resulted in increased
luciferase activity.  Although changes in luciferase activity were not significant 
according to one-way ANOVA testing, the same decreasing trend of luciferase activity 
at several different reporter:control vector concentrations is apparent.  Non-significant p 
values may become significant by transfection with higher amounts of Hoxa2 (ie. 5 µg 
of pRSV-Hoxa2) than those used in our studies.  Also, the number of transfections 
performed at a particular reporter concentration may also increase the statistical 
significance of the changes.  A lack in significant differences may be due to the lack of 
cell specific cofactors required by Hoxa2 for transcriptional activity.  A previous 
analysis of homeodomain intronic enhancers has shown their requirement in vivo for 
tissue specific expression while transfection studies were unable to demonstrate this 
requirement in cell culture (Dusing et al., 2001).  Although HeLa cells are commonly 
used for transient transfection with a variety of transcription factors many of which are 
homeodomain proteins, it may not be an optimal cell culture system for Hoxa2.  Western 
blot analysis of Hoxa2 expressed in HeLa cells demonstrated that a post-translational 
modification of Hoxa2 occured in this cell type, which is not observed in NE from 
mouse P1 CNS tissues (Figure 4.24).  If this modification is involved in proteolytic 
targeting of Hoxa2, overexpression of Hoxa2 in this cell type may not result in increased 
levels of active Hoxa2 protein.  In addition, this modification may alter the ability of 
Hoxa2 to interact with other nuclear factors and therefore may inhibit its ability to act on 
the target sequences.  Hoxa2 transfection into cell culture studying its autoregulatory 
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effects have been performed in COS7 and P19 cells (Lampe et al., 2004).  The activity of 
HOXB2 on the Otx2 promoter was analyzed using the NT2/D1 embryonal carcinoma 
cell line (Guazzi et al., 1998).  When similar transfection experiments were also 
conducted in HeLa and NIH3T3 cells, no effect was observed suggesting that the cellular 
environment plays a critical role in the transactivating activity of HOXB2 (Guazzi et al., 
1998).  Transfection studies may be optimized by using NT2/D1 cells or P19 cells, 
which also is a mouse embryonic carcinoma cell line capable of differentiation into 
many cell types (McBurney, 1993).  Treatment with RA at low concentrations causes 
differentiation of embryonal cells into endodermal and mesodermal derivatives, while 
high concentrations results in the formation of neurons and glia (Jones-Villeneuve et al., 
1982, 1983; Bain et al., 1994).  RA is well characterized for its important role in 
inducing Hox gene expression, and treatment of these cells at high concentrations of RA 
resulted in an upregulation of various Hox genes (Pratt et al., 1993).  However, due to 
functional redundancy of Hox genes it may also be valuable to assess transcriptional 
activity of Hoxa2 by underexpression using antisense oligonucleotides or siRNA. 
5.6  Analyses of Hoxa2 mediated expression of Tasp and Dryk4 In Vivo 
 Analyses of RNA by RT-PCR demonstrated expression of Dyrk4 and Tasp 
throughout murine embryonic development (E10-18), coinciding with the developmental 
stages at which Hoxa2 is expressed.  Expression of both genes was observed in adult and 
newborn mouse CNS tissues, and analyses of Hoxa2+/+ and -/- newborn mice also 
showed expression of Dyrk4 and Tasp within the hindbrain and spinal cord tissue 
(Figure 4.21 and Figure 4.22).  Although Dyrk4 and Tasp were isolated at the E18 stage 
of embryonic development, expression of the putative target genes was studied using P1 
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CNS tissue from mutant and wildtype mice.  The gestation period for mice is generally 
19-21 days (Kaufman et al., 1992), however Hoxa2+/- pregnant mice appear to deliver 
pups at day 18 or 19.  Hence, variation in Hoxa2 regulation of its target genes due to 
differences in development stages should be minimal. 
Band intensity measurements of RT-PCR amplified Tasp in Hoxa2-/- mice 
showed a significant increase in expression compared with their wildtype littermates.  
Changes in Tasp expression in the absence of Hoxa2 appeared to be more severe in some 
litters, and may reflect the presence of functional redundancy by other Hox genes or 
differences in mutation penetrance (Figure 4.23).  This increase in expression of Tasp in 
the absence of Hoxa2 corresponds with the negative regulatory effects of Hoxa2 on the 
Tasp intronic sequence (Figure 4.18). 
Overexpression of Hoxa2 in HeLa cells did not produce a reproducible effect on 
Tasp expression as determined by RT-PCR analysis (Figure 4.26).  Only a slight 
decrease in Tasp expression was observed after overexpression of Hoxa2.  This may be a 
result of the presence of a negative regulatory feedback loop controlling expression of 
Hoxa2 or Tasp.  As previously discussed above, HeLa cells may lack the necessary 
cofactors required by Hoxa2 for strong regulatory control, and overexpression of Hoxa2 
in this cell type may not represent levels of functionally active Hoxa2.  The transfection 
efficiency was assessed by cotransfection with a GFP expressing vector followed by 
visualization by fluorescence microscopy (Appendix XIII).  Although the number of 
GFP expressing cells was fairly consistent for each plate (~ 30%), this is only an 
approximate assessment of transfection efficiency.  It may be necessary to normalize the 
Tasp/β actin values further with measurement of an internal control for transfection 
  157
efficiency such as Renilla luciferase or β galactosidase.  However, it has been shown that 
expression of β actin is altered in cell cultures between treated samples and can therefore 
be unreliable under certain conditions as an internal control (Selvey et al., 2001). 
 Levels of detected Dyrk4 expression in P1 CNS tissues were low and analysis of 
the Hoxa2-/- and Hoxa2+/+ mice did not produce reliable results.  Although BLAST 
analysis of the primers designed for RT-PCR did not show significant cross-reactivity 
with other mouse EST sequences, it is still possible that an uncharacterized transcript is 
competing with Dyrk4 for one of the primers used in our study.  RT-PCR analysis may 
require designing alternative primers to various areas within the Dyrk4 cDNA sequence.  
Also, one-step RT-PCR using gene specific primers rather than the two-step method 
using random primers may be more specific and therefore more sensitive in 
amplification of Dyrk4.  RT inhibition of PCR amplification has been shown to occur for 
low copy number mRNAs and in some instances may be overcome by the addition of 
stabilizing factors such as the T4 gene 32 protein (Chandler et al., 1998). 
Although density readings for RT-PCR provide some measure of quantitation, highly 
sensitive and accurate detection of expression changes by RT-PCR requires Quantitive 
Real Time PCR (reviewed in Bustin, 2000).  It is also possible that levels of target gene 
expression do not significantly change, but instead their boundaries of expression are 
modified in Hoxa2-/- mice.  Therefore, gene expression analysis using in situ 
hybridization histochemistry of mouse tissues may provide more information of Hoxa2 
regulation of Tasp and Dyrk4.  
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5.7  Potential Post-translational modifications of Hoxa2 
 Translation of Hoxa2 mRNA in an in vitro system resulted in the appearance of a 
doublet protein, which was also observed when expressed in mammalian HeLa cell 
culture.  Also, Hoxa2 expressed in vitro and in mammalian systems displayed an 
increase in molecular weight, 48 and 62 kDa respectively (Figure 4.12 C, D and Figure 
4.24).  It is unlikely that multiple products of Hoxa2 in the in vitro translated system 
were due to proteolytic degradation, since the observed transcripts are above the 
expected size of 41 kDa. 
Although the murine Hoxa2 protein has been isolated by other research groups in 
mammalian cell culture systems, no biochemical analysis of the protein was presented 
nor was any data presented on the presence of potential post-translational modifications 
of the protein (Lampe et al., 2004; Matis et al., 2001).  Expression of the murine Hoxa2 
cDNA as a transgene under the control of a heat-shock promoter in Drosophila also 
produced Hoxa2 as a 62 kDa protein as demonstrated by western blot analysis (Percival-
Smith and Laing Bondy, 1999).  However, Hoxa2 expressed using a weaker promoter in 
Drosophila was observed by these researchers as migrating at a lower molecular weight 
(~ 42 kDa), the only difference between the two types of expression was high levels of 
transient expression (62 kDa) as opposed to lower levels of sustained expression (42 
kDa) (Percival-Smith and Laing Bondy, 1999).  The western blot detection of Hoxa2 
was performed using commercially produced rabbit polyclonal Hoxa2 antibodies raised 
against a Hoxa2 peptide (Percival-Smith and Laing Bondy, 1999).  High levels of 
transient Hoxa2 expression could in cell culture or in vivo activate a mechanism in 
which regulation of Hoxa2 occurs by post-translational modifications of the protein.  
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Regulation of many transcription factors occurs at the post-translational level; more 
specifically regulation of several homeodomain proteins is in part controlled through 
ubiquitin mediated proteolysis (Kurtzman et al., 2000; Gabellini et al., 2003; Zhang et 
al., 2003). 
Ubiquitination with subsequent proteolytic degradation of some proteins has been 
associated with the presence of PEST sequences, which are sequences rich in the amino 
acids proline (P), glutamic acid (E), serine (S) and threonine (T) targeted to the 26S 
proteasome (Yaglom et al., 1995; Won and Reed, 1996; Chen et al., 1998b; Marchal et 
al., 1998).  The PEST motif is important in degradation of the zebrafish Vsx-1 
homeodomain protein and may be involved in modulating neuronal differentiation, as 
well as restricting its expression to specific cell types (Kurtzman et al., 2000).  For the 
Drosophila Bicoid (Bcd) protein the PEST sequence determines whether Bcd functions 
as a translational repressor or as a transcriptional activator (Niessing et al., 1999).  
Analysis of the 372 aa Hoxa2 sequence with the program PESTfind (EMBnet Austria, 
Vienna Biocenter: http://vienna.at.embnet.org/htbin/embnet/PESTfind; Rechsteiner and 
Rogers, 1996) showed the presence of several sequences with poor PEST probability 
within the N- and C-terminal ends of the proteins.  The putative PEST sequences within 
the N-terminus present with a poor score of -5.30 and -1.05 (at positions 7-38 and 44-
64), while the C-terminal PEST sequences have a more significant score of +1.09 and 
+0.84 (at positions 242-271 and 285-369).  Although scores above +5 are considered to 
be of great importance, scores above 0 are considered to be possible PEST regions 
(Rechsteiner and Rogers, 1996).  Also, in several cases phosphorylation plays a role in 
activating latent PEST signals, converting a weak PEST into one that is recognized 
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(Marchal et al., 1998).  All six of the putative casein kinase II phosphorylation sites of 
the Hoxa2 sequence occur within the potential PEST sequences, one within the N-
terminal sequence and the remaining five are restricted to the C-terminal end of the 
protein (Tan et al., 1992).  Casein kinase II has been implicated in regulating 
ubiquitination of several proteins and PEST mediated proteolysis (Pando and Verma, 
2000; Penrose et al., 2004), and therefore may play a role in post-translational 
modification of Hoxa2. 
Alternatively, the increased molecular weight of Hoxa2 could be the result of a 
modification where the covalent attachment of a protein or peptide to cytoplasmic 
Hoxa2 is cleaved on entry into the nucleus.  Hence, it would be expected that in the 
nucleus Hoxa2 would be present as a 42 kDa protein, which is observed in NE from 
various murine tissues as opposed to the 62 kDa protein found in whole cell protein 
extracts of the murine P1 eye (Figure 4.24).  Proteolytic cleavage of proteins has been 
shown to be essential in the nuclear translocation of various membrane associated 
proteins and cell signaling molecules (Ryo et al., 2003; reviewed in Hoppe et al., 2001).  
However, this has not been demonstrated for any homeodomain proteins.  Also, this 
mechanism generally involves cleavage of multi-subunit proteins or of precursor 
molecules into their active form.  Therefore it is highly unlikely that post-translational 
modification of Hoxa2 is required for transport, and then removed upon translocation to 
the nucleus.  In fact, most identified post-translational modifications of homeodomain 
proteins thus far occur within the nucleus or are required for nuclear import and/or 
transcriptional activity and are therefore predominantly found to be a higher molecular 
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weight protein in the nucleus versus in the cytoplasm (Kishi et al., 2003; Lefebvre et al., 
2002).   
HeLa cells as well as pRSV-Hoxa2 expressing HeLa cells display migration of 
Hoxa2 at 62 kDa, indicating that it is unlikely for the discrepancy in molecular weight of 
Hoxa2 to be solely a result of overexpression, at least in the context of this particular cell 
type.  It is possible that levels of the 62 kDa cytoplasmic Hoxa2 are much higher than 
the nuclear 42 kDa Hoxa2 protein, which would then require longer exposure with 
chemiluminescence for visualization of the 42 kDa band.  It is more likely that this 
difference in molecular weight is a result of cell-specific expression, which has been 
observed for several post-translationally modified homeodomains (Heimberg et al., 
2000; Kurtzman et al., 2000; Wall et al., 1992).   
The homeodomain Pdx1 requires SUMOylation (SUMO is small ubiquitin-related 
modifier) for its nuclear localization, as well as stabilization by inhibiting its degradation 
by proteasomes (Kishi et al., 2003).  Although Hoxa2 only displays motifs that have a 
low probability of SUMOylation as determined by computational sequence analysis 
(SUMOplotTM by ABGENT, San Diego CA, USA: www.abgent.com/sumoplot.html), 
perhaps a similar ubiquitin like molecule is involved in transportation of Hoxa2 to the 
nucleus, proteolytic degradation, or increased protein stability in specific cell types. 
Many other post-translation modifications have been observed for homeodomain 
proteins such as acetylation (Chariot et al., 1999b; Li et al., 2000; Scaloni et al., 1999; Yi 
et al., 2002; Iioka et al., 2003), glycosylation (Lefebvre et al., 2002; Gao et al., 2003), 
and phosphorylation (Adachi and Lewis, 2002; Jaffe et al., 1997; Yi et al., 2002; 
Melamed et al., 2002).  It is unlikely that the differential molecular weight is due to 
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acetylation in part because most documented cases of homeodomain acetylation occur in 
the nucleus by binding with p300 acetyltransferase on a specific regulatory DNA 
sequence.  Also, the increase in molecular weight would be very low as acetyl groups 
added to lysine residues are small.  However, acetylation of several homeodomains 
occurs at conserved lysine residues and therefore is a potential regulatory mechanism for 
homeodomains in general (Li et al., 2000; Iioka et al., 2003).  Acetylation has been 
shown for homeodomain proteins to regulate cofactor interactions and thereby affect 
DNA binding in the regulation of gene transcription (Chariot et al., 1999b; Iioka et al., 
2003).   
Many eukaryotic proteins are modified by covalent attachment of O-linked N-
acetylglucosamine on their serine and threonine side chain hydroxyls or N-linked 
glycosylation on the amino residues of their asparagine side chains.  Cytosolic and 
nuclear proteins are O-linked glycosylated and many of these nuclear proteins are 
transcription factors (reviewed in Comer and Hart, 1999).  An analysis of the Hoxa2 
sequence using the YingOYang 1.2 Server and NetOGlyc 3.1 (Center for Biological 
Sequence Analysis, Technical University of Denmark: http://www.cbs.dtu.dk/services/) 
indicated the presence of multiple putative glycosylation sites, and hyperglycosylation of 
proteins can result in a marked increase in their molecular weight.  None of the putative 
glycosylation sites identified for Hoxa2 overlap with its potential phosphorylation sites, 
and most reside within the N-terminal region of the protein.  Thus far only O-linked N-
acetylglycosylation of homeodomians has been documented for the non-clustered 
homeodomain proteins Pdx1 and Pax6, although the specific effect of this glycosylation 
on their activity is not known (Gao et al., 2003; Lefebvre et al., 2002).  The only 
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clustered homeobox genes analyzed for glycosylation are HOXB7, HOXC6, and HOXD4 
(Corsetti et al., 1992).  Although these proteins were found to be phosphorylated, no 
glycosylation was observed.  However, this could be a result of the expression of these 
human homeobox genes using an insect system in that glycosylated forms of protein are 
often cell or tissue specific, or occurs at specific stages in development (Kane et al., 
2002; Hiromura et al., 2003; Shaufele et al., 1990).  It is interesting to note that all O-
linked glycosylated proteins are also phosphoproteins, and that there is a reciprocal 
relationship between both modifications with regard to regulation of transcription factor 
function (reviewed in Kamemura and Hart, 2003).  Glycosylation of transcription factors 
has been shown to affect protein-protein interactions by alteration of tertiary structures, 
as well as function to increase protein stability, and regulation of nuclear import (Comer 
and Hart, 1999; Kamemura and Hart, 2003).  Therefore, the possibility that Hoxa2 is 
glycosylated merits further study to help understand its function. 
Several putative phosphorylation sites have been identified within the Hoxa2 
sequence (Tan et al., 1992), and many homeodomain proteins have previously been 
shown to be phosphorylated in vivo (discussed in Nepveu, 2001; Fienberg et al., 1999; 
Kasahara et al., 1998; Bourbon et al., 1995; Li and Manley, 1999).  Hoxa2 displays four 
potential phosphorylation sites for protein kinase C, six for casein kinase II, and one for 
cAMP-dependent protein kinase A (Tan et al., 1992).  Several of these putative 
phosphorylation sites are within the homeodomain of Hoxa2.  Phosphorylation of the 
homeodomain often has been shown to affect the DNA binding ability of various 
homeodomain proteins.  In many instances the result of phosphorylation is decreased 
DNA binding activity (Berry and Gehring, 2000; Hjerrild et al., 2004; Jaffe et al., 1997; 
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Vijapurkar et al., 2004; discussed in Nepveu et al., 2001), increased DNA binding 
(Kasahara and Izumo, 1999), or in some cases both increased and decreased binding 
activity has been shown depending on the position of the phosphorylated target site 
(Bourbon et al., 1995; Hjerrild et al., 2004).  Other aspects of homeoprotein function are 
also affected by phoshorylation such as cellular secretion (Maizel et al., 2002), nuclear 
localization (Elrick and Docherty, 2001), and cellular stability (Zhu and Kirschner, 
2002; Yaron et al., 2001).  Results from in vitro translation and Hoxa2 expression within 
HeLa cells indicates that there are two forms of Hoxa2 present at very similar molecular 
weights (Figure 4.12 C, D and 4.24).  This information, coupled with sequence analysis 
of phosphorylation sites and the importance of phosphorylation for other homeodomain 
proteins, indicates that Hoxa2 is likely phosphorylated.  Southwestern blot analysis 
suggests that DNA binding by Hoxa2 in the context of clone 2 (Dyrk4 homolog) is 
affected by its phosphorylation state, as indicated by differential DNA binding in the 
presence of BSA as opposed to milk (Figure 4.18).  This is due to the presence of protein 
kinase/phosphatase activites in commercially available nonfat dried milk.  Therefore, 
blocking with lipid-free BSA, which contains only trace amounts of these activities, is 
sometimes preferred (Papavassiliou, et al., 1992; Polycarpou-Schwarz and Papavissiliou, 
1995). 
5.8  Conclusions 
 Hoxa2 is a member of the conserved clustered Hox gene family and is known to 
be expressed within murine CNS tissues throughout development and into adulthood.  
During early development Hox genes are required for proper specification of hindbrain 
and spinal cord morphology.  Most Hox targets isolated to date are involved in auto and 
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crossregulatory mechanisms.  The mechanism through which Hox genes control 
development is poorly understood and characterization of their downstream targets will 
reveal their function in embryonic pathways.  Hoxa2 has no known direct downstream 
targets except for its involvement in rhombomere specific autoregulation.  Its function as 
a morphological regulator in early hindbrain development has been shown through 
mutation analyses, however its function as a transcription factor expressed in the spinal 
cord and at later stages of CNS development is poorly understood. 
Isolation of downstream Hoxa2 target genes using ChIP resulted in the 
identification of two potential target genes, the murine homolog of the human dual 
specificity tyrosine kinase 4 (Dyrk4) gene and the Toll-associated serine protease (Tasp) 
gene.  In total seven sequences were cloned from immunoprecipitation of E18 hindbrain 
and spinal cord chromatin.  Two sequences resulted from promiscuous Hoxa2 binding to 
TAAT sites present within contaminating bacterial sequences, and the remaining three 
sequences are unidentifiable by BLAST query of the mouse genome.   
 Both clone 2 and clone 12 contain partial intronic sequences from the Dyrk4 and 
Tasp genes, respectively.  Many homeobox proteins regulate cell- and tissue-specific 
transcription through recognition of intronic regulatory elements (Dusing et al., 2001; 
Kim et al., 2002; Lampe et al., 2004).  In vitro binding and transfection analysis 
indicated that Hoxa2 binds to the Tasp intronic element and mediates repression of 
transcription.  Recognition of the target sequence may also involve several different 
cofactors.  Hoxa2-/- mutation results in an upregulation of Tasp expression within the 
CNS of newborn mice, indicating that Hoxa2 can act as a transcription repressor in vivo.  
This activity may be mediated by competition for DNA binding sites within the target 
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sequence between Hoxa2 and another positive regulatory factor.  Also, protein-protein 
interactions may result in the masking of the Hoxa2 activation domain and exposure of a 
repressor domain.  Many Hox genes are known to function as both a transactivator and 
as a repressor depending on their cellular environment.  This has been previously 
demonstrated for other homeodomain proteins such as HOXA9 (Lu et al., 2003), En 
(Alexandre and Vincent, 2003), HOXB1 (Saleh et al., 2000), and Pdx (Asahara et al., 
1999). 
Tasp is a serine protease family member that has been previously shown to 
interact with TGFβ signaling factors (Tocharus et al., 2004).  This signaling pathway is 
involved in determining dorsoventral patterning within Xenopus, and left-right symmetry 
within the murine system (reviewed in: Heasman, 1997; Whitman and Mercola, 2001).  
TGF signaling pathways have a key factor in regulating CNS development (reviewed in 
Böttner et al., 2000).  Several members of this superfamily have been implicated in 
determination of neuronal phenotypes, neuronal proliferation and differentiation, as well 
as regulation of oligodendroglial differentiation and cell adhesion (reviewed in Böttner 
et al., 2000).  Hoxa2 also has been implicated in specification of neuronal phenotypes 
(Hao et al., 1999; Ohnemus et al., 2001), and may mediate this role by regulation of the 
TGF signaling pathway via repression of Tasp in specific cell types at later stages of 
development. 
In contrast to the repression of Tasp by Hoxa2, Dyrk4 appeared to be positively 
regulated by Hoxa2 in transfection assays.  In vitro binding assays with recombinant 
protein indicate that this action may be mediated through direct recognition of the 
intronic sequence by Hoxa2.  Expression of Dyrk4 within the postnatal CNS appeared to 
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be quite low and further analyses are required to determine if Hoxa2 does indeed play a 
role as a transcription activator for Dyrk4 in vivo. 
Although the precise function of Dyrk4 has not been characterized, it potentially 
may have a function analogous to its family members which are involved in 
phosphorylation of proteins such as transcription factors.  Also, Dyrk4 in cell culture has 
been implicated in neuronal differentiation and several of its family members function in 
late neuronal differentiation, neurogenesis and proliferation of neuronal progenitors 
(reviewed in Hammerle et al., 2003).  Hoxa2 regulation of Dyrk4 may affect the activity 
of other transcription factors or signaling molecules involved in neuronal development 
pathways. 
Within the hindbrain several target genes such as Pax6 and MDK1 are believed 
to be regulated by Hoxa2.  Also, there are many examples of Hox auto and 
crossregulation as already observed for Hoxa2 (Lampe et al., 2004).  It may therefore be 
expected that isolation of in vivo downstream targets of Hoxa2 from the developing CNS 
would perhaps result in isolation of regulatory elements from these genes.  However, 
these genes are found to coincide with Hoxa2 expression early in CNS development and 
generally play key roles in A-P patterning and morphogenesis early on in development. 
Although Hoxa2 may function as a regulator of anteroposterior patterning in early 
development, it may also play a role in dorsoventral patterning at later stages of 
development.  Also, previous studies of Hoxa2 expression and the effects of its mutation 
have revealed a possible role in the specification of neuronal cell types (Hao et al., 1999; 
Ohnemus et al., 2001).  Therefore, regulation of the Dyrk4 and Tasp genes may reflect a 
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cell specific role for Hoxa2 in neuronal specification within the later stages of CNS 
development. 
5.9  Future Directions 
To verify that the intronic sequences isolated for Tasp and Dyrk4 contain Hox 
binding elements that are bound by and regulated by Hoxa2 several criteria should be 
fulfilled.  This could be assessed by assays using a DNA binding deficient Hoxa2 mutant 
protein in both transfection and in vitro DNA binding experiments (Lampe et al., 2004).  
DNase I footprinting reactions using recombinant protein would identify a specific in 
vitro Hoxa2 binding site within clone 12 and clone 2.  ChIP coupled with PCR may also 
be used to characterize a specific in vivo binding site for Hoxa2 (Johnson and Bresnick, 
2002; Wells and Farnham, 2002).  Also, the CCATCA/T sites present within clone 12 
merits further analysis to identify if Hoxa2 binds specifically to these sites and what 
cofactors are involved in recognition of this sequence.  This may be performed by DNA 
binding assays such as EMSA where supershifts using an anti-Pbx antibody will identify 
if Hoxa2 binds to this sequence with Pbx as a partner.  Mutation analysis of the 
consensus site will identify a Hoxa2 binding site which may in the future be helpful in 
identifying potential target genes using bioinformatics.   
It is important to examine the in vivo role of the Tasp and Dyrk4 intronic 
sequences to determine whether Hoxa2 is involved in tissue or cell specific regulation.  
As there are potentially multiple transcripts for both Dyrk4 and Tasp, it is important to 
identify if both or only one transcript is regulated by Hoxa2 in vivo.  This may be 
assessed by comparative quantitative RT-PCR in Hoxa2-/- and wildtype mice (Lowe et 
al., 2003).  Also, an expression profile of these target genes within the developing 
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murine CNS may reflect a dorsoventral specific pattern similar to that of Hoxa2.  In situ 
hybridization of mouse tissues will provide a more detailed analysis of the expression 
profiles for both targets within specific CNS structures.  It is possible that regulation of 
these target genes may occur more specifically within the hindbrain or spinal cord, rather 
than within the entire CNS.  Also, functional redundancy between Hox paralog members 
is well documented, and mutation analyses of Hoxa2 and Hoxb2 mutants indicate a 
functional overlap (Davenne et al., 1999).  Therefore, in the absence of Hoxa2 its 
paralog Hoxb2 may act to regulate these target genes.  Analysis of target gene 
expression in the absence of both Hoxa2 and Hoxb2 in the murine CNS may 
demonstrate further the function of Hoxa2 in regulation of these targets. 
Although it is apparent that Hoxa2 is post-translationally modified in some 
manner, it is important to determine whether this modification alters its function as a 
transcription factor or if it is a mechanism for post-translational regulation of Hoxa2 
protein.  Therefore, assessment of the phosphorylation and glycosylation state of Hoxa2 
would be valuable.  Identification of glycosylated or phosphorylated protein may be 
performed by a variety of different experiments.  Both glycosylation and 
phosphorylation of proteins may be detected by radiolabelling of translated protein and a 
variety of staining techniques (reviewed in: Patton, 2002; Larsen and Roepstorff, 2000).  
Ubiquitin conjugates may be identified by the His6 tagged ubiquitin method described by 
Salghetti et al. (1999), where cells are co-transfected with His6-ubiquitin and the protein 
of interest for subsequent affinity purification and western blot analysis.  An analysis of 
the binding capacity of Hoxa2 when post-translationally modified with the target 
sequences would be informative. 
  170
 Identification of specific temporal and spatial Hoxa2 target genes may be 
enhanced by utilizing ChIP on CHIP assays, where chromatin immunoprecipitation is 
followed by Microarray analysis of the target genes (Kirmizis et al., 2004).  Also, 
subtractive hybridization Microarray analysis using tissues from Hoxa2-/- mice would 
identify several targets of Hoxa2 that are affected in vivo.   
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Appendix I  Map of the pFLAG-2 expression vector (Eastman Kodak)
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Appendix II  Tabular Data from the Circular Dichroism Scan of recombinant 
Hoxa2 protein 
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Appendix III  pBluescript SKII+(Stratagene) vector used for subcloning target 
sequences 
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Appendix IV  Map of the pGL3 Promoter vector 
Clones 2 and 12 were subcloned into the Sal I and BamH I restriction sites present 
downstream from the luciferase coding region and the SV40 poly(A) signal. 
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Parameter
Table Analyzed
Tasp 1.0
Repeated Measures ANOVA
  P value
  P value summary
  Are means signif. different? (P < 0.05)
  Number of groups
  F
  R squared
 Was the pairing significantly effective?
  R squared
  F
  P value
  P value summary
  Is there significant matching? (P < 0.05)
ANOVA Table
  Treatment (between columns)
  Individual (between rows)
  Residual (random)
Value
0.1048
ns
No
3
8.538
0.8952
0.01587
0.3077
0.6349
ns
No
SS
0.3700
0.006667
0.04333
Data Set-B
df
2
1
2
Data Set-C
MS
0.1850
0.006667
0.02167
 
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error
Lower 95% CI of mean
Upper 95% CI of mean
Sum
0µg pR-Hoxa2
2
1.600
1.750
1.900
1.750
0.2121
0.1500
-0.1559
3.656
3.500
0.5µg pR-Hoxa2
2
1.200
1.250
1.300
1.250
0.07071
0.05000
0.6147
1.885
2.500
1.0µg pR-Hoxa2
2
1.200
1.200
1.200
1.200
0.0
0.0
1.200
1.200
2.400
 
Appendix V  Results of one way ANOVA for luciferase transfection data with 1 µg: 
4 ng pGL3-c12 to pCMV-RL 
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Parameter
Table Analyzed
Tasp 2
Repeated Measures ANOVA
  P value
  P value summary
  Are means signif. different? (P < 0.05)
  Number of groups
  F
  R squared
 Was the pairing significantly effective?
  R squared
  F
  P value
  P value summary
  Is there significant matching? (P < 0.05)
ANOVA Table
  Treatment (between columns)
  Individual (between rows)
  Residual (random)
  Total
Value
0.0875
ns
No
3
10.43
0.9125
0.6154
36.57
0.0263
*
Yes
SS
0.2433
0.4267
0.02333
0.6933
Data Set-B
df
2
1
2
5
Data Set-C
MS
0.1217
0.4267
0.01167
 
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error
Lower 95% CI of mean
Upper 95% CI of mean
Sum
0µg pR-Hoxa2
2
1.600
1.950
2.300
1.950
0.4950
0.3500
-2.497
6.397
3.900
0.5µg pR-Hoxa2
2
1.300
1.550
1.800
1.550
0.3536
0.2500
-1.627
4.727
3.100
1.0µg pR-Hoxa2
2
1.300
1.500
1.700
1.500
0.2828
0.2000
-1.041
4.041
3.000
 
Appendix VI  Results of one way ANOVA for luciferase assay of 2 µg: 40 ng pGL3-
c12 to pCMV-RL 
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Parameter
Table Analyzed
Tasp 4 with 4
Repeated Measures ANOVA
  P value
  P value summary
  Are means signif. different? (P < 0.05)
  Number of groups
  F
  R squared
 Was the pairing significantly effective?
  R squared
  F
  P value
  P value summary
  Is there significant matching? (P < 0.05)
ANOVA Table
  Treatment (between columns)
  Individual (between rows)
  Residual (random)
  Total
Value
0.0591
ns
No
3
15.92
0.9409
0.1875
7.811
0.1077
ns
No
SS
1.963
0.4817
0.1233
2.568
Data Set-B
df
2
1
2
5
Data Set-C
MS
0.9817
0.4817
0.06167
 
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error
Lower 95% CI of mean
Upper 95% CI of mean
Sum
0µg pR-Hoxa2
2
2.900
3.200
3.500
3.200
0.4243
0.3000
-0.6119
7.012
6.400
0.5µg pR-Hoxa2
2
2.100
2.550
3.000
2.550
0.6364
0.4500
-3.168
8.268
5.100
1.0µg pR-Hoxa2
2
1.700
1.800
1.900
1.800
0.1414
0.1000
0.5294
3.071
3.600
 
 
Appendix VII  Results for one way ANOVA of luciferase assay data from 
transfections with 4 µg:4 ng pGL3-c12 to pCMV-RL 
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Parameter
Table Analyzed
Dyrk 1.0
Repeated Measures ANOVA
  P value
  P value summary
  Are means signif. different? (P < 0.05)
  Number of groups
  F
  R squared
 Was the pairing significantly effective?
  R squared
  F
  P value
  P value summary
  Is there significant matching? (P < 0.05)
ANOVA Table
  Treatment (between columns)
  Individual (between rows)
  Residual (random)
  Total
Value
0.1842
ns
No
3
4.429
0.8158
0.5682
14.29
0.0634
ns
No
SS
0.1033
0.1667
0.02333
0.2933
Data Set-B
df
2
1
2
5
Data Set-C
MS
0.05167
0.1667
0.01167
 
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error
Lower 95% CI of mean
Upper 95% CI of mean
Sum
0µg pR-Hoxa2
2
1.200
1.450
1.700
1.450
0.3536
0.2500
-1.727
4.627
2.900
0.5µg pR-Hoxa2
2
1.600
1.700
1.800
1.700
0.1414
0.1000
0.4294
2.971
3.400
1.0µg pR-Hoxa2
2
1.600
1.750
1.900
1.750
0.2121
0.1500
-0.1559
3.656
3.500
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix VIII  Results for the one way ANOVA test of pGL3-c2 at 1.0 µg 
concentration to 4 ng of pCMV-RL 
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Appendix IX  One way ANOVA test for luciferase assay using 2 µg: 40 ng of pGL3-
c2 to pCMV-RL 
 
Parameter
Table Analyzed
Dyrk2with40
Repeated Measures ANOVA
  P value
  P value summary
  Are means signif. different? (P < 0.05)
  Number of groups
  F
  R squared
 Was the pairing significantly effective?
  R squared
  F
  P value
  P value summary
  Is there significant matching? (P < 0.05)
ANOVA Table
  Treatment (between columns)
  Individual (between rows)
  Residual (random)
  Total
Value
0.1250
ns
No
3
7.000
0.8750
0.3043
7.000
0.1181
ns
No
SS
0.1633
0.08167
0.02333
0.2683
Data Set-B
df
2
1
2
5
Data Set-C
MS
0.08167
0.08167
0.01167
 
Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error
Lower 95% CI of mean
Upper 95% CI of mean
Sum
0µg pR-Hoxa2
2
2.500
2.600
2.700
2.600
0.1414
0.1000
1.329
3.871
5.200
1.0µg pR-Hoxa2
2
2.800
2.850
2.900
2.850
0.07071
0.05000
2.215
3.485
5.700
2.0µg pR-Hoxa2
2
2.800
3.000
3.200
3.000
0.2828
0.2000
0.4588
5.541
6.000
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Appendix X  Specificity of anti-Hoxa2 antibodies purified from J3 rabbit polyclonal 
serum by Western Blot analysis 
Antibodies purified from the J3 rabbit polyclonal antiserum by affinity chromatography 
with recombinant FLAG-Hoxa2 protein was used for immunoblotting (Figure A) against 
whole bacterial protein extract from FLAG-Hoxa2 induced cultures (lane 1) and FLAG-
Hoxd1 induced cultures (lane 2).  Antibodies specifically recognize a 40 kDa size 
protein (black arrow) in FLAG-Hoxa2 induced cultures, but no bacterial protein is 
detected in cultures expressing FLAG-Hoxd1.  Both FLAG-Hoxa2 (lane 1, Figure B) 
and FLAG-Hoxd1 (lane 2, Figure B) induced cultures were analyzed by immunoblotting 
using the M2 anti-FLAG specific monoclonal antibody as a control.  Both proteins are 
detected at the expected migration of 40 kDa (lane 1) for Hoxa2 and 16 kDa for Hoxd1 
(lane 2, black arrow). 
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Appendix XI  In vitro binding analysis of clone 3 using E18 NE 
EMSA analysis was performed on clone 3 using NE from E18 mice resulting in no 
resolution of shift bands. In the absence of protein the probe migrates to the bottom of 
the gel (lane 1), but after incubation with of decreasing amounts of NE protein at 5, 3, 2 
and 1 µg (lanes 2-5) the protein-DNA complex is retained at the top of the gel (black 
arrow) and could not be resolved within the gel.  Addition of anti-Hoxa2 antiserum 
increased the amount of probe retained at the top of the gel (lane 6), Competition results 
in removal of the protein binding allowing for migration of the probe (lane 7 and 8). 
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Appendix XII  DNA footprinting analysis of clone 12 using E18 NE 
Digestion of clone 12 with DNase I in the presence of differing concentrations of NE 
(lanes 2-5) does not appear to result in protection of >4 DNA bases at any specific site 
when compared to the control reaction (lane 1). 
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Appendix XIII  Visualization by flourescence microscopy of GFP expression in 
transfected HeLa cells 
HeLa cells were cotransfected with pRSV-Hoxa2 at concentrations of 0, 1, and 2 µg 
pRSV-Hoxa2 (A, B, and C respectively).  RNA samples were used for RT-PCR analysis 
of Tasp expression.  Transfection efficiency was assessed by cotransfection of cells with 
pGFP, and the number of GFP expressing cells/total cell count was visualized by 
fluorescence microscopy. 
 
A 
B 
C 
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